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ABSTRACT 
To clarify the protective benefits of physical activity (PA), epidemiologists and public 
health researchers continue to seek improved methods of assessing PA.  In particular, 
accelerometers have gained acceptance with researchers as they provide reliable estimates of PA 
and can record both the amount and intensity of ambulatory movement.  However, there is 
concern that accelerometer data reduction techniques may not provide quantitatively accurate 
measurements of time spent in various PA intensity categories.  One way to circumvent these 
inaccuracies is to use the accelerometer-derived total activity counts (TAC), which is a more 
direct expression of what the monitor records.   
 In order to explore the efficacy of TAC as a measure of PA, this dissertation used data 
from the 2003 - 2006 National Health and Nutrition Examination Survey to: 1) investigate 
whether TAC was more strongly associated with cardiometabolic biomarkers than minutes of 
moderate-to-vigorous PA (MVPA), 2) determine population-referenced TAC percentiles for the 
U.S. population, and 3) determine which accelerometer-derived measure(s) of PA intensity and 
volume provided the best fit for assessing the association with the metabolic syndrome.   
The first study demonstrated that TAC had stronger associations with cardiometabolic 
biomarkers than time spent in MVPA bouts of ≥ 10 minutes, suggesting TAC is a more robust 
measure of PA (Part IV).  In the second study, age- and gender- specific population-referenced 
percentiles for TAC, MVPA, and light PA (LPA) were developed (Part V).  This is a different 
approach to accelerometer data reduction that complements the current method of looking at 
time spent in intensity sub-categories.   
 The third study used structural equation modeling to examine whether TAC, MVPA, or 
MVPA plus LPA provided the best fit for assessing the relationship with the metabolic syndrome 
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(Part VI).  This study also assessed the relative contribution of LPA, MPA, VPA, and TAC to the 
reduction in the prevalence of the metabolic syndrome.  Results indicated a model with TAC 
provided the best fit for assessing the relationship between PA and the metabolic syndrome.  
These findings suggest TAC, may be a better measure of PA when examining the reduction in 
the metabolic syndrome prevalence.    
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INTRODUCTION 
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 The metabolic syndrome is a clustering of cardiometabolic risk factors that include 
central adiposity, hyperglycemia, elevated blood pressure, and dyslipidemia (elevated 
triglycerides and attenuated high-density lipoprotein cholesterol [HDL-C])1.  Within the United 
States (U.S.), the metabolic syndrome is a growing public health concern with an estimated 
prevalence in adults ranging from 22.9 to 34.9% depending on the metabolic syndrome 
definition used1-3.  Additionally, individuals with the metabolic syndrome are at greater risk of 
developing and dying from cardiovascular disease and type II diabetes4-7.   
 To properly prevent and treat the metabolic syndrome, it is important to understand 
health behaviors that influence its development.  Physical activity (PA) is a modifiable behavior 
that has consistently demonstrated associations with the risk of the metabolic syndrome8-13.  At 
the population level in the U.S., the relationship between PA and the metabolic syndrome has 
been assessed using data obtained from the National Health and Nutrition Examination Survey 
(NHANES).   The NHANES currently uses both self-report methods and accelerometers to 
assess participants’ PA.  While self-report PA has historically been collected as part of the 
NHANES, the use of accelerometers to assess PA did not begin until the 2003 – 2004 survey 
cycle.  Thus, many studies using NHANES data have relied on self-report measures to determine 
associations with health outcomes.   
 Self-reported PA data, collected as part of the NHANES, have been used by researchers 
to assess the relationship of PA and the metabolic syndrome at the population level.  In a study 
by Park al.8, utilizing data from NHANES III, the intensities of the most commonly reported 
leisure-time physical activity (LTPA) (i.e., walking, jogging, swimming, gardening/yard work) 
were used to develop a PA intensity score, which was defined as the ratio of activity-related 
metabolic rate to resting metabolic rate.  A PA intensity score of ≤ 3.5 classified individuals as 
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physically inactive, while moderately active corresponded to a score between 3.6 and 14.9 and 
active a score of ≥ 15.  The cut-points for moderately active and active were chosen to represent 
the 15th and 65th percentile of PA for men and 25th and 75th percentile for women, respectively.   
Results of this study found inactive men had a 40% increased risk for being diagnosed with the 
metabolic syndrome compared to their active counterparts.  However, there was no significant 
association found for women8.   
 In another NHANES III study conducted by Zhu and colleagues10, the PA risk score was 
also used to assess the association of self-reported PA with the metabolic syndrome.  Results of 
this study indicated that being physically active was associated with a 31% and 17% reduction in 
the risk of being diagnosed with the metabolic syndrome in men and women, respectively10. 
Similarly, a study conducted by DuBose et al.9 utilized self-report PA data from NHANES III to 
assess the relationship with the metabolic syndrome.  In contrast to the studies by Zhu and Park, 
this study determined the intensity of self-reported LTPA using the Compendium of Physical 
Activities, which expresses intensity as metabolic equivalents (METs)14.  Moderate-intensity PA 
was defined as 3 – 6 METs and vigorous intensity defined as ≥ 6 METs14.  Participants were 
classified as active if they obtained ≥ 5 d/wk of moderate intensity and/or ≥ 3 d/wk of vigorous 
intensity LTPA.  Inactive participants were those who reported no LTPA over the past month. 
Results of this study indicated that inactive participants had a 45% increase in the odds of being 
classified as having the metabolic syndrome9.   
 Using data from the 1999-2000 NHANES, Ford et al.11 examined the relationship 
between self-reported MVPA, sedentary behavior, and the metabolic syndrome.  In this study, 
MVPA was classified into three categories based on the minutes of activity: 0, < 150, and ≥ 150 
min/wk.  Sedentary behavior was measured by a question which asked respondents how many 
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hours of television they watched daily over the past 30 days.  Results of this study revealed that 
both MVPA and sedentary behavior were associated with the metabolic syndrome; however 
there was no interaction between MVPA and sedentary time.  Additionally, it was found that 
individuals who engaged in 0-min/wk of MVPA had almost twice the odds of having the 
metabolic syndrome compared to those who engaged in 150 min/wk of MVPA11. 
 More recently, using data from the 1999 – 2004 continuous NHANES, Churilla and 
colleagues12 studied the relationship between the metabolic syndrome and LTPA using two 
definitions of the metabolic syndrome, developed by the American Heart Association/National 
Heart Lung and Blood Institute (AHA/NHLBI)15,16 and World Health Organization (WHO)17.  
Total LTPA was categorized into six levels with the first level comprised of individuals with no 
self-reported LTPA and the five remaining levels divided into MET· min1· wk-1 quintiles of self-
reported PA. Results of this study indicated an inverse association between both definitions of 
the metabolic syndrome and LTPA.  Between the two definitions, however, it was seen that the 
dose of PA necessary to provide protection against the metabolic syndrome varied.  Using the 
WHO criteria, protection began at the 3rd quintile of PA (393 – 736 MET· min1· wk-1), which 
provided a 30% reduction in risk of the metabolic syndrome.  Based on the AHA/NHLBI 
criteria, significant protection did not begin until the 4th quartile of PA (737 – 1360 MET· min1· 
wk-1), which reduced the risk of the metabolic syndrome by 35%.  Additionally, this study found 
adults meeting the American College of Sports Medicine/AHA PA recommendations for public 
health were 39 – 46% less likely to have the metabolic syndrome12.  These results indicate the 
reduction in metabolic syndrome risk with increased PA varies between metabolic syndrome 
definitions.    
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 In another study by Churilla et al.13, the total volume of PA acquired from leisure-time, 
domestic, and transportational PA was assessed to determine the association with the metabolic 
syndrome.  Results revealed individuals with higher volumes of total PA and LTPA had 
significantly lower prevalence of the metabolic syndrome.  For both total PA and LTPA, 
significant protection against the metabolic syndrome was seen starting in the 4th quintile of PA.  
The volume associated with the 4th quintile, however, was higher for total PA (1261 MET· min1· 
wk-1) compared to LTPA (736 MET· min1· wk-1).  The authors of this study hypothesized the 
greater volume of total PA necessary for protection was due to the lower intensity of domestic 
and transportational activities compared to leisure-time activities13.     
 Although the relationship between metabolic syndrome and PA has been demonstrated 
using self-report methods of PA, self-report measures are subject to substantial bias that has been 
well documented in the physical activity epidemiology literature18-21.  In contrast, objective 
measures of PA, such as accelerometers, may provide increased precision and decreased bias 
when investigating the dose-response relationship and potential threshold effect associated with 
the metabolic syndrome.  However, there are a limited number of studies using the 2003 – 2006 
NHANES data to assess the relationship between the metabolic syndrome and accelerometer-
based measures of PA22-24.   Furthermore, these studies use different accelerometer-derived 
measures of PA, limiting the interpretability of results.   
 Specifically, Metzger and colleagues23 explored whether MVPA performed in 1-minute 
bouts and accumulated in different patterns across the week (e.g., weekend warrior, consistent 
accumulation across the week, etc.) was associated with the metabolic syndrome.  Using data 
from the 2003 – 2004 NHANES, a structural equation model  (SEM) was proposed and 
subsequently tested in order to determine associations between the pattern of MVPA 
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accumulation, risk factors of the metabolic syndrome, and classification of the metabolic 
syndrome.  In this study MVPA was classified as the average daily minutes with counts above 
2020.  Results of the study revealed that individuals accumulating the weekly recommended 
amount of PA had a lower risk of developing the metabolic syndrome.  However, no differences 
in metabolic syndrome risk were seen when examining the pattern in which MVPA was 
accumulated throughout the week 23.   
 In another study, Sisson et al.24 used 2005 – 2006 NHANES data to determine the 
association of accelerometer-derived steps per day and the odds of having the metabolic 
syndrome.  Results of this study indicated for every 1,000 steps/day accumulated the odds of 
having the metabolic syndrome decreased by 10%.  In addition, active to highly active 
individuals (≥10,000 steps/day) had 72% lower odds of the metabolic syndrome compared to 
their sedentary counterparts24.      
 Accelerometer-based measures of PA were also used by Jansen et al.22 to investigate the 
relationship with the metabolic syndrome.  Using the 2003 – 2006 NHANES, the association 
between the metabolic syndrome and accelerometer-derived minutes of moderate-intensity PA 
(MPA), vigorous-intensity PA (VPA), and MVPA performed in 1-minute bouts was examined. 
The intensity of activity was first determined using the Freedson25 regression equation which 
estimated the METs from the counts/minute obtained from the accelerometer.  MET thresholds, 
consistent with the Compendium of Physical Activity14, were then used to classify the intensity 
of PA.  Results of this study revealed that the odds of the metabolic syndrome decreased with 
increasing levels of MPA, VPA, and MVPA.  Independent associations of VPA and MPA with 
the metabolic syndrome were also found.  It was also found that approximately 75 minutes/week 
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of VPA provided a greater reduction (37.1%) in the prevalence of the metabolic syndrome than 
an equivalent volume (150 minutes/week) of MPA (15.5%)22. 
 In another study, the association of the metabolic syndrome and related risk factors with 
PA accumulated in ≥ 10-min and < 10-min bouts was examined26.   The authors of this study 
used the 2003 – 2006 NHANES data and defined MVPA as minutes with ≥ 2020 counts.  Results 
of this study revealed both bout and non-bouted MVPA significantly reduce the risk of the 
metabolic syndrome and related cardiometabolic risk factors.  Non-bouted MVPA was also 
found to protect against classification of the metabolic syndrome after adjusting for bouted 
MVPA (OR: 1.02; p = 0.006), suggesting non-bouted MVPA may provide benefits for 
cardiometabolic health26 
 While these studies provide evidence for the use of accelerometer-derived PA measures, 
there is also concern that that accelerometers may not provide quantitatively accurate 
measurements of time spent in various intensity categories (e.g., sedentary, light, moderate, and 
vigorous)27-30.  One way to circumvent these inaccuracies is to use the accelerometer-derived 
total activity counts per day (TAC), which is a more direct expression of what the monitor 
records31,32.  More importantly, TAC is a measure of the total PA volume, and it incorporates all 
intensity categories, weighting each minute according to the intensity of the movement.   
 Recently, Wolff and colleagues conducted two pilot studies which explored the 
importance of a global, objective measure of PA using TAC derived from hip-worn 
accelerometers (Parts IV-V).  The first pilot study, which utilized accelerometer data obtained 
from the 2003 – 2006 NHANES, demonstrated that TAC had stronger associations with 
cardiometabolic biomarkers (e.g., blood pressure, body mass index, cholesterol, etc.) than 
traditional accelerometer-derived minutes spent in MVPA bouts of 10 minutes or greater (Part 
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IV).  Five cardiometabolic risk factors comprising the metabolic syndrome were more strongly 
related to TAC than MVPA: waist circumference, fasting glucose, triglycerides, HDL-C, and 
systolic blood pressure.  One risk factor, diastolic blood pressure, was not found to have 
significant associations with either TAC or MVPA.  These results suggest that TAC is a more 
robust measure of PA, as it is more closely related to health indicators associated with the 
metabolic syndrome (Part V).  
 In the second pilot study conducted by Wolff and colleagues (Part V), age- and gender- 
specific population-referenced percentiles for TAC, MVPA, and light PA (LPA) were developed.  
The population-reference values provide researchers with a measure of the total volume of PA 
that can be expressed relative to other adults (i.e., as percentiles).  Additionally, this is a different 
approach to accelerometer data reduction that complements the current method of looking at 
time spent in intensity sub-categories (Part V).     
Definitions 
The following section provides definitions of commonly used terms and variables discussed 
in this study.  Many of the variables discussed (i.e., the metabolic syndrome, and accelerometer-
derived PA measures) have multiple definitions.  Therefore, these definitions should not be 
applied in Part II, the review of literature. 
1. Metabolic Syndrome: a clustering of cardiometabolic risk factors that increase an 
individual’s risk of heart disease, stroke, and diabetes1, 4-7.  The present study used the 
AHA/NHLBI15,16 definition of the metabolic syndrome which requires an individual meet 
three of the following five risk factor criteria: 
a. Central adiposity: defined as a waist circumference > 102 centimeters (cm) in men 
and > 88 cm in women; 
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b. Elevated triglycerides: defined as triglyceride levels ≥ 150 milligrams per deciliter 
(mg/dL) or undergoing pharmacological treatment; 
c. Attenuated high-density lipoprotein cholesterol (HDL-C): defined as < 40 mg/dL in 
men and < 50 mg/dL in women, or undergoing pharmacological treatment; 
d. Elevated blood pressure: defined as blood pressure ≥ 130 / ≥ 85 mmHg, or 
undergoing pharmacological treatment; and, 
e. Impaired fasting glucose: defined as fasting glucose ≥ 100 mg/dL or undergoing 
pharmacological treatment.    
2. Activity Counts:  the raw output of an accelerometer.  The ActiGraph 7164 accelerometer 
used in this study produces activity counts through a three step process.  First, the 
bidirectional voltage signals recorded by the accelerometer are full-wave rectified to convert 
negative signals to positive signals.  Second, an integration algorithm is applied to the data to 
determine the maximal value for each 1-minute epoch, reflecting the raw counts for each 1-
minute period.  Third, the integration algorithm sums the raw counts to produce activity 
counts33. 
3. Total Activity Counts (TAC): in this study, TAC represented the sum of all activity counts 
accumulated on valid accelerometer wear days.    
4. Light-intensity Physical Activity (LPA): in this study, LPA was defined as the total number 
of minutes with 100 – 2019 counts/minute30, averaged across all valid wear days.  
5. Moderate-intensity Physical Activity (MPA): in this study, MPA was defined as the total 
number of minutes with 2020 – 5998 counts/minute30, averaged across all valid wear days.   
6. Vigorous-intensity Physical Activity (VPA): in this study, VPA was defined as the total 
number of minutes with ≥ 5999 counts/minute30, averaged across all valid wear days.   
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7. Structural Equation Modeling (SEM): a multivariate statistical technique that tests the  
relationships between exogenous and endogenous latent constructs, the loadings of manifest 
variables onto constructs, and measurement and prediction error34-36.   
8. Latent Construct: an unobservable measure that is comprised of multiple manifest variables 
that are hypothesized to underlie the construct34-36.  In SEM, latent constructs are indicated 
by ovals or circles. 
9. Exogenous Variable: variables that are not dependent on any other variables and are 
therefore thought of as the independent variables34-36.  In SEM, these variables have no 
arrows pointing to them. 
10. Endogenous Variable: a variable that is dependent on at least one other variable.  
Endogenous constructs are considered mediating or dependent variables34-36.  These variables 
have at least one arrow pointing to them in the structural model.   
11. Manifest Variable: a directly observed or measured variable.  In SEM, manifest variables are 
indicated by rectangles or squares34-36. 
12. Factor Loading: represents the correlation between each manifest variable and the latent 
construct34-36.   A higher factor loading indicates a stronger contribution of the manifest 
variable to the latent construct.   
13. Standardized Regression Weights (Path Weights): indicate the association of latent constructs 
with other variables or constructs specified in the model34-36.  Standardized regression 
weights reflect the standard deviation change in an outcome variable for every standard 
deviation unit change in a predictor variable.  For example, for every standard deviation 
increase in MPA the prevalence of the metabolic syndrome goes down by 0.512 standard 
deviations. 
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Statement of the Problem 
 The purpose of this study was to use a structural equation modeling (SEM) approach to 
examine the relationship between hip-worn accelerometer-derived measures of PA (e.g., MVPA, 
LPA, and TAC) and the metabolic syndrome in a representative sample of U.S. adults.  
Emphasis was placed on determining whether TAC is a viable alternative to other accelerometer-
based measures of PA when studying the metabolic syndrome.  Posed below are the specific 
research questions addressed by this study.  
Research Questions 
1. Does a SEM model measuring the relationship between the metabolic syndrome and PA 
with MPA and VPA (Appendix A, Figure A.1) perform as well as a model measuring PA 
with LPA, MPA, and VPA (Appendix A, Figure A.2)? 
2. Does a SEM model measuring the relationship between the metabolic syndrome and PA 
with MPA and VPA (Appendix A, Figure A.1) perform as well as a model measuring PA 
with TAC (Appendix A, Figure A.3)? 
3. Does a SEM model measuring the relationship between the metabolic syndrome and PA 
with LPA, MPA and VPA (Appendix A, Figure A.2) perform as well as a model 
measuring PA with TAC (Appendix A, Figure A.3)? 
Significance  
 The purpose of this study was to determine the relative contribution of accelerometer-
derived measures of PA in the reduction in the prevalence of the metabolic syndrome.  This is 
the first study to determine if TAC has greater associations with underlying risk factors of the 
metabolic syndrome compared to various intensities of PA (e.g., LPA, MPA, and VPA).  
Specifically, the results obtained from the structural equation models analyzed in this study will 
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guide future studies examining accelerometer-based PA metrics with the metabolic syndrome.  
Additionally, the results of this study may provide evidence for the use of the TAC metric in 
future studies examining the metabolic syndrome and other health outcomes.   
Delimitations 
 For this study, the sample was limited to adults ≥ 20 years of age who participated in a 
fasting morning examination in the 2003 – 2006 NHANES.  Participants with less than four days 
of accelerometer data that included ≤ 10 hours of wear time, and pregnant or lactating women 
were excluded from the analyses. 
Limitations 
The present study has several limitations inherent within its design. Therefore, the findings must 
be interpreted with caution.  The limitations are described below. 
1. Due to the cross-sectional design of this study, causality cannot be determined.   
2. Accelerometer counts are dependent on the characteristics of the specific brand of PA 
monitor.  This study used an ActiGraph 7164 accelerometer and thus, counts obtained 
from other PA monitors are not directly comparable.   
3. The choice of accelerometer cut-points may over- or under-estimate the amount of time 
spent in PA intensity sub-categories. Thus, the cut-points used in this study may not 
reflect the true volume of LPA, MPA, and VPA accumulated by participants.   
4. Other health variables (e.g., smoking, alcohol intake, and poor diet) involved in the 
interplay between PA and the metabolic syndrome were not controlled for in this study.  
In particular, dietary factors (e.g., saturated fat levels and caloric intake) were not 
controlled for in this study due to the complexity of the dietary data file within the 
NHANES.   
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5. SEM was performed using AMOS 20.0 (IBM SPSS AMOS 20, AMOS Development 
Corporation, Armonk, NY).  This software is unable to account for complex sampling 
design inherent within NHANES.  Therefore, the ability to discuss trends among U.S. 
adults is limited in this study.  
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The metabolic syndrome is defined as clustering of cardiovascular and metabolic risk 
factors that include central adiposity, hyperglycemia, elevated blood pressure, and dyslipidemia1.  
Physical activity (PA) is a modifiable behavior that has been shown to reduce an individual’s 
risk for developing the metabolic syndrome.  The accuracy of PA measures, however, may 
impact the strength of the relationship with the metabolic syndrome.  Recently, accelerometers 
have gained acceptance in the research community as they provide reliable estimates of PA and 
can record both the amount and intensity of an individual’s ambulatory movement2-4.  Despite 
the ability of accelerometers to capture the intensity of ambulatory activity, issues exist regarding 
their ability to accurately identify the number of minutes spent in light, moderate, and vigorous 
intensity categories5-7.   
The following review of literature will discuss: 1. the metabolic syndrome; 2. a review of 
studies examining the association between self-reported PA and the metabolic syndrome; 3. a 
review of studies examining the association between objectively-measured PA and the metabolic 
syndrome; and 4. accelerometer data reduction techniques.  Sections 2 and 3 will first discuss 
National Health and Nutrition Examination Survey (NHANES) studies, followed by other U.S.-
based studies, and internationally-based studies.  Studies within each group of sections 2 and 3 
will be presented chronologically.   
The Metabolic Syndrome 
History  
 The clustering of cardiovascular risk factors was first described in the 1920’s when 
Kylin, a Swedish physician, reported a syndrome marked by hypertension, hyperglycemia, and 
gout8.  Two decades later, central adiposity and diabetes were included as risk factors after work 
by Vague demonstrated a link with cardiovascular disease9.  It was not until 1977 however, that 
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Haller and colleagues10 used the term ‘metabolic syndrome’ to describe the clustering of five 
cardiovascular risk factors including: obesity, diabetes, hyperproteinemia, gout, and hepatic 
steatosis.   
The 1988 Banting Lecture, delivered by Reaven, drew the most attention to the clustering 
of cardiovascular disease risk factors which he termed ‘Syndrome X’11.  Specifically, Reaven 
discussed the role of insulin resistance and hyperinsulinemia in the etiology of type II diabetes, 
cardiovascular disease, and hypertension.  While Raven’s lecture established the clinical 
importance of Syndrome X, it is important to note that it did not include obesity as a risk factor11.  
Subsequent work by Kaplan12 termed the clustering of cardiovascular risk factors as the ‘deadly 
quartet,’ with others using the name ‘insulin resistance syndrome’13.  However, ‘metabolic 
syndrome’ is now recognized as the most appropriate term given the metabolic abnormalities 
underlying the syndrome.    
Common Medical Definitions 
 Diagnostic criteria for the metabolic syndrome were first proposed in 1998 by the World 
Health Organization (WHO)14.  Since this time, several medical societies have proposed their 
own definitions of the metabolic syndrome including: the European Group for the Study of 
Insulin Resistance (EGIR), the National Cholesterol Education Program (NCEP)15, American 
Heart Association and National Heart Lung and Blood Institute (AHA/NHLBI)16,17, and the 
International Diabetes Federation (IDF)18.  However, the lack of a unified definition became 
problematic as it led to a variety of prevalence estimates19 that resulted in confusion amongst 
clinicians and researchers20.  Thus, an attempt was made to create a harmonized definition of the 
metabolic syndrome in 2009.  In particular, the Joint Scientific Statement focused on reconciling 
the differences between the AHA/NHLBI and the IDF definitions (Table 2.1).      
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Table 2.1: Definitions of the metabolic syndrome. 
Table 2.1 summarizes the 2005 AHA/NHLBI and IDF definitions as well as the Joint 
Scientific Statement put forth by both organizations in 2009.  From this table it can be seen that 
many of the same metabolic syndrome diagnostic criteria of the 2005 AHA/NHLBI and IDF 
definitions were similar.  However, two differences existed between the definitions.  First, was 
that the IDF definition employed ethnic specific cut-points for determining central adiposity.  
Secondly, the IDF definition required that individuals meet the criteria for central adiposity to be 
  AHA/NHLBI 2005 IDF 2005 Joint Scientific  
Statement 2009 
Definition ≥ 3 of 5 components  Central adiposity AND 
 ≥ 2 remaining components 
≥ 3 of 5 components 
Central 
Adiposity 
WC ≥ 102 cm in men,  
       ≥ 88 cm in women; 
Asian Americans:  
       ≥ 90 cm in men,  
       ≥ 80 cm in women 
Central adiposity: ethnic 
specific 
WC specific to 
population and country 
Triglycerides ≥ 150 mg/dL or  
pharmacologic treatment 
≥ 150 mg/dL or   
pharmacologic treatment 
≥ 150 mg/dL or   
pharmacologic treatment 
HDL-C < 40 mg/dL in men,  
< 50 mg/dL in women, 
or pharmacologic treatment  
< 40 mg/dL in men,  
< 50 mg/dL in women, 
or  pharmacologic treatment 
< 40 mg/dL in men,  
< 50 mg/dL in women,   
pharmacologic treatment 
Blood Pressure SBP ≥ 130 mmHg, 
DBP ≥ 85 mmHg, 
or pharmacologic treatment 
SBP ≥ 130 mmHg, 
DBP ≥ 85 mmHg, 
or pharmacologic treatment 
SBP ≥ 130 mmHg, 
DBP ≥ 85 mmHg, or 
pharmacologic treatment 
Glucose fasting plasma glucose 
 ≥ 100 mg/dL or 
pharmacologic treatment 
fasting plasma glucose  
≥ 100 mg/dL  
or type II diabetic 
fasting plasma glucose  
≥ 100 mg/dL or  
pharmacologic treatment 
AHA, American Heart Association; DBP, diastolic blood pressure; HDL-C, high density lipoprotein-
cholesterol; IDF, International Diabetes Federation; NHLBI, National Heart Lung and Blood 
Institute; SBP, systolic blood pressure; WC, waist circumference.   
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classified as having the metabolic syndrome.  The Joint Scientific Statement21 resolved the 
differences between the definitions, using waist circumference cut-points specific to an 
individual’s population and country and removing the requisite condition of central adiposity.    
Prevalence  
In the U.S. it is estimated that over 65 million people have the metabolic syndrome1.   At 
the population level, the prevalence of the metabolic syndrome in the U.S. is typically estimated 
using data from the NHANES.  The first study to estimate the prevalence of the metabolic 
syndrome using NHANES data was conducted by Ford and colleagues in 200222.  Applying the 
NCEP definition to 1988 – 1994 NHANES III data, the study found that 23.7% of adults met the 
criteria for the metabolic syndrome22.   
In a follow-up study, Ford et al.23 used 1988 – 1994 NHANES III data to compare the 
prevalence of the metabolic syndrome obtained using NCEP and WHO definitions.  Results 
revealed no significant difference in the estimated prevalence between the NCEP and WHO 
criteria.  Specifically, the estimated prevalence of the metabolic syndrome was 23.9% when 
using the NCEP definition and 25.1% when using the WHO definition23.  In a subsequent study, 
Ford compared the prevalence estimates generated using IDF and NCEP criteria24.  The study, 
which used 1992 – 2002 NHANES data, found the prevalence of the metabolic syndrome was 
39.1% when using the IDF criteria and 34.6% when using the NCEP criteria24.   
More recently, using the 2003 – 2006 NHANES data, Ervin and colleagues25 and 
Mozumdar et al.1 reported the prevalence of the metabolic syndrome in adults to be 34.2% when 
using the NCEP criteria.  Mozumdar and colleagues also found a significant increase of 5% in 
the prevalence of the metabolic syndrome from the NHANES III to the 1999 - 2006 NHANES1.   
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The most recent estimates of the metabolic syndrome in U.S. adults were reported in 
2013 by Beltrán-Sánchez and colleagues26.  In this study the Joint Scientific Statement definition 
was used to determine the prevalence of the metabolic syndrome in the adult population from the 
1999 – 2010 NHANES.  The results of this study are inconsistent with previous findings using 
NHANES data.  Specifically, the results of this study indicate a significant, downward trend in 
the prevalence of the metabolic syndrome from 25.5% in 1999 – 2000 to 22.9% in 2009 – 2010.  
In addition, this study found no significant trend in the prevalence of the metabolic syndrome for 
U.S. males (23.7%), while females saw sharp declines from 27.5% to 21.8% between 1999-2000 
and 2009 – 2010.  While a decrease was seen for the metabolic syndrome as a whole; however, 
the waist circumference and fasting glucose of U.S. adults significantly increased across the 
timeframe of the study26.  The authors suggest that the decline in the metabolic syndrome, 
triglyceridemia, and attenuated HDL-C seen in this study may be due to their failure to classify 
adults with dyslipidemia if they were prescribed a lipid lowering medication.   
Self-Reported Physical Activity & the Metabolic Syndrome 
In the U.S., the association between the metabolic syndrome and self-reported PA has 
been investigated using a variety of data sources.  In particular, self-reported PA data collected 
as part of the NHANES have been used by researchers to assess the relationship of PA and the 
metabolic syndrome at the U.S. population level.  In a study by Park et al.27, using data from the 
1988 – 1994 NHANES III, the intensities of the most commonly reported leisure time physical 
activity (LTPA) (i.e., walking, jogging, swimming, gardening/yard work) were used to develop a 
PA intensity score, which was defined as the ratio of activity-related metabolic rate to resting 
metabolic rate.  A PA intensity score of ≤ 3.5 classified individuals as physically inactive, while 
moderately active corresponded to a score between 3.6 and 14.9 and active a score of ≥ 15.  The 
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cut-points for moderately active and active were chosen to represent the 15th and 65th percentile 
of PA for men and 25th and 75th percentile for women, respectively.  Results of this study found 
inactive men had a 40% increased risk for being diagnosed with the metabolic syndrome 
compared to their active counterparts.  However, there was no significant association found for 
women27.   
In another NHANES III study conducted by Zhu and colleagues28, the aforementioned 
PA intensity score was also used to assess the association of self-reported PA with the metabolic 
syndrome.  Results of this study indicated that being physically active was associated with a 31% 
and 17% reduction in risk of being diagnosed with the metabolic syndrome in men and women, 
respectively28. Similarly, a study conducted by DuBose et al.29 used self-report PA data from the 
NHANES III to assess the relationship with the metabolic syndrome.  In contrast to the studies 
by Zhu and Park, this study determined the intensity of self-reported LTPA using the 
Compendium of Physical Activities; which expresses intensity as metabolic equivalents 
(METs)30.  Moderate-intensity PA (MPA) was defined as 3 – 6 METs and vigorous intensity PA 
(VPA) defined as ≥ 6 METs30.  Participants were classified as active if they obtained ≥ 5 d/wk of 
MPA and/or ≥ 3 d/wk of VPA.  Participants were classified as irregularly active if they engaged 
in PA but did not accumulate ≥ 5 d/wk of MPA and/or ≥ 3 d/wk of VPA.  Inactive participants 
were those who reported no LTPA over the past month. Results of this study indicated inactive 
participants had a 45% increase in the odds of being classified as having the metabolic 
syndrome29.   
 Using data from the 1999-2000 NHANES, Ford et al.31 examined the relationship 
between self-reported MVPA, sedentary behavior, and the metabolic syndrome.  In this study, 
MVPA was classified into three categories based on the minutes of activity: 0, < 150, and ≥ 150 
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min/wk.  Sedentary behavior was measured using a question which asked respondents how many 
hours of television they watched daily over the past 30 days.  Results of this study revealed that 
both MVPA and sedentary behavior were associated with the metabolic syndrome; however 
there was no interaction between MVPA and sedentary time.  Additionally, it was found that 
individuals who engaged in 0 min/wk of MVPA had almost twice the odds of having the 
metabolic syndrome compared to those who engaged in 150 min/wk of MVPA31. 
 Data from the 1999 – 2004 continuous NHANES was used by Churilla and colleagues32 
to study the relationship between the metabolic syndrome and LTPA using two definitions of the 
metabolic syndrome developed by the AHA/NHLBI and WHO.  Total LTPA was categorized 
into six levels with the first level comprised of individuals with no self-reported LTPA and the 
five remaining levels divided into quintiles of LTPA. Results of this study indicated an inverse 
association between both definitions of the metabolic syndrome and LTPA.  Between the two 
definitions, it was seen that the dose of PA necessary to provide protection against the metabolic 
syndrome varied.  Using the WHO criteria, protection began at the 3rd quintile of PA (393 – 736 
MET· min1· wk-1), which provided a 30% reduction in risk of the metabolic syndrome.  Based on 
the AHA/NHLBI criteria, significant protection did not begin until the 4th quartile of PA (737 – 
1360 MET· min1· wk-1), which reduced the risk of the metabolic syndrome by 35%.  
Additionally, this study found adults meeting the American College of Sports Medicine/AHA 
PA recommendations for public health were 39 – 46% less likely to have the metabolic 
syndrome32.  These results indicate the reduction in metabolic syndrome risk with increased PA 
varies between metabolic syndrome definitions.    
  Sisson and colleagues33 examined the relationship between occupational and domestic 
PA and the metabolic syndrome in U.S. adults using data from the 2003 – 2006 NHANES.   In 
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this study the AHA/NHLBI definition was used to classify participants as having the metabolic 
syndrome.  Occupational/domestic PA was determined by a question that asked participants to 
classify their usual daily activities as one of the following: “sit during the day and do not walk 
about very much, stand or walk about quite a lot during the day but do not have to lift or carry 
things often, lift or carry light loads or have to climb stairs or hills often, and heavy work or 
carries heavy loads.” Responses indicating activity (i.e., standing, walking, and carrying loads) 
were collapsed into one category to compare against sitting.  Results of this study revealed that 
compared to individuals reporting occupational/domestic PA, subjects reporting sitting 
throughout the day were at increased risk for being classified as having the metabolic syndrome.  
Specifically, men and women were at a 66% and 17% increased risk of being classified as 
having the metabolic syndrome, respectively.  Men and women were also 58% and 40%, 
respectively, more likely to have a high waist circumference if they spent most of their day 
sitting33.  
 In another NHANES study by Churilla et al.34, the total volume of PA acquired from 
leisure-time, domestic, and transportational PA was assessed to determine the association with 
the metabolic syndrome.  Results revealed individuals with higher volumes of total PA and 
LTPA had significantly lower prevalence of the metabolic syndrome.  For both total PA and 
LTPA, significant protection against the metabolic syndrome was seen starting at the 4th quintile 
of PA.  The volume associated with the 4th quintile, however, was higher for total PA (1261 
MET· min1· wk-1) compared to LTPA (736 MET· min1· wk-1).  The authors hypothesized the 
greater volume of total PA necessary for protection was due to the lower intensity of domestic 
and transportational activities compared to leisure-time activities34.   
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 In addition to the aforementioned NHANES studies, researchers have used data from a 
variety of U.S.-based studies to assess the relationship of self-reported PA and the metabolic 
syndrome.  One of these studies is the Bogalusa Heart Study which was used by Gustat and 
colleagues35 in 2002 to examine this relationship in a sample of U.S. adults.  To assess PA, a 
questionnaire was used which asked participants to rank their work-related and LTPA on a scale 
of 1 (inactive) to 5 (very active).  Individuals indicating they did not work were excluded from 
the analysis.  Results of this study found moderately to very active individuals (scale 3 – 5) were 
44% to 69% less likely to be classified as having the metabolic syndrome compared to their 
inactive (scale 1) counterparts35.   
 The Coronary Artery Risk in Young Adults (CARDIA) study was also used to assess the 
relationship between PA and the development of the metabolic syndrome36 in a sample of U.S. 
adults.  The study followed CARDIA participants who were not diagnosed with the metabolic 
syndrome, from 1985 to 2001.   Participants were re-examined six times during the study, with 
the incidence of the metabolic syndrome determined at baseline, 7, 10, and 15 years using the 
National Adult Treatment Panel  III criteria.  The CARDIA Physical Activity History37 
questionnaire was used to assess participation in regular leisure-time and occupational PA.  
Participant’s PA level was classified as low activity, regular activity, or moderate activity.  Low 
activity was defined as having an activity level below the sample’s baseline median at all four 
follow-up examinations.  Regular activity was defined as having PA levels above the median of 
the baseline sample at each of the four follow-up examinations and moderate activity was 
defined as having PA levels that fluctuated over the course of the study36.    
Results of this study revealed an inverse association between the metabolic syndrome and 
regular PA36.  Specifically, regularly active participants were 51% less likely to have the 
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metabolic syndrome compared to inactive participants, independent of weight gain.  After 
adjustment for smoking and drinking status, dietary measures, and baseline (body mass index) 
BMI the association was still significant, with regularly active subjects 35% less likely to have 
the metabolic syndrome36.    
 The relationship between PA and the prevalence and incidence of the metabolic 
syndrome has also been assessed by researchers using data from the Atherosclerosis Risk in 
Communities (ARIC) Study38,39.  The ARIC study uses a prospective cohort design to investigate 
the etiology of cardiovascular disease in Non-Hispanic White and Black adults residing in four 
U.S. communities.  The baseline assessments were conducted from 1987 to 1989 and included 
15,792 participants.  Follow-up assessments were conducted every three years and LTPA was 
assessed using a modified version of the Baecke Physical Activity Questionnaire40. Using 
responses to this questionnaire, a LTPA score ranging from 1 (low activity) to 5 (high activity) 
was calculated for each person.  LTPA scores were further classified into one of three tertiles:  
lowest (1.0 – 2.0), middle (2.25– 2.5), and upper (≥ 2.75).  The metabolic syndrome was defined 
using the NCEP ATP III guidelines.   
 The first study using ARIC data was published in 2010 by Cheriyath et al.38 and reported 
the strength of the association between LTPA and the 6-year incidence of the metabolic 
syndrome.  Results of this study revealed the odds of developing the metabolic syndrome were 
20% lower for those in the upper activity tertile compared to the lower activity tertile.  The 
reduced incidence in the upper tertile also remained significant (OR = 0.85; 95% CI: 0.75 – 0.97) 
after adjusting for demographics, smoking, coronary heart disease, and total cholesterol.   
 The second ARIC study was published by Bradshaw and colleagues39 in 2013.  This 
study used all 9-years of ARIC data to determine factors associated with the incidence of the 
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metabolic syndrome by BMI category (i.e., normal weight, overweight, or obese). This study 
found the 9-year incidence rate (IR) of the metabolic syndrome was highest for obese individuals 
(IR: 70.3 per 1,000 person-years), with lower incidence seen in those who were overweight (IR: 
37.9 per 1,000 person-years) and normal weight (IR: 15.4 per 1,000 person-years).  LTPA was 
also found to reduce an individual’s risk of developing the metabolic syndrome over the 9-year 
period.  Specifically, those in the upper tertile of LTPA were 14% less likely to develop the 
metabolic syndrome compared to those in the low activity tertile.  This association also varied by 
BMI group, with highly active (i.e., third tertile), normal weight, and overweight individuals 
experiencing a 29% and 16% reduction in risk for developing the metabolic syndrome compared 
to their inactive counterparts39.  
 In addition to the aforementioned U.S.-based studies, a substantial body of literature 
exists from researchers across the globe.  One such study, the Kuopio Ischemic Heart Disease 
Risk Factor (KIHD) Study, has tracked a cohort of middle-aged males from Eastern Finland 
since the 1980’s.  The study measures a variety of health-related variables including LTPA, 
which is assessed using the KIHD 12-month Leisure-Time Physical Activity Questionnaire41.  In 
a study conducted by Laakenson et al.42, data from the 4-year follow-up of the KIHD study was 
used to assess the role of low levels of LTPA with the development of the metabolic syndrome.  
For the total volume of LTPA, which included all PA intensity sub-categories, logistic regression 
indicated men accumulating ≥ 487 min/wk of LTPA were 48% less likely to develop the 
metabolic syndrome compared to those accumulating < 270 min/wk.  Looking at the intensity of 
LTPA, results revealed low-intensity PA was not a significant predictor of the metabolic 
syndrome.  However, accumulating ≥ 18 min/wk of MVPA resulted in a 48% reduction in the 
risk of the metabolic syndrome.  VPA was also associated with reduced risk of developing the 
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metabolic syndrome.  Specifically, accumulating between 10 – 59 min/wk or ≥ 60 min/wk of 
VPA reduced the risk of the metabolic syndrome by 42% and 68%, respectively42.   
 Data from the 1999 – 2000 Australian, Diabetes, Obesity and Lifestyle Study (AusDiab) 
was used by Dunstan et al.43 to determine the association between TV viewing and PA with the 
metabolic syndrome in Australian adults.  The analysis included adults > 35 years of age who 
had complete data for the metabolic syndrome, TV viewing, and PA variables.  Individuals were 
excluded if they were pregnant, had health conditions affecting PA (i.e., diabetes, angina, 
stroke), or were taking medication for hypertension or dyslipidemia.  The Active Australia 
Survey Questionnaire44 captured the frequency and duration of participant’s PA over the past 
seven days.  Total PA was calculated as the sum of the time spent walking for ≥ 10 min, time 
spent engaging in other MPA, and two times the duration of VPA in order to create an equivalent 
MPA volume.  Time spent watching TV was classified into three categories: 0 – 7, 7.01 – 14, 
and > 14 hours/wk.  In the study, men and women participating in ≥ 2.5 hours/wk of MVPA 
were 28% and 47% less likely to be classified as having the metabolic syndrome, respectively.  
TV viewing, on the other hand, was found to increase the likelihood of having the metabolic 
syndrome 1.64 and 2.16 times for men and women watching > 14 hours/week of TV, 
respectively43.   
 Data from the Canadian Heart Health Survey (CHHS) was used by Brien and 
colleagues45 to examine the relationship between self-reported LTPA and the metabolic 
syndrome.  The CHHS was conducted from 1986 to 1992; utilizing a population-based design to 
obtain a representative sample of Canadian adults aged 18 – 74 years.   In the present study, the 
metabolic syndrome was defined using NCEP ATP III criteria.  Additionally, participants were 
classified as being physically active if they reported engaging in PA at least once a week for 30 
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minutes; with individuals falling below this level of PA being classified as inactive.  The 
prevalence of the metabolic syndrome was lower in physically active men (9.4%) and women 
(7.4%) compared to their inactive counterparts (Inactive: Men: 22.1%; Women: 13.0%).  In 
addition, physically active participants were 27% less likely to have the metabolic syndrome 
compared to inactive individuals.  When examined by gender, a significant reduction in risk was 
only seen in physically active males [OR: 0.45 (95% CI: 0.29 – 0.69)].  The authors indicate the 
lack of differentiation in PA levels and information on menopause status may have contributed to 
the gender differences.     
 In Norway, the Oslo Study has allowed researchers to determine the influence of LTPA 
on the development of the metabolic syndrome in older men46.  The study was comprised of Oslo 
men born between 1923 and 1932.  Baseline samples were taken in 1972 – 1973 with a follow-
up conducted 28 years later in 2000 – 2001.  Results from the Oslo study indicated males 
accumulating four hours or more per week of LTPA at baseline were 35% less likely to be 
diagnosed with the metabolic syndrome at follow-up, after adjustment for age and education46.     
 The association between the metabolic syndrome and PA was examined in Korean adults 
by Cho et al.47.  The study sample was comprised of 14,531 Korean men and women who 
completed a cancer screening at the Center for Cancer Prevention and Detection of the National 
Cancer Center in South Korea between 2002 and 2007.  After excluding those under the age of 
30 years and individuals with missing data, the final sample size was 11,925.  Based on 
participant’s responses to a self-report questionnaire, total LTPA was calculated as 
MET·min/wk.  Results of this study revealed a reduction in the risk of the metabolic syndrome 
occurred for Korean men and women accumulating over 990 and 945 MET·min/wk, 
respectively.  Specifically, Korean men were 16% less likely to have the metabolic syndrome if 
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they accumulated 990 – 1515 MET·min/wk of PA, with those accumulating over 1515 
MET·min/wk having a 25% reduction in risk.  Women engaging in 945– 1440 MET·min/wk of 
PA were 46% less likely to have the metabolic syndrome, with those accumulating over 1440 
MET·min/wk having a 35% reduction in risk.  The authors did not discuss why increased volume 
of PA did not result in a greater reduction in metabolic syndrome risk for women47.   
 In a recent study, the Joint Interim Statement definition was used to classify participants 
from the 2005 – 2008 Tehran Lipid and Glucose Study48.  Using participant’s responses to the 
Modifiable Activity Questionnaire49,50, LTPA was categorized as light (< 600 MET·min/wk), 
moderate (600 – 1499 MET·min/wk), and vigorous (≥ 1500 MET·min/wk).  Results indicated 
that there was no association between PA and the metabolic syndrome for normal weight and 
obese Iranian adults.  However, overweight Iranians with low levels of PA (i.e., < 600 
MET·min/wk) were found to have twice the risk for being classified as having the metabolic 
syndrome than Iranians accumulating ≥ 1500 MET·min/wk of PA.  The authors suggest that 
these results may be due in part to the use of the Joint Scientific Statement metabolic syndrome 
criteria and the limited number of participants in various activity and BMI categories48.   
Summary of Self-Report Physical Activity & the Metabolic Syndrome 
 Of the 17 studies reviewed, a consistent inverse association was found between higher 
levels of self-reported PA and the metabolic syndrome.  Across studies, physically active 
individuals were 14% to 69% less likely to have the metabolic syndrome compared to their 
inactive counterparts.  The observed range in risk reduction across studies may be related to 
variations in study design, study population, and the self-report PA measures used.  Consistent 
with the 2008 Physical Activity Guidelines51, the studies reviewed found a significant reduction 
in metabolic syndrome risk among individuals accumulating ≥ 150 min·wk of MVPA.    
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 While these studies consistently displayed a relationship between self-reported PA and 
the metabolic syndrome, there are several limitations that should be considered.  In particular, 
due to the cross-sectional design of many studies, causality could not be determined. Also, many 
of the studies lacked the PA measures necessary to calculate the total PA volume including: 
intensity, frequency, duration, and mode of PA.  The accurate calculation of total PA volume 
was also limited in many studies by the use of a questionnaire that only assessed LTPA.   
Objectively-Measured Physical Activity & the Metabolic Syndrome 
 Although the relationship between metabolic syndrome and PA has been demonstrated 
using self-report methods of PA, self-report measures are subject to substantial bias that has been 
well documented in the PA Epidemiology literature52-55.  In contrast, objective measures of PA, 
such as accelerometers, may provide increased precision and decreased bias when investigating 
the dose-response relationship and potential threshold effect associated with the metabolic 
syndrome.  However, there are a limited number of studies using accelerometers to assess the 
relationship between the metabolic syndrome and PA56-58.  Additionally, these studies use 
different accelerometer-derived measures of PA; limiting the interpretability of results across 
studies.   
The variation in accelerometer-derived measures has been seen in U.S.-based studies 
utilizing NHANES accelerometer data.  For example, Metzger and colleagues57 explored 
whether MVPA performed in 1-minute bouts and accumulated in different patterns across the 
week (e.g., weekend warrior, consistent accumulation across the week, etc.) was associated with 
the metabolic syndrome.  Using data from the 2003 – 2004 NHANES, a SEM was proposed and 
subsequently tested in order to determine associations between the pattern of MVPA 
accumulation (i.e., how PA was accumulated throughout the week), risk factors of the metabolic 
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syndrome, and classification of the metabolic syndrome in U.S. adults.  In this study, MVPA was 
classified as the average daily minutes with counts at or above 2020.  The NCEP15 criteria were 
used to classify adults as having the metabolic syndrome.  Results of the study revealed that 
individuals accumulating the weekly recommended amount of PA had a lower risk of developing 
the metabolic syndrome.  However, no difference in the risk of the metabolic syndrome was seen 
when examining the pattern in which MVPA was accumulated throughout the week 57.   
In another study, Sisson et al.58 used 2005 – 2006 NHANES data to determine the 
association of accelerometer-derived steps/day and the odds of having the metabolic syndrome in 
U.S. adults.  The AHA/NHLBI17 criteria were used to classify participants as having the 
metabolic syndrome.  Results of this study indicated for every 1,000 steps/day accumulated the 
odds of having the metabolic syndrome decreased by 10%.  In addition, active to highly active 
individuals (≥10,000 steps/day) had 72% lower odds of the metabolic syndrome compared to 
their sedentary counterparts58.      
 Accelerometer-based measures of PA were also used by Jansen et al.56 to investigate the 
relationship with the metabolic syndrome.  Using the 2003 – 2006 NHANES, the association 
between the metabolic syndrome and accelerometer-derived minutes of MPA, VPA, and MVPA 
performed in 1-minute bouts was examined. The intensity of activity was first determined using 
the Freedson3 regression equation, which estimated the METs from the counts/minute obtained 
from the accelerometer.  MET thresholds, consistent with the Compendium of Physical 
Activity30, were then used to classify the intensity of PA.  Results of this study revealed that the 
odds of the metabolic syndrome decreased with increasing levels of MPA, VPA, and MVPA.  
Independent associations of VPA and MPA with the metabolic syndrome were also found.  It 
was also found that approximately 75 minutes/week of VPA provided a greater reduction 
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(37.1%) in the prevalence of the metabolic syndrome than an equivalent volume (150 
minutes/week) of MPA (15.5%)56. 
 The effects of both LPA and MVPA on metabolic syndrome risk were also highlighted 
by Loprinzi and colleagues59.  Their study used the 2003 – 2006 NHANES data and classified 
individuals as having the metabolic syndrome based on AHA/NHLBI criteria.  MVPA was 
classified as the average number of minutes with counts above ≥ 2020 and LPA was defined as 
minutes with counts between 100 and 2019.  Minutes of MVPA and LPA were then categorized 
into deciles in order to examine the dose-response relationship with the metabolic syndrome.  
Results of the study indicated individuals with the highest levels of LPA and the highest levels of 
MVPA were least likely to be classified as having the metabolic syndrome.  Specifically, 
individuals in the 9th decile for LPA and 10th decile for MVPA were 45% and 80% less likely to 
be classified as having the metabolic syndrome compared to those in the 1st decile, 
respectively59.   
 In another NHANES study by Loprinzi et al.60, the association of the metabolic syndrome 
and related risk factors with PA accumulated in ≥ 10-min and < 10-min bouts was examined.   
The authors of this study used the 2003 – 2006 NHANES data and defined PA with the 
commonly used cut-point for MVPA of 2020 counts/min.  Results of this study revealed both 
bouted and non-bouted MVPA significantly reduced the risk of the metabolic syndrome and 
related cardiometabolic risk factors.  Non-bouted MVPA was also found to protect against 
classification of the metabolic syndrome after adjusting for bouted MVPA (OR: 1.02; p = 0.006), 
suggesting non-bouted MVPA may provide benefits for cardiometabolic health60.    
In addition to U.S.-based NHANES studies, a variety of internationally-based studies 
have examined the relationship between the metabolic syndrome and accelerometer-derived PA.  
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In particular, data from the 2005 AusDiab Study was used by Healy al.61 (2008) to examine the 
associations between the percent of time spent in various accelerometer-derived intensities of PA 
and the metabolic syndrome.  Sedentary time was defined as minutes with < 100 counts62 and 
LPA was defined as minutes between 100 – 1951 counts.  Freedson3 cut-points were also used to 
determine MVPA (≥ 1952 counts/min).  The percentage of time spent in each intensity level was 
calculated using the number of minutes at the intensity level as the numerator and the total 
monitoring time (i.e., wear time) as the denominator.  The mean activity intensity was also 
calculated and represented the total counts accumulated over the total monitoring time.   
Instead of using accepted medical society criteria to classify individuals as having the 
metabolic syndrome, a continuous metabolic syndrome risk score was computed using principal 
component analysis.  Specifically, a varimax rotation principal component analysis was applied 
to normalized risk factors of the metabolic syndrome, using IDF criteria18, for men and women 
separately.  The risk factor loadings from the principle component analysis were then summed 
and weighted to account for their relative influence on the metabolic syndrome; producing the 
continuous metabolic syndrome risk score.  Results of this study revealed a significant 
association with the clustered metabolic syndrome risk score was found for all PA variables.  
After adjusting for MVPA, the associations of sedentary time [ß = 0.23 (95% CI: 0.08 – 0.38)], 
LPA [ß = –0.23 (95% CI: –0.35 to –0.04)] and mean activity intensity [ß = –0.25 (95% CI: -0.41 
to –0.09)] with the clustered metabolic syndrome risk score remained statistically significant61. 
In a prospective study conducted by Park et al.63 (2008), the relationship between habitual 
PA and the metabolic syndrome was assessed in older adults. Using accelerometer/pedometer 
data from the Nakanojo study, 1-year averages for step counts and daily duration of exercise > 3 
METs was calculated.  Results of this study indicated older adults accumulating < 4700 
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steps/day were 4.32 more likely to have the metabolic syndrome than individuals accumulating > 
8,500 steps/day.  Additionally, older adults accumulating ≤ 8.5 min/day of PA above 3 METs 
were 3.33 times more likely to have the metabolic syndrome than those engaging in over 24 
min/day63.   
 The influence of very short bouts of MVPA (< 5 minutes) on the metabolic syndrome 
was examined in 2012 by Ayabe and colleagues64.  The sample consisted of 42 Japanese females 
between 40 – 60 years of age who were free of chronic disease.  A Lifecorder-Ex accelerometer 
measured participant’s PA over a 10 day period.  Participants were excluded from the analysis if 
they did not wear the accelerometer for more than 10 hours on at least seven days.  The 
following bout lengths were used to classify time spent in MVPA: > 32 s, > 1 min, > 3 min, and 
> 5 min.  Results revealed the frequency of 1-minute bouts of MVPA were significantly greater 
in females without the metabolic syndrome compared to those classified as having the metabolic 
syndrome (6.2 ± 3.8 vs. 3.4 ± 2.5 bouts/day, p = 0.043).   The frequency of all other bout lengths, 
however, was not found to be statistically different between those classified with and without the 
metabolic syndrome64.   
 In a study by Kim al.65, the association of accelerometer-derived LPA with the metabolic 
syndrome was examined in Japanese adults.  A tri-axial accelerometer (Omron HJA-350IT, 
Active Style Pro) was used to assess PA.  The intensity of PA was classified as sedentary (≤ 1.5 
METs), LPA (1.6 – 2.9 METs), and MVPA (≥ 3 METs).  A significant, negative association was 
found between LPA and the frequency of the metabolic syndrome (ptrend = 0.001).  In addition, it 
was found that individuals with higher LPA were at lower risk for the metabolic syndrome, 
independent of MVPA.  Specifically, individuals accumulating 11.2 – 14.5 or ≥ 14.6 
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MET·hr/day of LPA were 49% and 56% less likely to have the metabolic syndrome, 
respectively65. 
Data from the 2007 – 2011 Canadian Health Measures Survey (CHMS) was used by 
Clarke and Janssen66 to examine the relationship between the frequency of MVPA and the 
metabolic syndrome in Canadian adults.   In the study, the metabolic syndrome was defined 
using the Joint Interim Statement criteria.  PA was assessed using an Actical accelerometer.  A 
regression equation was used to calculate the energy expenditure (METs) of time spent in MVPA 
(i.e., minutes with ≥1535 counts).  MVPA was also classified as minutes accumulated in bouts of 
10 minutes or more with sporadic MVPA defined as bouts of < 9 min.  Participants were also 
classified into the following three groups based on their total MVPA (bouted + sporadic MVPA) 
and bouted MVPA: 1) inactive (< 250 MET·min/wk), 2) somewhat active (250 - 499 
MET·min/wk), and 3) active (≥ 500 MET·min/wk).  The results for bouted MVPA revealed the 
risk of being classified with the metabolic syndrome was 3.1 times higher in the inactive group 
compared to the active group.  When examining total MVPA, individuals in the somewhat active 
and inactive groups were at 3.34 and 4.43 greater risk of being classified with the metabolic 
syndrome than those in the active group66.     
In another study by Clarke and Janssen67, 2007 – 2009 CHMS data was used to examine 
whether bouted MVPA or sporadic MVPA was more strongly related to the metabolic syndrome.  
The study utilized the same definitions for the metabolic syndrome and MVPA as the 
aforementioned CHMS study.  Independent associations of bouted MVPA and sporadic MVPA 
with the metabolic syndrome were found to be similar.  Specifically, each additional MET·hr/wk 
of bouted MVPA and sporadic MVPA was associated with a 9% and 11% reduction in the risk 
of the metabolic syndrome.  The association of different durations of sporadic MVPA (e.g., 7 – 
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9, 4 – 9, and 1 – 9 minutes) with the metabolic syndrome was also examined.  Results revealed 
that sporadic MVPA accumulated in one to nine minute bouts was the best fitting model for 
predicting the metabolic syndrome (Akaike Weight %: 95.86); indicating MVPA accumulated in 
one to three minute bouts may reduce the risk of the metabolic syndrome67.   
Summary of Objectively-Measured Physical Activity & the Metabolic Syndrome 
 Of 13 studies reviewed, a consistent inverse association was found between higher levels 
of accelerometer-derived PA and the metabolic syndrome.  In particular, physically active 
individuals were 15.5% to 80% less likely to have the metabolic syndrome compared to inactive 
individuals.  The range in risk reduction between these studies may be related to variations in 
study design, study population, the accelerometer used, and the accelerometer-derived PA 
intensity of volume measure used.  Results of these studies also highlight the importance of all 
intensity sub-categories of PA.  Specifically, a significant reduction in metabolic syndrome risk 
was found with increased levels of LPA, non-bout MVPA, and bouted MVPA.   
 However, there are several limitations of these studies.  First, the cross-sectional design 
of these studies prevents researchers from determining causality. Second, the variety of activity 
monitors and accelerometer-derived PA measures used in these studies limits researchers from 
drawing comparisons across studies.   In addition, many of these studies utilized hip-worn, uni-
axial accelerometers which may have failed to capture non-ambulatory activity including 
cycling, weight training, and swimming.   
Accelerometer Data Reduction Techniques 
Over the past two decades, the use of objective monitors in research has increased 
exponentially68.  While accelerometers have gained acceptance within the research community, 
there is concern that accelerometers may not provide quantitatively accurate measurements of 
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time spent in various intensity categories (i.e., sedentary, light, moderate, and vigorous).  The 
following section will discuss the use of regression equations, and address concerns associated 
with classifying intensity using cut-points derived from this technique.  This section will also 
discuss the use of an accelerometer-derived total volume measure as an alternative to traditional 
accelerometer data reduction techniques.   
Regression Equations  
 Regression equations have been developed by researchers in order to translate the counts 
obtained from an accelerometer into energy expenditure which is used to estimate the time spent 
in various intensities of activity.  The first regression equation was developed by Freedson et al.3 
in 1998 for the Computer Science Applications (CSA) accelerometer.  The Freedson equation 
determined the intensity of activity based on counts accumulated at three different walking 
speeds (4.8, 6.4, and 9.7 km/hr).  Based on the regression equation, cut-points were developed 
which corresponded to light (<1952 counts per minute (cpm)), moderate (1952 – 5724 cpm), 
hard (5725 – 9498 cpm), and very hard intensity (≥ 9499 cpm)3.   
During this time, Hendelman et al.69 were also interested in the relationship between 
accelerometer counts and energy expenditure.  However, the focus of Hendelman’s work was on 
developing equations for the CSA accelerometer and Tritrac monitor that were based on 
moderate-intensity lifestyle activities (i.e., playing golf, household tasks, washing windows, 
vacuuming, lawn mowing).  Using all activities, the following equations were developed to 
calculate MET values from the devices counts per minute: [METsCSA = 2.922 + 
0.000409*CPMCSA] and [METsTritrac = 2.817 + 0.0011*CPMTritrac]69.   
In 2000, Bassett and colleagues70 conducted a study to compare the accuracy of the 
Freedson3, Hendelman69, and CSA manual71 (work-energy theorem) equations.  Participants in 
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the study completed activities related to yard work, housework, occupation, family case, 
conditioning, and recreation. During the activities, which lasted 15 minutes each, oxygen 
consumption (VO2) was measured using the Cosmed K4b2 portable indirect calorimetry system 
and the CSA (model 7164) accelerometer was worn on the participant’s waist.   After data 
collection, the equation specific algorithms were applied to the accelerometer outputs and 
correlations were calculated to compare the equations and indirect calorimetry outputs.  Results 
revealed the estimated energy expenditure derived from the Hendelman (r = 0.62) and CSA 
manual (r = 0.62) equations had the strongest relationship with the actual energy expenditure 
(i.e., indirect calorimetry).  However, both accelerometer equations were found to underestimate 
the intensity of the activities by 30.5 – 56.8%.  The largest difference was seen for household 
activities, as the accelerometer equations underestimated four of the five activities by over 
50%70.       
These results are consistent with other studies which have found that accelerometer-
derived estimates of time spent in various PA intensity categories do not correspond with 
measurements obtained by indirect calorimetry6,7.  For example, one study found the total 
amount of time spent in MVPA, regardless of bout duration, was underestimated by 50% when 
using NHANES ActiGraph cut-points6.  In another study, Lyden et. al72 evaluated the ability of 
different regression equations for the ActiGraph, Actical, and RT3 accelerometers to accurately 
classify time spent in PA intensity sub-categories.  Results of this study found that none of the 
regression equations examined were able to correctly classify minutes spent in each intensity 
category, with the misclassification error ranging from 8.9 - 34.3% for MPA and 28.2 - 54.5% 
for VPA.  The authors note that the misclassification error of MPA may be related to the 
insensitivity of the regression equations to distinguish LPA due to the high y-intercept of 2.6 
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METs.  While regression equations with a lower y-intercept had increased sensitivity to LPA, 
they tended to underestimate MPA and VPA72.    
Due to this misclassification error, the PA estimates derived from cut-points vary widely.  
This was demonstrated by Loprinzi et al., using the NHANES data, who found the time spent in 
MVPA ranged from 17 to 59 minutes per day and the percentage meeting PA guidelines ranged 
from 6.2 – 59.3%, depending on the regression equation used73.   Therefore, it is unclear which 
cut-point(s), if any, provide an accurate representation of the time spent in LPA, MPA, and VPA.  
This is important as the misclassification error may affect the relationship with disease, leading 
to conflicting results.  In addition to the estimation error associated with accelerometer 
algorithms, the numerous cut-points also hinders the ability to draw comparisons between 
studies74,75.   Thus, Freedson et al.75 have therefore urged researchers to discontinue the 
development of cut-points to categorize accelerometer-derived PA.    
Total Volume 
 One way to circumvent the issues with other accelerometer data reduction techniques is 
to use the total activity counts (TAC) output by the device.  TAC may be a better measure of PA 
as it is the most direct expression of what the accelerometer measures.  It is also a proxy for total 
volume of PA as it encompasses the frequency, intensity, and duration of activity.  
In addition, recent evidence suggests that LPA, MPA, and VPA all have health benefits.  
This is reflected in work by Healy et al.76 which showed that individuals who perform greater 
amounts of LPA have a reduced incidence of diabetes.  Kim et al.65 also found that individuals 
with higher levels of LPA were at lower risk for the metabolic syndrome, independent of MVPA.  
Furthermore, research related to sedentary behavior has indicated that LPA is highly inversely 
correlated with sedentary time (r = - 0.98) after adjusting for wear time77.  In addition to LPA, 
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recent evidence suggests that MVPA accumulated in short, intermittent bouts may provide 
similar or additional benefits for cardiovascular and metabolic health, as MVPA accumulated in 
bouts of 10 minutes or longer67,78,79.  The effects of both LPA and MVPA were highlighted by 
Loprinzi et al.59 who found individuals with the highest levels of both LPA and non-bout MVPA 
were least likely to be classified as having the metabolic syndrome.  Taken together, these 
studies suggest that LPA and intermittent (non-bout) MVPA have health benefits and should be 
accounted for.  
Recently the importance of a global, objective measure of PA such as TAC was explored 
by Wolff and colleagues (Part IV and V).  The first study, which utilized accelerometer data 
obtained from the 2003 – 2006 NHANES, demonstrated that TAC had stronger associations with 
cardiometabolic biomarkers (e.g., blood pressure, body mass index, and cholesterol) than 
traditional accelerometer-derived minutes spent in MVPA bouts of 10 minutes or greater (Part 
IV).  Five cardiometabolic risk factors comprising the metabolic syndrome were found to be 
more strongly related to TAC than MVPA: waist circumference, fasting glucose, triglycerides, 
HDL-C, and systolic blood pressure.  One risk factor, diastolic blood pressure, was not found to 
have significant associations with either TAC or MVPA.  These results suggest that TAC is a 
more robust measure of PA, as it is more closely related to health indicators associated with the 
metabolic syndrome (Part IV).  
 In the second study conducted by Wolff and colleagues (Part V), age- and gender- 
specific population-referenced percentiles for TAC, MVPA, and LPA were developed.  The 
population-reference values provide researchers with a measure of the total volume of PA that 
can be expressed relative to other adults (i.e., as percentiles).  Additionally, this is a different 
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approach to accelerometer data reduction that complements the current method of looking at 
time spent in intensity sub-categories.   
Despite the aforementioned results highlighting the benefit of a total volume measure of 
PA, future research is necessary to explore the relationships of TAC with various health 
indicators.  In particular, it is necessary to determine whether TAC or another accelerometer-
derived PA measure has the greatest contribution to chronic disease risk reduction.  Statistically, 
the relative contribution of each PA measure in the reduction of disease risk can be determined 
using SEM.  The following section describes this advanced statistical technique and its use in 
Physical Activity Epidemiology. 
Structural Equation Modeling 
Over the past two decades, SEM has gained popularity in the social and behavior 
sciences80.  Within the field of Physical Activity Epidemiology, SEM provides a novel tool that 
gives researchers the opportunity to examine multiple disease risk factors and health behaviors 
(e.g., PA) simultaneously. Also, SEM enables researchers to include correlated measures, 
through the use of latent constructs.  This is particularly important when examining the role of 
multiple intensity levels of PA, which are highly correlated.   The following section provides a 
brief introduction to SEM and discusses its use in NHANES studies assessing the relationship of 
PA with various chronic diseases.   
Structural equation modeling (SEM) is an advanced statistical technique which tests 
hypotheses about the relationships between observed (manifest) variables and latent constructs81.  
Latent constructs are comprised of multiple measures that are classified as being exogenous or 
endogenous.  Exogenous constructs are not dependent on any other variables and are therefore 
thought of as the independent variables.  Endogenous constructs are considered mediating or 
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dependent variables as these constructs are dependent on at least one other construct.  A 
structural equation model contains the relationship between exogenous and endogenous latent 
constructs, the loadings of manifest variables onto each construct, and measurement and 
prediction error81-83.   
There are several advantages of SEM compared to other multivariate statistical 
approaches. In particular, SEM uses multiple measures to define a construct and it yields 
unbiased parameter estimates.  SEM enables researchers to examine both direct and indirect 
effects (i.e., moderating and mediating variables) simultaneously.  Additionally, SEM allows for 
the comparison of multiple theoretical models which are well-specified and complex81,84.   
SEM gives researchers statistical flexibility to analyze both simple and complex models.  
Specifically, SEM can be used to analyze longitudinal and cross-sectional data.  It can also be 
used to analyze dependent observations such as family data80,81.  SEM also fits the raw data 
instead of using summary statistics, reducing the problems associated with missing observations.  
Furthermore, this technique is not limited by the measurement level of the variable as it manages 
interval and categorical data simultaneously80,81,83.   
The ability of SEM to simultaneously determine the mediating and moderating effects of 
multiple health behaviors on chronic diseases makes it an ideal tool for analyzing data from the 
NHANES.  To our knowledge, however, only two studies have applied SEM to the NHANES 
data.   The first study by Metzger and colleagues57 examined whether the pattern by which 
accelerometer-derived MVPA is accumulated during the week is associated with the metabolic 
syndrome.  The MVPA accumulated by participants on each day of the week was classified into 
one of five groups, indicating a specific pattern of PA accumulation (i.e., weekend warrior, 
occupational-related accumulation, consistent accumulation).  Results of the study revealed that 
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individuals accumulating the weekly recommended amount of PA had lower risk of developing 
the metabolic syndrome.  However, no differences in metabolic syndrome risk were seen when 
examining the pattern in which MVPA was accumulated throughout the week57.   
The second NHANES study using SEM was conducted by Bardenheier and colleagues85, 
who examined factors associated with pre-diabetes in older adults.  This study utilized 2001 – 
2006 NHANES data and classified individuals as pre-diabetic if they had a fasting glucose ≥ 126 
mg/dL or HbA1c ≥ 6.5%.  Several measures of PA, obtained from questionnaire, were used to 
define the PA construct including: MET·hr·wk-1 of MPA and VPA, minutes of walking/biking, 
muscle strengthening exercise, and house/yard work.  Results of this study revealed the best 
fitting model was one which included causal paths of socioeconomic status, poor diet, and PA on 
pre-diabetes.  However, the causal pathway between PA and pre-diabetes was not significant.  
Instead, the PA construct was found to have a direct effect on HDL-C (0.137), triglycerides (-
0.136), high blood pressure (-0.132), and high waist circumference (-0.067)85.   
In summary, SEM is a powerful, multivariate statistical tool.  While the use of SEM has 
grown in many fields, within Physical Activity Epidemiology SEM remains a novel approach to 
understanding the complex relationship of health behaviors and chronic disease risk.  Therefore, 
future studies exploring the inter-relationships of health behavior and chronic disease should 
consider utilizing SEM.   
Summary 
In the United States, the current prevalence of the metabolic syndrome ranges from 22.926 
to 32.4%1,25; with older individuals and males having the highest prevalence estimates.  The 
almost 10% variation in the prevalence is most likely due to the medical society definitions of 
the metabolic syndrome applied to the study populations.  While the 2009 Joint Interim 
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Statement21 attempted to create a unified definition of the metabolic syndrome, there have been 
few studies that have applied this definition.  This may be due in part to the similarities of the 
Joint Statement21 with the more commonly used AHA/NHLBI16,17 definition.   
For both self-report and accelerometer-based PA, a consistent inverse association was 
found between the metabolic syndrome and higher levels of PA.  However, the variety of self-
report and accelerometer-derived measures used in these studies makes it difficult to determine 
the minimum dose of PA associated with a reduced risk of the metabolic syndrome.  In addition, 
while a reduced risk in the metabolic syndrome was seen with increased volume of PA, the total 
PA volume measures were limited by the domains they captured via self-report or the sub-
intensity level that was assessed via accelerometer.     
Despite these limitations, the results of these studies provided substantial evidence for the 
use of a total volume measure of PA derived from accelerometers.  In particular, accelerometer-
derived minutes of LPA, non-bout MVPA, and bouted MVPA were associated with a significant 
reduction in metabolic syndrome risk. Furthermore, pilot work (Part IV) has demonstrated that 
total activity counts, an indicator of the total volume of PA, is more strongly associated with 
cardiometabolic biomarkers than MVPA performed in 10 minute bouts (Part IV). In light of 
these results, future research is necessary to determine the role of PA intensity in the 
development of the metabolic syndrome.    
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The purpose of this study, presented in Part VI, was to determine whether accelerometer-
derived TAC, MVPA, or LPA provided the best fit for assessing the relationship with the 
metabolic syndrome.  This study also assessed the relative contribution of LPA, MPA, VPA, and 
TAC to the reduction in the prevalence of the metabolic syndrome.  This study utilized cross-
sectional data from the 2003 –2006 National Health and Nutrition Examination Survey 
(NHANES).  The following section describes the measures and analyses that were utilized in this 
study.  
Subjects 
For this study, the sample was limited to adults ≥ 20 years of age who participated in a 
fasting morning examination (N = 4312).  Participants with less than four days of ≥ 10 hours of 
accelerometer wear time (n = 1513), pregnant or lactating women (n = 146), and individuals with 
missing data (n = 415) were excluded from the analyses, resulting in a final sample of (n = 
2238).  The original survey protocols were approved by National Center for Health Statistics 
ethics review board, and informed consent was obtained from all NHANES participants. The 
University of Tennessee institutional review board approved the use of NHANES data in this 
analysis. 
Data Collection 
  The present study used data from the 2003 – 2006 National Health and Nutrition 
Examination Survey (NHANES).  The NHANES is a cross-sectional survey utilizing a complex, 
multistage probability design in order to obtain a representative sample of the non-
institutionalized United States (U.S.) population1.  The NHANES data are collected during an in-
person home interview and a visit to a mobile examination center (MEC).  The interview collects 
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demographic, socioeconomic, and health-related information.  The examination consists of 
laboratory tests and medical and physiological measurements.   
All ambulatory individuals examined in the MEC were eligible participants for the 
accelerometer component.  Eligible participants were instructed to wear an ActiGraph model 
7164 accelerometer for seven days on their right hip during waking hours, and to take it off for 
swimming or bathing2.  Details of the accelerometer protocol can be found on the Centers for 
Disease Control and Prevention (CDC) website3.   
Study Measures 
The 2003 – 2006 NHANES required extensive recoding and data management to create 
the measures used in this study.  A description of these measures is presented below.   
Dependent measure: The Metabolic Syndrome 
 The dependent variables were cardiometabolic risk factors of the metabolic syndrome 
based on criteria established by the American Heart Association and National Heart, Lung, and 
Blood Institute (AHA/NHLBI)4.  The AHA/NHLBI definition was selected over other 
definitions of the metabolic syndrome as it is the most appropriate criteria for the U.S. 
population based on the joint scientific statement of the International Diabetes Federation and the 
AHA/NHLBI5.  The AHA/NHLBI definition of the metabolic syndrome is unique in that no 
specific condition is required (i.e., obesity, insulin resistance) for diagnosis.  Instead this 
definition requires an individual display any three of the five risk factors for a positive diagnosis 
of the metabolic syndrome.  The five metabolic syndrome criteria defined by the AHA/NHLBI 
include4:   
1. Central adiposity defined as a waist circumference > 102 centimeters (cm) in men and 
> 88 cm in women; 
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2. Elevated triglycerides ≥ 150 milligrams per deciliter (mg/dL) or undergoing 
pharmacological treatment; 
3. Attenuated high-density lipoprotein cholesterol (HDL-C) defined as < 40 mg/dL in 
men and < 50 mg/dL in women, or undergoing pharmacological treatment; 
4. Elevated blood pressure ≥ 130 / ≥ 85 mmHg, or undergoing pharmacological 
treatment; and, 
5. Impaired fasting glucose ≥ 100 mg/dL or undergoing pharmacological treatment.    
Using the AHA/NHLBI definition of the metabolic syndrome, measures of waist 
circumference, lipoprotein concentrations, blood pressure, and fasting glucose were obtained 
using data from the MEC component of the NHANES survey.  Details of the laboratory methods 
can be found on the Centers for Disease Control and Prevention (CDC) website6.  To determine 
whether a component of the metabolic syndrome meet inclusion criteria, each risk factor was 
dichotomized using the cut-off values and pharmacological treatment criteria (0 = does not meet 
criteria; 1 = meets criteria).  In addition, individuals were classified as having the metabolic 
syndrome if they displayed three or more of the five aforementioned risk factors.   The recoding 
of the metabolic syndrome variable and the five risk factors as dichotomized variables (0 = does 
not meet criteria, and 1 = meets criteria) provides an estimate of the prevalence for each variable.   
Independent measures 
 A variety of independent variables were assessed in this study.  The primary independent 
variables were average daily accelerometer-derived physical activity (PA) measures.  Depending 
on the model, the following four PA measures were used: average daily minutes of light- (LPA), 
moderate- (MPA), or vigorous intensity PA (VPA) and total activity counts per day (TAC).  All 
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other variables served as covariates for both studies.  The following section describes each 
independent variable in further detail.   
Objectively measured physical activity 
The NHANES accelerometer data were collected in one-minute epochs using an 
ActiGraph model 7164, which is a uniaxial accelerometer measuring vertical acceleration.  In 
this study, accelerometer data was analyzed using the SAS macro provided by the National 
Cancer Institute7.  Non-wear time was defined as ≥ 60 consecutive minutes with zero 
accelerometer counts, allowing up to two minutes with limited movement (< 100 counts/minute).  
Daily wear time was determined by subtracting non-wear time from 24 hours.   A valid day was 
defined as a day with 10 or more hours of monitor wear8.  Only participants with at least four 
days of valid monitor wear time were eligible to be included in this analysis.   
• Total Activity Counts per day (TAC): The variable total activity counts per day 
(TAC) was created by summing the counts accumulated on each valid day.  As TAC 
captured all counts accumulated during valid wear times it therefore included time 
spent in sedentary activity and all PA intensity sub-categories.   
• Light Physical Activity (LPA): Using thresholds described by Troiano2, LPA was 
defined as the total number of minutes with 100 – 2019 counts per minute.  
• Moderate Physical Activity (MPA): Using thresholds described by Troiano2, MPA 
was defined as the total number of minutes with 2020 – 5998 counts per minute.   
• Vigorous Physical Activity (VPA): Using thresholds described by Troiano2, VPA was 
defined as the total number of minutes with ≥ 5999 counts per minute.   
All PA metrics were averaged across the number of valid days to provide an average of 
the total minutes or counts accumulated daily.   
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Covariates 
 Several confounding variables served as covariates in this study, including four 
demographic variables: age, race/ethnicity, education, and income level.  Additionally, one 
variable assessing family history of disease was included as a covariate. 
• Age:  Age, measured in years, was categorized into the following six categories: 20 – 29, 
30 – 39, 40 – 49, 50 – 59, 60 – 69, and ≥ 70 years of age.   
• Race/Ethnicity:  Participants were classified into one of three race/ethnicity groups.  The 
four categories were the following:  Non-Hispanic White, Non-Hispanic Black, and 
Mexican American/Other.   
• Education: A five level variable was used to classify participant’s education level: less 
than 9th grade, 9 – 11th grade, HS graduate or General Educational Development (GED) 
diploma, some college or Associates of Arts degree, and college graduate or greater.   
• Income: Participants were classified into one of eight categories based on their self- 
reported annual household income.  The eight categories, in thousand (K) dollar units 
were : <$20K, $20 – 24.9K, $25 – 34.9K, $35 – 44.9K, $45 – 54.9K, $55 – 64.9K, $65 – 
74.9K, and ≥ 75K.    
• Family History of Coronary Heart Disease:  The AHA/NHLBI recognizes that a family 
history of coronary heart disease increases an individual’s risk of the metabolic 
syndrome4.  Participants were classified as having a family history of coronary heart 
disease if they reported a parent and/or sibling had the condition.  The variable was 
dichotomized with one category indicating family history and the other reflecting no 
family history.    
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Statistical Analysis: Structural Equation Modeling 
The 2003 – 2006 NHANES data used in this study were downloaded from the 
demographics, examination, laboratory, and questionnaire sections of the CDC website3.  All 
recodes were performed using SAS 9.2 (SAS Institute, Inc., Cary, NC).  In addition, the SAS 
macro provided by the National Cancer Institute7 was used to recode accelerometer-derived 
measures of PA.  Descriptive analyses (i.e., Chi-square tests and independent-samples T-tests) 
were also performed using SAS 9.2.  These analyses did not account for the complex sampling 
design of the NHANES in order to make comparisons to the results obtained from the structural 
equation modeling (SEM) analyses.   
Specifically, SEM was performed using AMOS 20.0 (AMOS Development Corp., 
Meadville, PA), which is unable to take into account the NHANES sampling weights and 
sampling design variables which account for complex sampling design.  In the present analysis, 
three hypothetical models were tested using SEM.  The three models were stratified by gender 
and used various accelerometer-derived measures of PA to examine the association between the 
prevalence of the metabolic syndrome, the prevalence of the five components of the metabolic 
syndrome, and accelerometer-derived PA.  The dependent variable in these models was 
prevalence of the metabolic syndrome, which had five manifest variables (e.g., waist 
circumference, blood pressure).  The independent variable, accelerometer-derived PA, was 
measured continuously, with each model including different intensity sub-categories.  In model 
1, the PA construct was comprised of two manifest variables: accelerometer-derived MPA and 
VPA.  Model 2 had three manifest variables (LPA, MPA, and VPA) loading onto the PA 
construct.  For model 3, TAC was the only manifest variable loading onto the PA construct.   
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  Maximum likelihood (ML) estimation was used to estimate model parameters.  This 
estimation method is the most commonly used procedure in SEM as it is robust against moderate 
non-normality9.  The fit of each model was also compared to determine which accelerometer 
model best explained the reduction in the prevalence of the metabolic syndrome associated with 
PA.  This analysis evaluated four different fit indices: chi-square (χ2) to degrees of freedom (df) 
ratio (χ2/df), Root Mean Square Error of Approximation (RMSEA), Comparative Fit Index 
(CFI), and Akaike Information Criterion (AIC).  The χ2/df ratio assesses the fit of a model and 
the data, with ratios < 4 indicating reasonable fit and < 2 suggesting very good fit.  RMSEA 
indicates the fit of the model in the population’s covariance matrix; with 0.05 considered “close” 
fit, < 0.08 reflecting moderate fit, and > 0.10 indicating unacceptable fit10.  CFI compares the 
independence model (i.e., worst possible fitting model) to the substantive model (i.e., tested) 
with values ≥ 0.90 indicating good fit10.  AIC will be used to compare the adequacy of the three 
models with the smallest AIC representing the best model11.    
Factor loadings were also used to determine the relative contribution of each manifest 
variable in explaining a latent construct.  A higher factor loading indicated a stronger 
contribution of the variable to the latent construct.  Standardized regression weights or path 
weights assessed the standard deviation change in an outcome variable (e.g., the metabolic 
syndrome) for every one standard deviation unit change in a predictor variable (e.g., PA). As the 
metabolic syndrome variable and the five risk factors were dichotomized (0 = does not meet 
criteria, and 1 = meets criteria), the standard deviation represents a percentage of the variable.  
Thus, the percent change in the outcome variable (for every standard deviation change in the 
predictor variable) was determined by multiplying the standardized path weight by the standard 
deviation of the outcome variable.     
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PART IV  
 
TOTAL ACTIVITY COUNTS AND BOUTED MINUTES OF MODERATE-TO-
VIGOROUS PHYSICAL ACTIVITY: RELATIONSHIPS WITH CARDIOMETABOLIC 
BIOMARKERS USING 2003-2006 NHANES 
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Abstract 
PURPOSE: To contrast associations of accelerometer-measured moderate-to-vigorous physical 
activity (MVPA) accumulated in bouts and total activity counts (TAC) with cardiometabolic 
biomarkers in U.S. adults.  METHODS: Using 2003 – 2006 National Health and Nutrition 
Examination Survey (NHANES) data, the sample was comprised of adults ≥ 20 years, not 
pregnant or lactating, with self-reported PA and at least 4 days of ≥ 10 hours accelerometer wear 
time (N = 5668).  Bouted MVPA represented the minutes/day with ≥ 2020 counts/minute in 
bouts of 10 minutes or longer and TAC represented the total activity counts per day.  Biomarkers 
included: cholesterol, triglyceride, glycohemoglobin, plasma glucose, C-peptide, insulin, C-
reactive protein, homocysteine, blood pressure, body mass index (BMI), waist circumference, 
and skinfolds.  Nested regression models were conducted which regressed each biomarker on 
bouted MVPA and TAC simultaneously, while adjusting for relevant covariates.  RESULTS: 
Results indicated TAC was more strongly associated with 11 biomarkers: HDL-C, triglyceride, 
plasma glucose, C-peptide, insulin, C-reactive protein, homocysteine, systolic blood pressure, 
waist circumference, triceps skinfold, and subscapular skinfold.  Bouted MVPA, however, only 
displayed stronger associations with BMI.    CONCLUSIONS: The total volume of PA, 
represented by TAC, appears to have stronger associations with cardiometabolic biomarkers than 
MVPA accumulated in bouts.   
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Introduction 
Physical activity (PA) has numerous health benefits including reduced risk of 
cardiovascular and metabolic diseases1.  To further clarify the protective benefits of PA, 
epidemiologists and public health researchers continue to seek improved methods of assessing 
PA2.  In order to address this issue, many population-based studies have begun to supplement 
self-report measures of PA with objective methods such as pedometers and accelerometers3-5.   
Accelerometers are widely accepted to provide valid and reliable measures of PA6-8 and 
sedentary behavior9,10.  However, there is concern that accelerometers may not provide 
quantitatively accurate measurements of time spent in various intensity categories (i.e., 
sedentary, light, moderate, and vigorous).  Specifically, studies in free-living environments have 
found that accelerometer-derived estimates of time spent in moderate-to-vigorous physical 
activity (MVPA) do not correspond with measurements obtained by portable indirect 
calorimetry11-13.  For example, one study found the total amount of time spent in MVPA, 
regardless of bout duration, was underestimated by 50% when using National Health and 
Nutrition Examination Survey (NHANES) ActiGraph cut-points11. These results help to explain 
why 2003-2004 NHANES accelerometer data indicated that less than 5% of United States (U.S.) 
adults met recommended levels of PA (i.e., ≥ 30 min of bouted MVPA, on 5 or more 
days/week), while approximately 51% met the recommendation based on NHANES self-report 
questionnaire data14.  In general, most experts believe that the true prevalence lies somewhere in 
between these extremes.  Another point is that various cut-point methods give estimates of time 
spent in bouted MVPA that fluctuate wildly; as much as a 10-fold difference in minutes of 
bouted MVPA15.  Thus, the choice of cut-points has a significant impact on prevalence estimates 
of U.S. adults meeting PA guidelines. 
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 An additional concern related to measuring PA with accelerometers is that most research 
focuses on MVPA performed in bouts.  However, the exclusion of other intensity levels such as 
light PA and non-bout MVPA may underestimate the association between PA and 
cardiometabolic biomarkers.  This is reflected in work by Healy et al.16 which showed that 
individuals who perform greater amounts of light PA have a reduced incidence of diabetes.  Kim 
al.17 also found that individuals with higher levels of light-intensity PA were at lower risk for the 
metabolic syndrome, independent of MVPA.  Furthermore, research related to sedentary 
behavior has indicated that light PA is highly inversely correlated with sedentary time (r = - 
0.98) after adjusting for wear time18.  In addition to light PA, recent evidence suggests that 
MVPA accumulated in short, intermittent bouts may provide similar or additional benefits for 
cardiovascular and metabolic health, as MVPA accumulated in bouts of 10 minutes or longer19-
21
.  The effects of both light PA and MVPA were highlighted by Loprinzi al.22 who found 
individuals with the highest levels of both light PA and non-bout MVPA were least likely to be 
classified as having the metabolic syndrome.  Given the importance of different sub-categories of 
PA intensity/duration, the most important variable to consider may be the total volume of PA 
performed. 
Thus, we examined a global measure of PA captured by accelerometers, total activity 
counts (TAC) per day, which is a proxy for the total volume of PA performed.  TAC mirrors the 
minutes spent in sedentary, light, moderate, and vigorous PA, and weights each minute 
according to intensity.  While Troiano et al.14 previously reported the mean values for total 
activity counts per minute for U.S. adults, no study has examined whether TAC shows stronger 
associations with cardiometabolic risk factors than MVPA in bouts of 10 minutes or longer.  
Therefore, the purpose of this study is to compare the associations of objectively measured 
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MVPA, accumulated in ≥ 10 minute bouts, and TAC with biomarkers in a representative sample 
of U.S. adults.   
Methods 
To answer the research question, the approach taken by Atienza et al.5 was followed.  
Thus, we used the same data source and variable definitions, in addition to replicating the 
selection protocol.  The NHANES is a cross-sectional survey utilizing a complex, multistage 
probability design in order to obtain a representative sample of the non-institutionalized U.S. 
population23.  The NHANES data are collected during an in-person home interview and a visit to 
a mobile examination center (MEC).  The interview collects demographic, socioeconomic, and 
health-related information.  The examination consists of laboratory tests and medical and 
physiological measurements.  Due to the availability of accelerometer data, the present study 
used data from the 2003–2004 and 2005–2006 NHANES cycles.   
The sample was limited to adults ≥ 20 years of age with accelerometer data (N = 8228).  
Participants with less than four days of ≥ 10 hours of wear time (n = 2135), those missing self-
reported PA data (n = 141), and pregnant or lactating women (n = 284) were excluded from the 
analysis, resulting in a final sample of 5668.  The original survey protocols were approved by 
National Center for Health Statistics ethics review board, and informed consent was obtained 
from all NHANES participants. The University of Tennessee institutional review board approved 
the use of NHANES data in this analysis.    
 Accelerometer data collection and analysis 
All ambulatory participants examined in the MEC were eligible to participate in the 
accelerometer component.  Eligible participants were asked to wear an ActiGraph model 7164 
activity monitor for seven days following their MEC examination. The ActiGraph model 7164 
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objectively measures vertical acceleration to indicate the intensity of bodily movement24. 
Participants were instructed to wear the monitor over their right hip during waking hours and to 
take it off for swimming or bathing14.  Monitors were returned via mail to the NHANES 
contractor who downloaded that data and checked the calibration of the monitor.  The 
acceleration signal was filtered, full-wave rectified, and integrated over a 1-min epoch25.   
Details of the accelerometer protocol can be found on the Centers for Disease Control 
and Prevention (CDC) website26, and the Statistical Analysis Software (SAS) code for 
accelerometer data is available at the National Cancer Institute (NCI) website27.  Data were 
recorded in 1-min epochs for the 7-day study period.  Non-wear time was defined as ≥ 60 
consecutive minutes with zero accelerometer counts, allowing up to two minutes with limited 
movement (< 100 counts/minute (cpm)).  Daily wear time was determined by subtracting non-
wear time from 24 hours.   A valid day was defined as a day with 10 or more hours of monitor 
wear28.  Only participants with at least four days of valid monitor wear were eligible to be 
included in this analysis. 
The TAC variable was created by summing TAC per day and dividing it by the total 
number of valid wear days.  The threshold for MVPA was defined ≥ 2020 cpm, as described by 
Troiano14.  For the present analyses, only minutes of MVPA accumulated during bouts (≥ 10 
consecutive min, allowing for 1-2 minutes below the 2020 cpm threshold) were used to create 
the bouted MVPA variable28.  Minutes of bouted MVPA were then averaged across the total 
number of valid days. Since the denominator for the calculation of bouted MVPA is the total 
number of valid days, it is therefore possible to have an average below the 10-min bout 
threshold. 
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Outcomes  
The outcome variables in this study were clinically measured and laboratory-based 
cardiometabolic biomarkers.  Clinically measured biomarkers included: systolic blood pressure 
(SBP), diastolic blood pressure (DBP), body mass index (BMI), waist circumference, triceps 
skinfolds, and subscapular skinfolds.  Laboratory-based biomarkers included: total cholesterol, 
high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), 
triglycerides, glycohemoglobin, plasma glucose, C-peptide, insulin, C-reactive protein, and 
homocysteine.  More information on these biomarkers can be found online on the NHANES web 
site24.  All biomarkers were treated continuously, with log transformation applied to biomarkers 
with non-normal distributions.   
Covariates 
Consistent with Atienza et al.5, relevant socio-demographic, health/behavior status, and 
clinical diagnosis variables served as covariates in this analysis.  Socio-demographic variables 
included: age (continuous variable), gender (male vs. female), race/ethnicity (recoded white vs. 
non-white), and education (recoded as less than high school, high school or general equivalency 
degree, and more than high school).   
Smoking status, BMI, and general health condition were included to adjust for the health 
status of participants.  Smoking status was categorized as current smoker and not current smoker.   
BMI was treated as a continuous variable in this analysis.  General health condition was a self-
report measure on a scale from one to five with a score of one indicating poor and five indicating 
excellent health.       
Self-reported clinical diagnoses were included as covariates.  Variables were 
dichotomized (yes/no) representing if participants had ever been diagnosed with the following 
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medical condition:  diabetes, high blood pressure, osteoporosis, coronary heart disease, angina, 
and heart attack.    
Statistical Analysis 
All analyses were conducted using SAS 9.2 (SAS Institute, Inc., Cary, NC) and SAS-
callable SUDAAN 11.0 (Research Triangle Park, NC) and accounted for the complex sampling 
design inherent to NHANES using sample weights calculated according to the NHANES 
analytical guidelines21.  Weighted means and prevalence estimates were calculated for all 
variables utilized in this study.   
Simple linear regressions were performed in which each biomarker was regressed on 
TAC and bouted MVPA, separately, after adjusting for age.  In order to determine the 
independent association of both PA metrics with each biomarker, two nested regression models 
were conducted in which bouted MVPA and TAC were entered simultaneously.  Model one 
adjusted for socio-demographic, health status, and clinical diagnosis variables.  Model two 
adjusted for the same covariates in model one except BMI was added as a covariate.  For both 
nested regression models, the variance inflation factors were < 5, indicating that the assumption 
of multicollinearity was not violated29-31.  For both nested regression models, the adjusted Wald 
F statistic was used to determine which accelerometer measure had stronger associations with a 
biomarker.  A larger adjusted Wald F statistic indicated a greater association with a biomarker32.  
For all analyses, statistical significance was assessed using two-tailed tests with P ≤ 0.05.     
Results 
The weighted mean for TAC was 279,685 (SE = 2,708), with 6.9 (SE = 0.3) minutes 
spent in bouted MVPA.  The average age of participants was 46.5 (SE = 0.1) years, with 
weighted means, geometric means, and medians for each biomarker are displayed in Table 1.  
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Prevalence estimates indicate the sample consisted of 50.6% females, 74.3% Non-Hispanic 
Whites, and 84.5% having attained a high school education/GED or greater.  Only 35.6% of the 
respondents reported having a medical condition (e.g., diabetes, high blood pressure, 
osteoporosis, etc.) and almost half (48.5%) reported their health condition as “excellent” or “very 
good.”   
Table 2 displays the results of age-adjusted, linear regressions.  Of the 16 biomarkers, 
bouted MVPA and TAC were significantly associated with 13 biomarkers, while two biomarkers 
(i.e., total cholesterol and DPB) had no significant association with either PA metric.  
Additionally, LDL-C was not significantly associated with bouted MVPA and homocysteine was 
not significantly associated with TAC.  These results indicate that when examined separately, 
both TAC and bouted MVPA appear to be associated with cardiometabolic biomarkers.   
Therefore, a more stringent set of regression analyses were performed to determine the 
independent associations of both PA metrics with biomarkers.  Table 3 displays the results of 
these regression models, which simultaneously controlled for both PA indices.  Results of model 
1 indicated that after controlling for potential confounders, TAC displayed significant, 
independent associations with 12 biomarkers: HDL-C, triglycerides, plasma glucose, C-peptide, 
insulin, C-reactive protein, homocysteine, BMI, waist circumference, SBP, triceps skinfold, and 
subscapular skinfold (Table 3).  Similarly, bouted MVPA displayed significant, independent 
associations with triglycerides and BMI.  However, the adjusted Wald F statistics indicated only 
BMI was more strongly associated with bouted MVPA, while triglycerides was more strongly 
associated with TAC (Table 3).   
After adjustment for BMI in model 2, bouted MVPA displayed significant, independent 
associations with two biomarkers: triglycerides and insulin (Table 4).  However, TAC displayed 
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significant, independent associations with eight biomarkers: HDL, triglycerides, plasma glucose, 
C-peptide, insulin, C-reactive protein, homocysteine, and SBP.  Except for triglycerides, the 
adjusted Wald F statistics for the aforementioned biomarkers were greater for TAC; indicating 
TAC had a stronger association with the biomarkers than MVPA.  In addition, the standardized 
beta coefficient for triglycerides indicated an increase in triglycerides with increasing levels of 
bouted MVPA.  Consistent with previous research, a decrease in triglyceride levels was found 
for increasing TAC.  Thus, it was determined that TAC was more strongly associated with 
triglycerides. 
Discussion 
The current study provides insights into the objective measurement of PA using 
accelerometers, and has implications for epidemiological and public health research.  The major 
finding was that TAC consistently displayed stronger associations with cardiometabolic 
biomarkers than bouted minutes of MVPA.  Specifically, when examining both bouted MVPA 
and TAC simultaneously, several biomarkers were only associated with TAC (i.e., HDL-C, 
glucose, triglycerides, C-peptide, C-reactive protein, homocysteine, SBP, waist circumference, 
triceps skinfolds, and subscapular skinfolds.  In addition, only two biomarkers (i.e., insulin and 
BMI) were found to have to have significant, independent associations with both MVPA and 
TAC.  These results suggest that the total volume of PA, represented by TAC, may be more 
important to cardiometabolic health than MVPA accumulated in bouts of 10 minutes or longer.  
TAC is a marker of the total volume of PA, while bouted MVPA represents only a subset of the 
total volume. 
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Table 4.1: Weighted means, geometric means, and medians of cardiometabolic biomarkers among adults in the 
United States, NHANES 2003 – 2006. 
Biomarker N Mean (SE) Geometric Mean (SE) Median (IQR)  
Total Cholesterol (mg•dL-1) 5484 200.99 (0.64) 196.97 (0.62) 197.37 (172.20 – 224.30) 
HDL-C (mg•dL-1) 5483 54.45 (0.29) 52.30 (0.27) 51.34 (41.89 – 62.97)  
LDL-C (mg•dL-1) 2346 116.78 (0.89) 111.35 (0.86) 114.46 (90.97 – 137.52)  
Triglyceride (mg•dL-1) 2417 145.56 (3.33) 120.87 (1.73) 114.92 (79.46 – 174.33) 
Glycohemoglobin 5501 5.49 (0.02) 5.45 (0.02) 5.29 (5.06 – 5.56)  
Glucose (plasma) 2428 102.45 (0.87) 100.28 (0.67) 96.94 (90.61 – 104.97) 
C-peptide:  SI (nmol•L-1)a 1248 0.83 (0.01) 0.75 (0.01) 0.75 (0.53 – 1.05) 
Insulin (µU•mL-1) 2406 10.59 (0.21) 7.91 (0.16) 7.62 (4.79 – 13.02) 
C-reactive protein (mg•dL-1) 5624 0.41 (0.01) 0.20 (0.001) 0.19 (0.08 – 0.44) 
Homocysteine (µU•mL-1) a 2815 9.16 (0.13) 8.63 (0.10) 8.38 (7.02 – 10.30) 
SBP 5433 123.68 (0.37) 122.41 (0.37) 120.54 (110.58 – 133.1) 
DBP 5433 71.21 (0.15) 70.39 (0.26) 71.28 (63.71 – 78.32) 
BMI 5622 28.30 (0.15) 27.68 (0.14) 27.27 (24.01 – 31.46) 
Waist Circumference (cm) 5519 97.46 (0.35) 96.30 (0.33) 96.32 (86.47 – 106.99) 
Triceps skinfold (mm) 5030 19.49 (0.18) 17.58 (0.17) 18.40 (12.91 – 25.64) 
Subscapular skinfold (mm) 4408 20.17 (0.18) 18.67 (0.17) 14.13 (19.72 – 25.18)  
N = sample size; SE = standard error; IQR = interquartile range; HDL-C = high density lipoprotein cholesterol; LDL-C = 
low density lipoprotein cholesterol; SBP = systolic blood pressure; DBP = diastolic blood pressure; BMI = body mass 
index. 
a Only the NHANES 2003-2004 data were used due to unavailability of 2005-2006 data. 
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Table 4.2:  Age-adjusted linear regressions – Relationship of accelerometer-determined moderate-to-vigorous physical 
activity (minutes per day) with biomarkers and mean daily total activity counts with biomarkers among U.S. adults, 
NHANES 2003 – 2006. 
 MVPA        Mean daily total activity counts   
Biomarker β (SE)  Adj. Wald F β (SE)  Adj. Wald F 
Total Cholesterol (mg•dL-1)   -0.02 (0.04)     0.33  0.000007 (0.000005) 1.98 
HDL (mg•dL-1)    0.15 (0.03)   30.60****  0.000008 (0.000002) 14.62*** 
LDL (mg•dL-1)   -0.01 (0.08)     0.03    0.00002 (0.000008) 5.13* 
Log Triglyceride (mg•dL-1) -0.001 (0.0005) 8.26** -0.0000003 (0.0000001) 16.77*** 
Log Glycohemoglobin (%) -0.0003 (0.00005) 40.98**** -0.00000002 (0.00000000001) 9.62** 
Log Glucose (plasma) -0.00005 (0.0001) 23.61**** -0.00000006 (0.00000001) 14.16*** 
C-peptide:  SI (nmol•L-1)a -0.005 (0.001)   12.33** -0.0000007 (0.0000001) 22.18**** 
Log Insulin (µU•mL-1) -0.005 (0.0006) 52.47**** -0.000001 (0.0000001) 65.23**** 
Log C-reactive protein (mg•L-1) -0.006 (0.0006)   85.06**** -0.0000008 (0.00000008) 102.11**** 
Log Homocysteine (µmol•mL-1) a -0.0004 (0.0002) 6.51* -0.00000003 (0.00000002) 1.21 
SBP   -0.04 (0.01)     8.16** -0.000003 (0.000002)  4.73* 
DBP   -0.01 (0.01)     0.97  0.000002 (0.000002) 0.48 
BMI   -0.08 (0.01)   93.31**** -0.000008 (0.0000007) 108.72**** 
Waist Circumference (cm)   -0.18 (0.02)   66.42****   -0.00002 (0.000002)  57.23**** 
Triceps skinfold (mm)   -0.09 (0.01) 116.55****   -0.00002 (0.000001) 288.44**** 
Subscapular skinfold (mm)   -0.07 (0.01)   52.71**** -0.000008 (0.000001)   45.38**** 
β  = standardized beta. 
 a Only the NHANES 2003-2004 data were used in the analyses.      
* P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.   
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Table 4.3: Simultaneous multiple regressions– relationship of mean daily moderate-to-vigorous physical activity and total 
accelerometer counts with cardiometabolic biomarkers among adults in the United States, NHANES 2003 – 2006. 
 Model 1 Model 2 
Biomarker β (SE)  Adj. Wald F β (SE)  Adj. Wald F 
Total Cholesterol (mg•dL-1)  
 MVPA -0.11 (0.09)    1.41 -0.1 (0.09) 1.11 
 TAC 0.00002 (0.00001)      1.97 0.00002 (0.00001) 2.20 
 HDL-C (mg•dL-1)  
 MVPA 0.02 (0.03)  0.53 -0.007 (0.03) 0.07 
 TAC   0.00002 (0.000004) 14.04*** 0.00001 (0.000004) 11.21** 
LDL-C (mg•dL-1) 
 MVPA  -0.06 (0.1) 0.24 -0.02 (0.13) 0.03 
 TAC  0.00001 (0.00001)  0.74 0.00001 (0.00001) 0.87 
Log Triglyceride (mg•dL-1) 
 MVPA 0.001 (0.0005) 4.88* 0.001 (0.0005) 8.12** 
 TAC  -0.0000003 (0.0000001)  5.48*   -0.0000003 (0.0000001) 4.55* 
Log Glycohemoglobin (%)a 
 MVPA -0.0002 (0.0001) 3.68 -0.0002 (0.0001) 2.36 
 TAC 0.000000007 (0.00000002) 0.13 0.00000001 (0.00000002) 0.36 
Log Glucose (plasma) a 
 MVPA -0.0002 (0.0002)  1.69 -0.00004 (0.0001) 0.13 
 TAC  -0.0000001 (0.00000002) 11.97** -0.00000006 (0.00000002) 15.14*** 
C-peptide:  SI (nmol•L-1)b 
 MVPA 0.0002 (0.001) 0.03 0.002 (0.001) 3.98 
 TAC -0.0000007 (0.0000001) 30.48**** -0.0000007 (0.0000001) 32.47**** 
Log Insulin (µU•mL-1) 
 MVPA 0.0004 (0.0009)  0.27  0.002 (0.0008) 5.71* 
 TAC   -0.0000007 (0.0000001) 35.34**** -0.00000006 (0.0000001) 16.75*** 
Log C-reactive protein (mg•L-1) 
 MVPA -0.001 (0.001) 1.29 0.0001 (0.0009) 0.02 
 TAC -0.0000005 (0.0000001) 28.24**** -0.0000004 (0.0000001) 16.86*** 
Log Homocysteine (µmol•mL-1) b 
 MVPA 0.0002 (0.0003) 0.29 0.0002 (0.0003) 0.37 
 TAC -0.0000001 (0.00000004) 7.48* -0.0000001 (0.00000003)    7.73** 
SBP c  
 MVPA 0.005 (0.02) 0.04 0.02 (0.02) 0.52 
 TAC -0.00001 (0.000004) 6.11* -0.00001 (0.000004) 4.40* 
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Table 4.3: Continued. 
 Model 1 Model 2 
Biomarker β (SE)  Adj. Wald F β (SE)  Adj. Wald F 
DBP c  
 MVPA  0.02 (0.03)     0.61 0.02 (0.02) 1.52 
 TAC -0.000006 (0.000003) 2.73 -0.000004 (0.000004) 1.46 
BMI   
 MVPA   -0.04 (0.01)   7.58**  -- -- 
 TAC -0.000004  (0.000001) 6.95*  -- -- 
Waist Circumference (cm) 
 MVPA -0.06 (0.03)   2.84  -- -- 
 TAC -0.000015 (0.000003) 19.72***  -- -- 
Triceps skinfold (mm) 
  MVPA   -0.01 (0.02) 0.37  -- -- 
 TAC -0.000008 (0.000002) 12.94**  -- -- 
Subscapular skinfold (mm) 
  MVPA   -0.06 (0.02)   1.18  -- -- 
 TAC  -0.000006  (0.000003) 4.49*  -- -- 
MVPA=moderate-to-vigorous physical activity; TAC=total accelerometer counts; β=standardized beta; SE=standard error; HDL-C=high 
density lipoprotein cholesterol; LDL-C=low density lipoprotein cholesterol; SBP=systolic blood pressure; DBP=diastolic blood pressure; 
BMI=body mass index. 
Model 1: adjusted for age, gender, race, education, smoking, general perceived health, diabetes (yes/borderline vs. no), high blood pressure, 
osteoporosis, coronary heart disease, angina & heart attack; Model 2: adjusted for all covariates in model 2 & BMI.   
a
 Model didn’t include diabetes as a covariate.  
b
 Only the NHANES 2003-2004 data were used due to unavailability of 2005-2006 data.  
 c
 Model didn’t include high blood pressure as a covariate. 
--, Not applicable as BMI is in the model; * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001 
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The advantage to using TAC is that it incorporates all intensities and patterns of PA.  
Additionally, TAC is the most direct expression of what the accelerometer measures.  If a 
uniform method of accelerometer data collection were established, TAC could be reported as a 
standardized measure.  This could allow for comparisons to be drawn across studies using waist-
worn ActiGraph accelerometers.  TAC could also complement other measures of PA as it still 
allows reporting of other PA variables (e.g., minutes spent in various intensity categories). 
There are two key strengths of the current study. The first is the sampling design of 
NHANES, which produces a large, nationally representative sample of U.S. citizens.  The second 
is that the use of accelerometers, an objective measure of PA, improves the precision with which 
PA is measured.  It is also important to note there are several limitations of this study.  
Specifically, the use of a uniaxial, hip-worn accelerometer may have failed to capture non-
ambulatory activity including cycling, weight training, and swimming.  Also, the definition of 
MVPA in this study was limited to minutes accumulated in bouts of 10 minutes or longer and 
used a cut-point of ≥ 2020 cpm. This definition, however, is consistent with previous research 
using NHANES accelerometer data5,14.  Another limitation is that accelerometer counts are 
dependent on the characteristics of the specific brand of PA monitor.  Thus, the counts obtained 
from different device brands are not comparable to each other.  However, the ActiGraph is the 
most common accelerometer used in PA research today.  This was reflected in the results of a 
PubMed search (1990 to 2012), which revealed 56% of studies using accelerometers used the 
ActiGraph.  Additionally, the ActiGraph has been shown to have adequate reliability and 
validity9,33-35, providing stable results for acceleration in the vertical axis across multiple 
generations of the device34,36-38.   
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In summary, the results of this study suggest that TAC is more strongly associated with 
cardiometabolic biomarkers than MVPA accumulated in ≥ 10 minute bouts.   More importantly, 
TAC remained more strongly associated with biomarkers after adjustment for BMI.  In contrast, 
bouted MVPA only displayed stronger associations with one biomarker (i.e., BMI).  Future 
studies are needed to examine the extent to which TAC is associated with chronic diseases.    
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PART V 
 
WAIST-WORN ACTIGRAPHY: POPULATION-REFERENCED PERCENTILES FOR 
TOTAL ACTIVITY COUNTS IN U.S. ADULTS 
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Physical Activity and Health in 2014 by Dana L. Wolff, Eugene C. Fitzhugh, David R. Bassett, 
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Wolff DL, Fitzhugh EC, Bassett DR, Churilla JR (In Press). Waist-worn Actigraphy: Population-
referenced standards for total activity counts in U.S. adults. J Phys Act Health.  
 
 
Abstract 
BACKGROUND:  Accelerometer-derived total activity counts is a measure of total physical 
activity (PA) volume.  The purpose of this study was to develop age- and gender-specific 
percentiles for daily total activity counts (TAC), minutes of moderate-to-vigorous physical 
activity (MVPA), and minutes of light physical activity (LPA) in U.S. adults.   METHODS: 
Waist-worn accelerometer data from the 2003 – 2006 NHANES were used for this analysis.  The 
sample included adults ≥ 20 y with ≥ 10 h accelerometer wear time on ≥ 4 d (N = 6093).  MVPA 
and LPA were defined as the number of one-min epochs with counts ≥ 2020 and 100 – 2019, 
respectively.  TAC represented the activity counts acquired daily.  TAC, MVPA, and LPA were 
averaged across valid days to produce a daily mean.  RESULTS: Males in the 50th percentile 
accumulated 288,140 TAC/day, with 357 and 22 min/d spent in LPA and MVPA, respectively.  
The median for females was 235,741 TAC/d, with 349 and 12 min/d spent in LPA and MVPA, 
respectively.  CONCLUSIONS: Population-referenced TAC percentiles reflect the total volume 
of PA, expressed relative to other adults.  This is a different approach to accelerometer data 
reduction that complements the current method of looking at time spent in intensity sub-
categories.    
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Introduction 
Over the past two decades, the assessment of physical activity (PA) in research studies 
has shifted towards an increased use of objective monitors.  In particular, waist-mounted 
accelerometers have gained acceptance with researchers as they provide reliable estimates of PA 
and can record both the amount and intensity of an individual’s ambulatory movement2-4.  
Although these devices capture the intensity of activity, their ability to accurately identify the 
number of minutes spent in light, moderate, and vigorous intensity categories has been 
problematic5-7. 
One way to circumvent these inaccuracies is to use the accelerometer-derived total 
activity counts per day (TAC), which is a more direct expression of what the monitor records.  
More importantly, TAC is a measure of the total PA volume, and it incorporates all intensity 
categories, weighting each minute according to the intensity of the movement.  Preliminary 
research by Wolff and colleagues8 shows the importance of a global, objective measure of PA 
such as TAC.  Using accelerometer data obtained from the 2003 – 2006 National Health and 
Nutrition Examination Survey (NHANES), they found that TAC had more robust associations 
with cardiometabolic biomarkers (i.e., blood pressure, body mass index, cholesterol, etc.) than 
accelerometer-derived minutes spent in moderate-to-vigorous physical activity per day 
(MVPA)8.   
Intervention studies in adults and children have also begun to quantify PA using TAC9-14.  
For example, in a 12-month randomized-controlled trial, men in the treatment arm of a PA 
intervention had a 15% greater increase in TAC than participants in the control group10.  
Additionally, no association was found between the change in MVPA and the change in two-
hour insulin levels, but a significant inverse association was demonstrated between the change in 
  
94 
 
TAC and the change in two-hour insulin levels.  The results of this study provide further support 
for using TAC as a measure of PA.   
TAC is a PA outcome measure that could provide a standardized measure of 
accelerometer-derived PA and allow for comparisons between studies.  Thus, the main purpose 
of this study was to develop age- and gender-specific percentiles for TAC, MVPA, and minutes 
of light-intensity physical activity per day (LPA) in U.S. adults.  A secondary purpose of this 
study was to compare the age-related decline in activity across percentiles of TAC, MVPA, and 
LPA. 
Methods 
The present study used data from the 2003 – 2006 National Health and Nutrition 
Examination Survey (NHANES).  Data collected through NHANES are representative of the 
non-institutionalized U.S. population.  Participants are selected using a complex, multistage 
probability design15.  Each participant completes both an in-person home interview and a visit to 
a mobile examination center (MEC).  Participant’s demographic, socioeconomic, and health-
related information are obtained during the interview, with the examination consisting of various 
medical and laboratory tests and measurements.   
For this study, the sample was limited to adults 20 years and older with accelerometer 
data (N = 8228).  Participants with less than four days that included ≥ 10 hours of wear time (n = 
2135), were excluded from the analysis, resulting in the final sample (N = 6093).  The original 
survey protocols were approved by National Center for Health Statistics ethics review board, and 
informed consent was obtained from all NHANES participants. The University of Tennessee 
institutional review board approved the use of NHANES data in this analysis.  
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Accelerometer data collection and analysis 
All ambulatory individuals examined in the MEC were eligible participants for the 
accelerometer component.  Eligible participants were instructed to wear an ActiGraph model 
7164 accelerometer on their right hip during waking hours for seven days, and to remove it when 
swimming or bathing16.  Details of the accelerometer protocol can be found on the Centers for 
Disease Control and Prevention (CDC) website17.  The ActiGraph model 7164 is a uniaxial 
accelerometer measuring vertical acceleration in one-minute epochs.  Vertical accelerations are 
filtered, full-wave rectified, and integrated over time18, resulting in “activity counts per minute” 
that correspond to the intensity of ambulatory activity19. 
Accelerometer data were analyzed using the SAS macro provided by the National Cancer 
Institute website20.  Non-wear time was defined as ≥ 60 consecutive minutes with zero 
accelerometer counts, allowing up to two minutes with limited movement (< 100 counts/min).  
Daily wear time was determined by subtracting non-wear time from 24 hours.   A valid day was 
defined as a day with 10 or more hours of monitor wear21.  Only participants with at least four 
valid days of monitor wear time were eligible to be included in this analysis.  The TAC variable 
was created by averaging the total counts per day across all valid days.   Using thresholds 
described by Troiano16, LPA was defined as the total number of minutes with 100 – 2019 
counts/min, while MVPA was defined the total number of minutes with ≥ 2020 counts/min. LPA 
and MVPA were averaged across all valid days.  
Statistical Analysis 
Descriptive analyses were conducted using SAS 9.2 (SAS Institute, Inc., Cary, NC) and 
SAS-callable SUDAAN 11.0 (Research Triangle Park, NC) and accounted for the complex 
sampling design using sample weights calculated according to NHANES analytical guidelines15.  
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Age-adjusted prevalence estimates and weighted means were calculated for all variables utilized 
in this study.   
Smoothed, sex- and age-specific percentile curves corresponding to the 5th, 10th, 25th, 
50th, 75th, 90th, 95th, and 97th were calculated using the LMS method.   The LMS method is a 
statistical approach that normalizes a measure (i.e., TAC, MVPA, or LPA) across age using a 
Box–Cox power transformation22.  The LMS parameters are skewness (L: Box–Cox power), 
median (M), and coefficient of variation (S).  At each age, penalized likelihood is used to fit the 
L, M, and S parameters as cubic splines22.  Models that minimize the deviance and provide good 
fit for the LMS parameters are selected to achieve smooth curves.  In the present analysis, LMS 
curves were generated using LMS ChartmakerPro (LMS Chartmaker version 2.54) software, 
which adjusts for NHANES sample weights.   
Results 
Demographic characteristics of the 6093 adults included in this analysis are presented in 
Table 1.  The average age of participants was 48.3 (SE = 0.4) years and age-adjusted prevalence 
estimates indicated the sample consisted of 51.5% females, 73.1% Non-Hispanic Whites, and 
84.3% having attained a high school education/GED or greater.  As shown by the 50th percentile 
or median, males accumulated 282,476 TAC per day, with approximately 352 minutes per day 
spent in LPA and 22 minutes per day spent in MVPA.  Females in the 50th percentile 
accumulated 234,322 TAC per day, with approximately 351 minutes per day spent in LPA and 
12 minutes per day spent in MVPA.  For tables including percentile values please see the 
supplemental content (Tables 4.2 – 4.7).    
Figure 1 presents age- and gender-specific TAC percentiles.  Across all ages, TAC was 
consistently higher in males than females.  For males at or above the 50th percentile, the highest 
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levels of TAC were seen at age 20, with TAC then declining with increasing age.  In females 
above the 50th percentile, TAC peaked between 38 to 41 years of age before a steady decline was 
seen with increasing age. 
 
 
 
Table 5.1: Characteristics of Study Population 
Variable % (SE)  
Age in years (  ± SE) 48.3 ± 0.4 
Gender 
 Female 51.5 (0.7) 
 Male 48.5 (0.7) 
Race/ethnicity 
 Non-Hispanic White 73.1 (2.1)  
 Non-Hispanic Black 9.8 (1.2) 
 Mexican American 8.2 (1.1) 
 Other 8.9 (0.5) 
Education Level 
 < HS 15.7 (0.6) 
 HS Degree/GED  25.4 (0.8) 
 Some College or AA 32.1 (0.9) 
 ≥ College Degree 26.8 (1.5) 
Note:  Prevalence estimates are age-adjusted.  
SE: Standard Error; HS: High School; GED: General 
Equivalency Degree; AA: Associate of Arts. 
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Figure 5.1:  Percentiles of daily total activity counts for males (A) and females (B), 20+ 
years of age: 2003 – 2006 National Health and Nutrition Examination Survey.     
Note: Data obtained with waist-worn accelerometer (ActiGraph 7164). 
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Age- and gender-specific percentiles for MVPA are displayed in Figure 2.  MVPA was 
consistently higher in males than females and was highest at 20 years of age.  An exception was 
seen for females in the 95th and 97th percentiles, where the highest levels of MVPA were seen at 
age 42 and 54, respectively.  Age-related declines were also seen in both genders.  Specifically, 
90%  of males between 20 to 42 years of age accumulated 10 minutes or more of MVPA per day 
compared to less than 10% of males 85 years of age and older.  Similarly, 75% of females 
between 20 to 36 years of age accumulated 10 minutes or more of MVPA per day compared to 
less than 5% of those 85+ years of age.      
LPA percentiles specific to age and gender are presented in Figure 3.  For males, LPA 
peaked between 35 to 40 years of age.    In females, LPA peaked between the ages of 45 and 51 
years of age, before beginning to decline.  Additionally, in the 5th and 10th percentiles females 
acquired greater amounts of LPA compared to males.  Between the 25th and 50th percentiles 
males in their mid to late forty’s or younger accumulated higher levels of LPA than females.  
Figure 4 compares the percent change in TAC, LPA, and MVPA with increasing age for 
the 50th percentile of U.S. adults.  In males, TAC began a steady decline at age 35, with a 73% 
decrease seen by age 85.  In females, a decline in TAC began at age 40, resulting in a 66% 
decrease by age 85.  Minutes spent in LPA increased in females through age 50 and males 
through age 40.  The decline in LPA after the aforementioned ages resulted in a decrease of 37% 
in males and 33% in females by the time individuals reached 85 years of age. The magnitude of 
the change in MVPA with increasing age was the highest of the three PA measures, with a 95% 
and 92% decrease in MVPA seen between 20 and 85 years of age, in males and females, 
respectively. 
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Figure 5.2: Percentiles of daily minutes of moderate to vigorous physical activity for 
males (A) and females (B), 20+ years of age: 2003 – 2006 National Health and Nutrition 
Examination Survey.     
Note: Data obtained with waist-worn accelerometer (ActiGraph 7164). 
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Figure 5.3: Percentiles of daily minutes of light physical activity for males (A) and 
females (B), 20+ years of age: 2003 – 2006 National Health and Nutrition Examination 
Survey.     
Note: Data obtained with waist-worn accelerometer (ActiGraph 7164). 
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Figure 5.4: Relationship of accelerometer-derived physical activity levels and age, for males (A) 
and females (B) 20+ years of age in the 50th percentile:  2003 – 2006 National Health and 
Nutrition Examination Survey. 
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Discussion 
This study is the first to report population-referenced data for TAC in U.S. adults.  These 
percentiles provide researchers with a measure of the total volume of PA that can be expressed 
relative to others of the same age and gender (i.e., as percentiles).   Furthermore, these results 
provide insights into how the intensity and volume of PA changes throughout adulthood. 
Consistent with previous research, our results indicate TAC, LPA, and MVPA levels 
were higher in males than females16,23.  A dramatic decline in MVPA was seen in individuals 
older than 20 - 29 years of age.  However, LPA remained relatively stable until age 50 - 59 years, 
and only declined in older age groups.  The age-related decline in LPA was much less 
pronounced than the decline in MVPA.  As a result, the age-related decline in TAC was modest, 
since this metric incorporates both LPA and MVPA.   
Our results indicate that while there is a modest age-related decline in the total volume of 
PA (i.e., TAC), LPA remains fairly stable over much of the adult lifespan.   However, the 
standard cut-point for MVPA (i.e., 2020 counts/min) gives the impression that older adults 
perform little to no MVPA in one-minute bouts.  This finding is consistent with previous 
research indicating that the use of cut-point methods can result in misclassification of time spent 
in different intensities, particularly in older adults24.  In fact, the 2008 national PA 
recommendations state that relative intensity, rather than absolute intensity, should be used for 
older adults and individuals with impaired functional capacities25-27.  Thus, a limitation of the 
current study, and most other accelerometer studies, is that an absolute cut-point was used to 
define the lower bounds of MVPA. 
TAC is a useful metric because it captures all PA performed, regardless of the intensity, 
frequency, or duration of the activities. This is important because previous research has 
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demonstrated that both LPA28 and MVPA accumulated in bouts less than 10 minutes29 are 
associated with health benefits.  TAC is simple to calculate and can easily be converted to age 
and gender specific percentiles.  Additionally, this measure allows for standardization of PA for 
studies using waist-worn ActiGraph accelerometers and it still allows researchers to report other 
measures of PA (e.g., minutes spent in various intensity categories). Hence, TAC complements, 
rather than replaces, other PA variables. 
A potential criticism of TAC is that it has no intuitive meaning.  However, when Quetelet 
first proposed the index that later became known as body mass index (BMI)30,31, that metric had 
no intuitive meaning either.  BMI gained acceptance with the development of population 
reference data, and eventually criterion-referenced standards were developed that gave meaning 
to the units.  Thus, we believe the same thing could apply to TAC if it were to be used as a 
standardized measure of accelerometer-derived PA. 
This paper describes population-referenced TAC percentiles, for the U.S. adult 
population.  These percentiles can provide PA and public health researchers with a measure of 
the total volume of PA, allowing comparisons to be made at the individual and population levels.  
Future research should explore the use of TAC in establishing criterion-based standards for PA.  
Towards this end, we are currently conducting follow-up studies exploring the relationships of 
TAC with various health indicators.   
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Table 5.2: Percentiles for Waist-Worn Accelerometer-Derived Total Activity Counts in US Males (N=3002).   
 Percentiles  
 Age L M S 5 10 25 50 75 90 95 97 
20 0.32 345920 0.45 148253 182516 251151 345920 462459 587941 673129 732725 
21 0.32 346218 0.45 149988 184115 252309 346218 461435 585269 669238 727943 
22 0.32 346497 0.44 151666 185656 253420 346497 460444 582698 665502 723354 
23 0.32 346741 0.44 153263 187118 254462 346741 459474 580224 661920 718964 
24 0.32 346918 0.43 154754 188473 255408 346918 458491 577811 658457 714734 
25 0.32 347018 0.43 156128 189711 256247 347018 457487 575455 655108 710663 
26 0.32 347046 0.42 157380 190827 256977 347046 456472 573166 651889 706767 
27 0.32 347000 0.42 158505 191819 257598 347000 455447 570951 648807 703055 
28 0.32 346862 0.42 159488 192670 258092 346862 454389 568782 645832 699495 
29 0.32 346609 0.42 160315 193365 258439 346609 453270 566627 642926 696046 
30 0.32 346217 0.41 160977 193892 258625 346217 452060 564442 640040 692654 
31 0.32 345666 0.41 161462 194239 258632 345666 450728 562193 637133 689273 
32 0.32 344935 0.41 161761 194394 258447 344935 449247 559838 634157 685852 
33 0.32 344006 0.41 161866 194348 258056 344006 447594 557353 631084 682358 
34 0.32 342865 0.41 161769 194090 257447 342865 445750 554713 627886 678762 
35 0.32 341505 0.40 161465 193618 256615 341505 443706 551904 624546 675046 
36 0.32 339923 0.40 160955 192931 255560 339923 441458 548922 621058 671203 
37 0.32 338115 0.40 160236 192026 254278 338115 438998 545756 617411 667217 
38 0.32 336083 0.40 159311 190905 252771 336083 436329 542408 613606 663094 
39 0.32 333826 0.40 158179 189569 251039 333826 433448 538875 609638 658825 
40 0.32 331335 0.40 156842 188016 249078 331335 430342 535137 605483 654384 
41 0.32 328611 0.41 155305 186252 246891 328611 427006 531181 601126 649752 
42 0.32 325664 0.41 153580 184288 244490 325664 423447 527015 596569 644931 
43 0.32 322507 0.41 151679 182139 241888 322507 419679 522648 591822 639929 
44 0.32 319149 0.41 149615 179815 239097 319149 415707 518084 586886 634744 
45 0.32 315593 0.41 147397 177324 236121 315593 411530 513315 581748 629361 
46 0.32 311837 0.41 145031 174674 232966 311837 407136 508320 576381 623750 
47 0.32 307875 0.41 142527 171869 229630 307875 402511 503071 570750 617866 
48 0.32 303698 0.42 139891 168915 226116 303698 397635 497540 564817 611668 
49 0.32 299309 0.42 137131 165820 222428 299309 392505 491716 558566 605137 
50 0.32 294720 0.42 134261 162597 218581 294720 387133 485606 552003 598274 
51 0.32 289949 0.43 131296 159262 214590 289949 381534 479226 545142 591096 
52 0.32 285015 0.43 128253 155833 210474 285015 375729 472597 538003 583620 
53 0.32 279937 0.43 125146 152325 206252 279937 369735 465734 530601 575861 
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Table 5.2: Continued   
 Percentiles  
 Age L M S 5 10 25 50 75 90 95 97 
54 0.32 274730 0.43 121990 148754 201937 274730 363569 458653 522950 567833 
55 0.32 269409 0.44 118797 145132 197546 269409 357245 451367 515063 559546 
56 0.32 263989 0.44 115579 141472 193091 263989 350779 443892 506957 551018 
57 0.32 258487 0.44 112347 137787 188588 258487 344188 436248 498649 542267 
58 0.32 252920 0.45 109112 134090 184050 252920 337493 428455 490163 533315 
59 0.32 247303 0.45 105885 130391 179491 247303 330710 420531 481516 524183 
60 0.32 241648 0.46 102675 126701 174923 241648 323851 412490 472723 514884 
61 0.32 235964 0.46 99487 123026 170353 235964 316928 404343 463794 505428 
62 0.32 230262 0.46 96329 119373 165789 230262 309951 396102 454744 495829 
63 0.32 224548 0.47 93203 115748 161239 224548 302930 387778 445581 486099 
64 0.32 218831 0.47 90116 112156 156708 218831 295871 379376 436313 476242 
65 0.32 213111 0.47 87068 108598 152197 213111 288778 370900 426941 466261 
66 0.32 207393 0.48 84062 105077 147712 207393 281652 362351 417468 456158 
67 0.32 201679 0.48 81100 101596 143253 201679 274497 353733 407895 445933 
68 0.32 195973 0.48 78183 98156 138823 195973 267317 345050 398229 435593 
69 0.32 190278 0.49 75313 94759 134426 190278 260117 336306 388473 425143 
70 0.32 184598 0.49 72490 91407 130063 184598 252900 327508 378633 414589 
71 0.32 178935 0.49 69717 88101 125738 178935 245671 318660 368717 403937 
72 0.32 173295 0.50 66994 84843 121452 173295 238437 309771 358733 393198 
73 0.32 167680 0.50 64321 81634 117208 167680 231201 300846 348687 382378 
74 0.32 162093 0.51 61698 78475 113006 162093 223967 291891 338586 371484 
75 0.32 156537 0.51 59127 75366 108850 156537 216741 282912 328437 360526 
76 0.32 151014 0.51 56607 72308 104739 151014 209526 273915 318249 349511 
77 0.32 145527 0.52 54137 69300 100676 145527 202327 264905 308026 338445 
78 0.32 140076 0.52 51717 66343 96659 140076 195143 255885 297771 327332 
79 0.32 134661 0.52 49346 63435 92689 134661 187976 246854 287486 316174 
80 0.32 129282 0.53 47023 60576 88765 129282 180827 237816 277173 304972 
81 0.32 123940 0.53 44748 57765 84887 123940 173696 228771 266833 293730 
82 0.32 118634 0.53 42518 55001 81054 118634 166585 219721 256471 282449 
83 0.32 113367 0.53 40335 52285 77267 113367 159496 210671 246090 271138 
84 0.32 108140 0.54 38197 49615 73527 108140 152433 201626 235698 259802 
85+ 0.32 102955 0.54 36105 46993 69834 102955 145400 192592 225301 248450 
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Table 5.3 Percentiles for Waist-Worn Accelerometer-Derived Total Activity Counts in U.S. Females (N=3091).   
 Percentiles  
Age L M S 5 10 25 50 75 90 95 97 
20 0.17 259903 0.34 144810 165610 205895 259903 325218 395166 442712 476069 
21 0.17 260403 0.34 144633 165532 206041 260403 326210 396746 444720 478389 
22 0.17 260898 0.34 144459 165454 206185 260898 327194 398313 446713 480693 
23 0.17 261394 0.34 144289 165381 206331 261394 328175 399876 448701 482991 
24 0.17 261887 0.35 144123 165310 206478 261887 329151 401429 450677 485275 
25 0.17 262366 0.35 143954 165235 206617 262366 330107 402957 452622 487526 
26 0.17 262821 0.35 143775 165147 206737 262821 331030 404443 454520 489726 
27 0.17 263245 0.35 143581 165040 206834 263245 331916 405884 456369 491874 
28 0.17 263635 0.35 143366 164910 206902 263635 332760 407278 458167 493967 
29 0.17 263982 0.35 143125 164752 206936 263982 333553 408613 459902 495996 
30 0.17 264274 0.36 142851 164555 206924 264274 334282 409874 461556 497940 
31 0.17 264497 0.36 142533 164309 206853 264497 334929 411043 463112 499781 
32 0.17 264641 0.36 142163 164006 206716 264641 335485 412109 464558 501508 
33 0.17 264696 0.36 141736 163639 206502 264696 335938 413060 465883 503108 
34 0.17 264649 0.36 141242 163198 206202 264649 336274 413879 467066 504563 
35 0.17 264492 0.36 140677 162679 205810 264492 336482 414554 468095 505856 
36 0.17 264217 0.37 140036 162074 205317 264217 336552 415073 468958 506977 
37 0.17 263810 0.37 139309 161374 204712 263810 336469 415419 469636 507904 
38 0.17 263254 0.37 138487 160569 203982 263254 336211 415567 470102 508611 
39 0.17 262529 0.37 137561 159647 203111 262529 335755 415486 470320 509057 
40 0.17 261620 0.37 136522 158598 202089 261620 335077 415149 470259 509210 
41 0.17 260514 0.38 135367 157416 200905 260514 334163 414535 469897 509044 
42 0.17 259207 0.38 134092 156101 199558 259207 333007 413637 469223 508548 
43 0.17 257699 0.38 132699 154650 198047 257699 331606 412453 468237 507721 
44 0.17 255993 0.38 131191 153069 196375 255993 329965 410987 466940 506567 
45 0.17 254094 0.39 129573 151362 194548 254094 328090 409244 465342 505092 
46 0.17 252010 0.39 127849 149534 192571 252010 325987 407233 463447 503303 
47 0.17 249744 0.39 126025 147590 190450 249744 323661 404956 461260 501202 
48 0.17 247302 0.40 124105 145536 188190 247302 321116 402415 458780 498789 
49 0.17 244689 0.40 122097 143378 185797 244689 318355 399613 456009 496065 
50 0.17 241915 0.40 120009 141126 183281 241915 315389 396560 452956 493039 
51 0.17 238990 0.41 117849 138786 180650 238990 312228 393267 449633 489721 
52 0.17 235923 0.41 115622 136367 177913 235923 308882 389743 446049 486121 
53 0.17 232721 0.41 113337 133876 175078 232721 305357 385993 442208 482242 
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Table 5.3: Continued.   
 Percentiles  
Age L M S 5 10 25 50 75 90 95 97 
54 0.17 229389 0.42 111000 131319 172149 229389 301657 382018 438107 478079 
55 0.17 225935 0.42 108617 128704 169136 225935 297787 377823 433751 473637 
56 0.17 222368 0.42 106196 126038 166047 222368 293759 373418 429150 468924 
57 0.17 218697 0.43 103743 123328 162888 218697 289580 368812 424313 463950 
58 0.17 214930 0.43 101265 120582 159669 214930 285261 364014 419247 458722 
59 0.17 211076 0.43 98769 117806 156398 211076 280809 359032 413961 453248 
60 0.17 207142 0.44 96260 115007 153081 207142 276233 353873 408461 447532 
61 0.17 203133 0.44 93741 112189 149722 203133 271535 348539 402748 441577 
62 0.17 199052 0.44 91216 109353 146324 199052 266719 343035 396827 435385 
63 0.17 194902 0.45 88687 106505 142892 194902 261791 337365 390701 428961 
64 0.17 190688 0.45 86157 103645 139428 190688 256752 331530 384371 422303 
65 0.17 186413 0.46 83627 100778 135936 186413 251606 325533 377838 415415 
66 0.17 182080 0.46 81102 97906 132418 182080 246357 319377 371107 408297 
67 0.17 177694 0.46 78584 95033 128879 177694 241008 313066 364179 400954 
68 0.17 173257 0.47 76074 92160 125322 173257 235563 306603 357058 393385 
69 0.17 168772 0.47 73575 89290 121748 168772 230024 299990 349745 385595 
70 0.17 164243 0.47 71089 86425 118161 164243 224396 293231 342243 377584 
71 0.17 159674 0.48 68617 83568 114564 159674 218681 286330 334556 369357 
72 0.17 155068 0.48 66163 80721 110961 155068 212887 279293 326692 360921 
73 0.17 150431 0.49 63728 77887 107354 150431 207019 272127 318658 352285 
74 0.17 145768 0.49 61314 75068 103748 145768 201082 264840 310462 343455 
75 0.17 141083 0.49 58924 72268 100147 141083 195085 257440 302113 334443 
76 0.17 136384 0.50 56559 69490 96554 136384 189035 249938 293625 325264 
77 0.17 131676 0.50 54223 66736 92975 131676 182941 242346 285010 315930 
78 0.17 126966 0.50 51916 64009 89413 126966 176813 234675 276281 306456 
79 0.17 122256 0.51 49641 61310 85871 122256 170653 226930 267445 296849 
80 0.17 117549 0.51 47397 58640 82348 117549 164465 219115 258506 287114 
81 0.17 112844 0.52 45183 55998 78846 112844 158249 211232 249466 277254 
82 0.17 108141 0.52 42999 53383 75364 108141 152006 203280 240325 267266 
83 0.17 103441 0.52 40844 50797 71901 103441 145736 195259 231082 257152 
84 0.17 98746 0.53 38720 48238 68460 98746 139442 187175 221743 246918 
85+ 0.17 94061 0.53 36628 45710 65043 94061 133131 179035 212318 236573 
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Table 5.4: Percentiles for Waist-Worn Accelerometer-Derived Minutes of Moderate-to-Vigorous Physical Activity in U.S. Males (N=3002) 
 Percentiles  
Age L M S  5 10 25 50 75 90 95 97 
20 0.35 37 0.74 8 12 21 37 58 83 100 113 
21 0.35 36 0.73 8 12 21 36 57 82 99 112 
22 0.35 36 0.73 8 12 21 36 57 81 99 111 
23 0.35 36 0.73 8 12 21 36 57 81 98 110 
24 0.35 36 0.73 8 12 21 36 56 80 97 110 
25 0.35 36 0.72 8 12 21 36 56 80 96 109 
26 0.34 35 0.72 8 12 21 35 55 79 96 108 
27 0.34 35 0.72 8 12 21 35 55 78 95 107 
28 0.34 35 0.72 8 12 20 35 54 78 94 106 
29 0.34 35 0.72 8 11 20 35 54 77 93 105 
30 0.34 34 0.71 8 11 20 34 54 76 92 104 
31 0.33 34 0.71 8 11 20 34 53 75 91 103 
32 0.33 34 0.71 8 11 20 34 52 75 90 102 
33 0.33 33 0.71 8 11 20 33 52 74 89 101 
34 0.33 33 0.71 8 11 20 33 51 73 89 100 
35 0.33 33 0.71 7 11 19 33 51 72 88 99 
36 0.32 32 0.71 7 11 19 32 50 72 87 98 
37 0.32 32 0.71 7 11 19 32 50 71 86 97 
38 0.32 31 0.71 7 11 19 31 49 70 85 96 
39 0.32 31 0.72 7 10 18 31 49 69 84 95 
40 0.31 31 0.72 7 10 18 31 48 69 84 94 
41 0.31 30 0.73 7 10 18 30 47 68 83 94 
42 0.31 30 0.73 7 10 17 30 47 67 82 93 
43 0.30 29 0.74 6 9 17 29 46 67 82 92 
44 0.30 28 0.75 6 9 16 28 45 66 81 92 
45 0.30 28 0.76 6 9 16 28 45 65 80 91 
46 0.29 27 0.76 6 9 16 27 44 64 79 90 
47 0.29 27 0.77 5 8 15 27 43 64 79 89 
48 0.29 26 0.79 5 8 15 26 42 63 78 89 
49 0.28 25 0.80 5 8 14 25 41 62 77 88 
50 0.28 24 0.81 5 7 13 24 40 61 75 87 
51 0.27 24 0.82 4 7 13 24 39 59 74 85 
52 0.27 23 0.83 4 6 12 23 38 58 73 84 
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Table 5.4 Continued. 
 Percentiles  
Age L M S  5 10 25 50 75 90 95 97 
53 0.26 22 0.85 4 6 12 22 37 57 72 83 
54 0.25 21 0.86 4 6 11 21 36 56 71 82 
55 0.25 20 0.88 3 5 11 20 35 54 69 81 
56 0.24 19 0.90 3 5 10 19 34 53 68 79 
57 0.23 18 0.92 3 5 9 18 33 52 67 78 
58 0.22 17 0.94 3 4 9 17 31 50 66 77 
59 0.21 16 0.96 2 4 8 16 30 49 64 76 
60 0.20 16 0.98 2 4 8 16 29 48 63 75 
61 0.19 15 1.00 2 3 7 15 28 46 62 73 
62 0.18 14 1.02 2 3 7 14 26 45 60 72 
63 0.16 13 1.04 2 3 6 13 25 43 59 71 
64 0.15 12 1.06 2 3 6 12 24 42 57 70 
65 0.13 11 1.08 2 2 5 11 23 40 56 68 
66 0.12 11 1.09 1 2 5 11 22 39 54 67 
67 0.10 10 1.10 1 2 5 10 20 37 52 65 
68 0.08 9 1.11 1 2 4 9 19 35 51 64 
69 0.07 9 1.12 1 2 4 9 18 34 49 62 
70 0.05 8 1.13 1 2 4 8 17 32 47 60 
71 0.03 7 1.14 1 2 3 7 16 30 45 58 
72 0.01 7 1.14 1 2 3 7 15 29 43 57 
73 -0.02 6 1.14 1 1 3 6 13 27 41 55 
74 -0.04 6 1.13 1 1 3 6 12 25 40 53 
75 -0.06 5 1.13 1 1 3 5 11 24 38 51 
76 -0.08 5 1.12 1 1 2 5 11 22 36 49 
77 -0.11 4 1.11 1 1 2 4 10 21 34 47 
78 -0.13 4 1.09 1 1 2 4 9 19 32 45 
79 -0.16 4 1.07 1 1 2 4 8 18 30 43 
80 -0.18 4 1.05 1 1 2 4 8 17 28 41 
81 -0.21 3 1.03 1 1 2 3 7 15 26 39 
82 -0.23 3 1.01 1 1 2 3 6 14 24 36 
83 -0.26 3 0.98 1 1 1 3 5 12 21 33 
84 -0.29 2 0.95 1 1 1 2 5 10 19 29 
85+ -0.32 2 0.93 1 1 1 2 4 9 16 25 
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Table 5.5: Percentiles for Waist-Worn Accelerometer-Derived Minutes of Moderate-to-Vigorous Physical Activity in U.S. Females (N=3091)  
  Percentiles  
Age L M S 5 10 25 50 75 90 95 97 
20 0.32 19.20 0.75 4 6 11 19 31 44 54 62 
21 0.31 19.15 0.75 4 6 11 19 31 44 54 62 
22 0.31 19.08 0.75 4 6 11 19 31 44 54 62 
23 0.31 19.01 0.76 4 6 11 19 31 44 55 62 
24 0.31 18.94 0.76 4 6 11 19 30 44 55 62 
25 0.31 18.85 0.76 4 6 11 19 30 44 55 62 
26 0.30 18.76 0.77 4 6 11 19 30 44 55 62 
27 0.30 18.65 0.77 4 6 11 19 30 44 55 62 
28 0.30 18.54 0.77 4 6 11 19 30 44 55 62 
29 0.29 18.42 0.78 4 6 10 18 30 44 55 62 
30 0.29 18.29 0.78 4 6 10 18 30 44 55 62 
31 0.29 18.15 0.79 4 6 10 18 30 44 55 62 
32 0.28 18.00 0.79 4 5 10 18 30 44 55 62 
33 0.28 17.84 0.80 3 5 10 18 29 44 55 63 
34 0.27 17.67 0.80 3 5 10 18 29 44 55 63 
35 0.27 17.48 0.81 3 5 10 17 29 44 55 63 
36 0.26 17.28 0.82 3 5 10 17 29 44 55 63 
37 0.26 17.08 0.82 3 5 9 17 29 43 55 63 
38 0.25 16.86 0.83 3 5 9 17 28 43 55 63 
39 0.25 16.62 0.84 3 5 9 17 28 43 55 63 
40 0.24 16.37 0.85 3 5 9 16 28 43 55 63 
41 0.23 16.11 0.86 3 5 9 16 28 43 55 63 
42 0.23 15.83 0.87 3 4 8 16 27 43 55 63 
43 0.22 15.54 0.88 3 4 8 16 27 42 54 64 
44 0.21 15.24 0.89 3 4 8 15 27 42 54 64 
45 0.20 14.91 0.90 3 4 8 15 26 42 54 64 
46 0.19 14.57 0.91 3 4 8 15 26 42 54 64 
47 0.18 14.22 0.92 2 4 7 14 26 41 54 64 
48 0.17 13.85 0.93 2 4 7 14 25 41 54 64 
49 0.16 13.46 0.94 2 4 7 13 25 41 54 64 
50 0.15 13.06 0.95 2 3 7 13 24 40 53 64 
51 0.14 12.65 0.97 2 3 6 13 24 40 53 64 
52 0.13 12.22 0.98 2 3 6 12 23 39 53 64 
  
112 
 
Table 5.5: Continued  
  Percentiles  
Age L M S 5 10 25 50 75 90 95 97 
53 0.12 11.78 0.99 2 3 6 12 22 39 52 64 
54 0.10 11.32 1.00 2 3 6 11 22 38 52 64 
55 0.09 10.86 1.02 2 3 5 11 21 37 52 63 
56 0.08 10.39 1.03 2 3 5 10 20 37 51 63 
57 0.06 9.92 1.04 2 2 5 10 20 36 51 63 
58 0.05 9.44 1.05 2 2 5 9 19 35 50 63 
59 0.03 8.97 1.07 1 2 4 9 18 34 49 62 
60 0.02 8.49 1.08 1 2 4 8 17 33 49 62 
61 0.00 8.02 1.09 1 2 4 8 17 32 48 62 
62 -0.02 7.56 1.10 1 2 4 8 16 31 47 61 
63 -0.03 7.11 1.10 1 2 3 7 15 30 46 61 
64 -0.05 6.66 1.11 1 2 3 7 14 29 45 61 
65 -0.07 6.23 1.11 1 2 3 6 13 28 44 60 
66 -0.09 5.82 1.12 1 2 3 6 13 27 43 60 
67 -0.11 5.43 1.12 1 1 3 5 12 26 42 59 
68 -0.13 5.05 1.12 1 1 2 5 11 25 41 59 
69 -0.15 4.70 1.11 1 1 2 5 10 23 40 58 
70 -0.17 4.37 1.11 1 1 2 4 10 22 39 58 
71 -0.20 4.06 1.10 1 1 2 4 9 21 38 57 
72 -0.22 3.77 1.08 1 1 2 4 8 20 36 56 
73 -0.24 3.50 1.07 1 1 2 3 8 18 35 55 
74 -0.27 3.25 1.05 1 1 2 3 7 17 33 54 
75 -0.29 3.02 1.02 1 1 2 3 7 16 31 52 
76 -0.32 2.81 1.00 1 1 2 3 6 15 29 49 
77 -0.35 2.63 0.97 1 1 1 3 6 13 26 46 
78 -0.37 2.46 0.93 1 1 1 2 5 12 24 43 
79 -0.40 2.30 0.90 1 1 1 2 5 11 22 39 
80 -0.43 2.16 0.86 1 1 1 2 4 10 19 34 
81 -0.46 2.04 0.82 1 1 1 2 4 9 17 30 
82 -0.49 1.92 0.77 1 1 1 2 4 7 14 25 
83 -0.52 1.80 0.73 1 1 1 2 3 6 12 20 
84 -0.55 1.69 0.68 1 1 1 2 3 6 10 16 
85+ -0.59 1.57 0.63 1 1 1 2 3 5 8 12 
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Table 5.6: Percentiles for Waist-Worn Accelerometer-Derived Minutes of Light Physical Activity in U.S. Males (N=3002).   
 Percentiles  
Age L M S 5 10 25 50 75 90 95 97 
20 0.79 364 0.29 203 237 296 364 436 503 543 570 
21 0.79 365 0.28 204 238 297 365 437 503 544 571 
22 0.79 366 0.28 204 238 298 366 438 504 545 572 
23 0.79 367 0.28 205 239 298 367 439 505 546 573 
24 0.79 368 0.28 206 240 299 368 439 506 547 574 
25 0.79 369 0.28 207 241 300 369 440 507 548 574 
26 0.79 369 0.28 208 242 301 369 441 508 548 575 
27 0.79 370 0.28 208 242 301 370 442 508 549 576 
28 0.79 371 0.28 209 243 302 371 442 509 549 576 
29 0.79 371 0.28 210 244 303 371 443 509 550 577 
30 0.79 372 0.28 210 244 303 372 443 510 550 577 
31 0.79 372 0.28 211 245 304 372 443 510 550 577 
32 0.79 373 0.28 211 245 304 373 444 510 550 577 
33 0.79 373 0.28 212 245 304 373 444 510 550 577 
34 0.79 373 0.28 212 246 305 373 444 510 550 577 
35 0.79 373 0.28 212 246 305 373 444 510 550 576 
36 0.79 373 0.28 212 246 305 373 443 509 549 576 
37 0.79 372 0.28 212 246 304 372 443 508 549 575 
38 0.79 372 0.28 212 246 304 372 442 508 548 574 
39 0.79 371 0.28 212 246 304 371 442 507 547 573 
40 0.79 371 0.27 212 245 303 371 441 506 546 572 
41 0.79 370 0.27 211 245 303 370 440 505 544 570 
42 0.79 369 0.27 211 244 302 369 439 503 543 569 
43 0.79 368 0.27 210 243 301 368 437 502 541 567 
44 0.79 367 0.27 210 243 300 367 436 500 540 566 
45 0.79 365 0.27 209 242 299 365 435 499 538 564 
46 0.79 364 0.28 208 241 298 364 433 497 536 562 
47 0.79 363 0.28 207 240 297 363 431 495 534 560 
48 0.79 361 0.28 206 238 295 361 429 493 532 558 
49 0.79 359 0.28 204 237 294 359 427 491 530 555 
50 0.79 357 0.28 203 236 292 357 425 489 527 553 
51 0.79 355 0.28 202 234 290 355 423 486 525 550 
52 0.79 353 0.28 200 232 288 353 420 483 522 547 
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Table 5.7: Continued  
 Percentiles  
Age L M S 5 10 25 50 75 90 95 97 
53 0.79 351 0.28 198 230 286 351 418 480 519 544 
54 0.79 348 0.28 196 228 284 348 415 477 515 540 
55 0.79 345 0.28 194 226 281 345 412 474 512 537 
56 0.79 342 0.28 192 224 279 342 409 470 508 533 
57 0.79 339 0.28 190 221 276 339 405 467 504 529 
58 0.79 336 0.28 188 219 273 336 402 463 500 525 
59 0.79 333 0.29 185 216 270 333 398 459 496 520 
60 0.79 329 0.29 183 213 267 329 394 455 491 516 
61 0.79 326 0.29 180 211 264 326 390 450 487 511 
62 0.79 322 0.29 177 208 261 322 386 446 483 507 
63 0.79 319 0.29 175 205 258 319 382 442 478 502 
64 0.79 315 0.29 172 202 254 315 378 437 473 497 
65 0.79 311 0.29 169 199 251 311 374 433 469 492 
66 0.79 307 0.30 167 196 248 307 370 428 464 487 
67 0.79 304 0.30 164 193 244 304 366 423 459 482 
68 0.79 300 0.30 161 190 241 300 361 419 454 477 
69 0.79 296 0.30 158 187 237 296 357 414 449 472 
70 0.79 292 0.30 155 184 234 292 353 409 444 467 
71 0.79 288 0.30 152 181 230 288 348 405 439 462 
72 0.79 284 0.31 149 177 227 284 344 400 434 457 
73 0.79 280 0.31 146 174 223 280 339 395 429 451 
74 0.79 276 0.31 143 171 219 276 335 390 424 446 
75 0.79 272 0.31 141 168 216 272 331 385 419 441 
76 0.79 268 0.31 138 165 212 268 326 380 414 436 
77 0.79 264 0.32 135 162 209 264 322 375 409 430 
78 0.79 260 0.32 132 159 205 260 317 371 403 425 
79 0.79 256 0.32 129 156 202 256 313 366 398 420 
80 0.79 252 0.32 126 152 198 252 308 361 393 414 
81 0.79 248 0.33 123 149 195 248 304 356 388 409 
82 0.79 244 0.33 121 146 191 244 299 351 382 403 
83 0.79 240 0.33 118 143 188 240 295 346 377 398 
84 0.79 236 0.33 115 140 184 236 290 341 372 392 
85+ 0.79 232 0.33 112 137 181 232 285 336 366 387 
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Table 5.8:  Percentiles for Waist-Worn Accelerometer-Derived Minutes of Light Physical Activity in U.S. Females (N=3091).   
 Percentiles  
Age L M S 5 10 25 50 75 90 95 97 
20 0.67 351 0.24 221 248 295 351 409 465 499 522 
21 0.67 351 0.24 221 248 295 351 410 465 499 522 
22 0.67 351 0.24 221 248 296 351 410 465 500 522 
23 0.67 351 0.24 221 248 296 351 410 466 500 523 
24 0.67 352 0.24 222 249 296 352 411 466 501 523 
25 0.67 352 0.24 222 249 296 352 411 467 501 524 
26 0.67 352 0.24 222 249 296 352 411 467 502 524 
27 0.67 353 0.24 222 249 297 353 412 468 502 525 
28 0.67 353 0.24 222 249 297 353 412 468 503 526 
29 0.67 354 0.24 222 250 297 354 413 469 503 526 
30 0.67 354 0.24 223 250 298 354 413 469 504 527 
31 0.67 354 0.24 223 250 298 354 414 470 505 528 
32 0.67 355 0.24 223 250 298 355 415 471 505 528 
33 0.67 355 0.24 223 251 299 355 415 471 506 529 
34 0.67 356 0.24 224 251 299 356 416 472 507 530 
35 0.67 356 0.24 224 251 300 356 416 473 508 531 
36 0.67 357 0.24 224 252 300 357 417 474 509 532 
37 0.67 357 0.24 224 252 300 357 418 474 509 533 
38 0.67 358 0.24 224 252 301 358 418 475 510 534 
39 0.67 358 0.24 225 252 301 358 419 476 511 534 
40 0.67 359 0.24 225 253 301 359 419 476 512 535 
41 0.67 359 0.24 225 253 302 359 420 477 513 536 
42 0.67 359 0.24 225 253 302 359 420 478 513 537 
43 0.67 360 0.25 225 253 302 360 421 478 514 537 
44 0.67 360 0.25 225 253 302 360 421 479 514 538 
45 0.67 360 0.25 225 253 302 360 421 479 515 539 
46 0.67 360 0.25 224 252 302 360 421 479 515 539 
47 0.67 360 0.25 224 252 302 360 421 479 515 539 
48 0.67 360 0.25 223 252 301 360 421 479 515 539 
49 0.67 359 0.25 223 251 301 359 421 479 515 539 
50 0.67 359 0.25 222 250 300 359 421 479 515 539 
51 0.67 358 0.25 221 249 299 358 420 478 515 539 
52 0.67 357 0.25 220 248 298 357 419 478 514 538 
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Table 5.8: Continued   
 Percentiles  
Age L M S 5 10 25 50 75 90 95 97 
53 0.67 356 0.25 219 247 297 356 418 477 513 537 
54 0.67 355 0.25 217 246 296 355 417 476 512 536 
55 0.67 353 0.26 216 244 294 353 416 475 511 535 
56 0.67 351 0.26 214 242 292 351 414 473 510 534 
57 0.67 350 0.26 212 240 290 350 412 471 508 532 
58 0.67 347 0.26 210 238 288 347 410 469 506 530 
59 0.67 345 0.26 208 236 286 345 408 467 504 529 
60 0.67 343 0.26 205 233 283 343 406 465 502 526 
61 0.67 340 0.27 202 231 281 340 403 463 500 524 
62 0.67 337 0.27 199 228 278 337 400 460 497 522 
63 0.67 334 0.27 196 225 275 334 398 457 495 519 
64 0.67 331 0.28 193 222 272 331 395 455 492 517 
65 0.67 328 0.28 190 218 268 328 391 452 489 514 
66 0.67 325 0.28 186 215 265 325 388 448 486 511 
67 0.67 321 0.29 183 211 261 321 385 445 483 508 
68 0.67 317 0.29 179 207 258 317 381 442 479 504 
69 0.67 314 0.29 175 203 254 314 377 438 476 501 
70 0.67 310 0.30 171 199 250 310 374 435 472 498 
71 0.67 305 0.30 167 195 245 305 370 431 469 494 
72 0.67 301 0.31 163 191 241 301 365 427 465 490 
73 0.67 297 0.31 158 187 237 297 361 423 461 486 
74 0.67 292 0.32 154 182 232 292 357 418 457 482 
75 0.67 288 0.32 150 177 227 288 352 414 452 478 
76 0.67 283 0.33 145 173 223 283 347 409 448 474 
77 0.67 278 0.33 140 168 218 278 343 405 443 469 
78 0.67 273 0.34 136 163 213 273 338 400 438 464 
79 0.67 268 0.35 131 159 208 268 333 395 433 459 
80 0.67 263 0.35 127 154 203 263 327 389 428 454 
81 0.67 257 0.36 122 149 198 257 322 384 423 449 
82 0.67 252 0.36 117 144 193 252 317 379 418 443 
83 0.67 247 0.37 112 139 187 247 311 373 412 438 
84 0.67 241 0.38 107 134 182 241 305 367 406 432 
85+ 0.67 236 0.39 103 129 177 236 300 362 401 427 
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PART VI: 
 
EXAMINING ASSOCIATIONS OF TOTAL ACTIVITY COUNTS AND PHYSICAL 
ACTIVITY INTENSITY WITH THE METABOLIC SYNDROME: A NOVEL USE OF 
STRUCTURAL EQUATION MODELING 
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Abstract 
PURPOSE: To determine the relative contribution of accelerometer-derived measures of light- 
(LPA), moderate- (MPA), and vigorous- physical activity (VPA) intensities and total activity 
counts (TAC) in reduction of the prevalence of the metabolic syndrome.  METHODS: Using 
2003 – 2006 National Health and Nutrition Examination Survey (NHANES) data, the sample 
included adults ≥ 20 years of  age, who participated in a fasting morning examination, were not 
pregnant or lactating, and had at least 4 days of  ≥ 10 hours accelerometer wear time (n = 2238).  
The presence of the metabolic syndrome and associated risk factors was determined using 
established criteria.  LPA, MPA, and VPA were defined as the number of minutes with counts 
between 100 - 2019, 2020 – 5998, and ≥ 5999, respectively.  TAC represented the total activity 
counts acquired daily.  LPA, MPA, VPA, and TAC were averaged across valid days to produce a 
daily mean.  Structural equation modeling was used to fit three, gender specific models (1. MPA 
+ VPA; 2. LPA + MPA + VPA; and 3. TAC) which examined the association of the metabolic 
syndrome and PA.  All models controlled for relevant socio-demographic and genetic 
confounders.  RESULTS:  Across all models the PA indictors were found to have significant 
loadings on the latent construct PA.  For both genders, the indirect association of the PA 
construct with the metabolic syndrome was the highest when PA was measured using TAC in 
model 3 (M: -1.14; F: -1.04) compared to MPA and VPA in model 1 (M: -0.88; F: -0.70) or 
LPA, MPA, and VPA in model 2 (M: -0.86; F: -0.84).  Model 3 (TAC) also provided a better 
model fit than the two intensity-based models.  CONCLUSIONS: The results of this study 
indicate a model with TAC provided the best fit for assessing the relationship between PA and 
the prevalence of the metabolic syndrome.  Thus, TAC may be a better measure of PA when 
examining the association with the metabolic syndrome.   
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Introduction 
 The metabolic syndrome is a clustering of cardiometabolic risk factors that include 
central adiposity, hyperglycemia, elevated blood pressure, and dyslipidemia (elevated 
triglycerides and attenuated high-density lipoprotein cholesterol [HDL-C])1.  Within the U.S., the 
metabolic syndrome is a growing public health concern; with the estimated prevalence in adults 
ranging from 22.9 to 34.9% depending on the metabolic syndrome definition used1-3.   
 Physical activity (PA) is a modifiable behavior that has consistently demonstrated inverse 
associations with the metabolic syndrome4-9.  The majority of this research, however, has relied 
on self-report measures of PA, which are subject to substantial bias that has been well 
documented in the PA Epidemiology literature10-13.  In contrast, objective measures of PA, such 
as those derived from accelerometers, may provide increased precision and decreased bias when 
investigating the dose-response relationship and potential threshold effect of PA associated with 
the metabolic syndrome.  However, there are a limited number of epidemiological studies that 
have assessed the relationship between the metabolic syndrome and objectively-measured PA14-
16
.  Furthermore, these studies use different accelerometer-derived measures of PA, limiting the 
interpretability of results.   
 Specifically, Kim et al.17 and Loprinzi et al.18 examined the association between 
accelerometer-derived light-intensity PA (LPA) and the metabolic syndrome and found that 
individuals with higher levels of LPA were less likely to be classified with the metabolic 
syndrome, independent of moderate-to-vigorous-intensity PA (MVPA).  In another study, Jansen 
et al.14 explored the benefits of VPA and found that approximately 75 minutes/week of VPA 
provided a greater reduction (37.1%) in the prevalence of the metabolic syndrome than an 
equivalent volume (150 minutes/week) of MPA (15.5%).  The benefits total volume, measured 
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as steps/day, was also examined by Sisson al.16 who found that the prevalence of the metabolic 
syndrome decreased by 10% for every 1,000 steps accumulated daily.         
  While these studies provide evidence that all PA intensities have health benefits, there is 
also concern that accelerometer data reduction techniques may not provide accurate 
measurements of time spent in various intensity categories (i.e., sedentary, LPA, MPA, and 
VPA)19-22.  One way to circumvent these inaccuracies is to use the accelerometer-derived total 
activity counts per day (TAC), which is a more direct expression of what the monitor records.  
More importantly, TAC is a proxy for the total volume of PA as it incorporates all intensity 
categories and weights each minute according to the intensity of movement.  Recent work by 
Wolff and colleagues (Part IV) demonstrated that TAC had stronger associations with 
cardiometabolic biomarkers (i.e., blood pressure, body mass index, cholesterol, etc.) than 
accelerometer-derived minutes spent in MVPA bouts of 10 minutes or greater; suggesting that 
TAC is a more robust measure of PA.  
In light of these results, it is necessary to determine whether TAC or another 
accelerometer-derived PA measure has the greatest contribution to reduction in the prevalence of 
the metabolic syndrome and its components.  Structural equation modeling (SEM) is a novel 
statistical approach within the field of PA Epidemiology that allows researchers to determine the 
relative contribution of multiple PA measures to the reduction of disease23.  In particular, SEM 
enables us to simultaneously analyze direct and indirect effects of factors known to influence the 
prevalence of the metabolic syndrome and its components.  This provides an advantage over 
traditionally used regression models, which treat covariates as having a direct effect on the 
metabolic syndrome.  Additionally, SEM allows for the comparison of multiple theoretical 
models that are well-specified and complex23,24.   
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Thus, the purpose of this study was to use SEM to examine whether MPA+VPA, 
LPA+MPA+VPA, or TAC provides the best fit for assessing the relationship with the metabolic 
syndrome.  This study also assessed the relative contribution of LPA, MPA, VPA, and TAC to 
the reduction in the prevalence of the metabolic syndrome and it's components.  Emphasis was 
placed on determining whether TAC is a viable alternative to more traditional accelerometer-
based measures of PA (e.g., MVPA) when examining the reduction in the prevalence of the 
metabolic syndrome.   
Methods 
The present study used data from the 2003 – 2006 National Health and Nutrition 
Examination Survey (NHANES).  The NHANES is a cross-sectional survey utilizing a complex, 
multistage probability design in order to obtain a representative sample of the non-
institutionalized U.S. population25.  The NHANES data are collected during an in-person home 
interview and a visit to a mobile examination center (MEC).  The interview collects 
demographic, socioeconomic, and health-related information.  The examination consists of 
laboratory tests and medical and physiological measurements.   
For this study, the sample was limited to adults ≥ 20 years of age who participated in a 
fasting morning examination (N = 4312).  Participants with less than four days of ≥ 10 hours of 
accelerometer wear time (n = 1513), pregnant or lactating women (n = 146), and individuals with 
missing data (n = 415) were excluded from the analysis, resulting in a final sample of (n = 2238).  
The original survey protocols were approved by National Center for Health Statistics ethics 
review board, and informed consent was obtained from all NHANES participants. The 
University of Tennessee institutional review board approved the use of NHANES data in this 
analysis. 
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The Metabolic Syndrome  
 The American Heart Association/National Heart Lung and Blood Institute 
(AHA/NHLBI)26 guidelines were used to determine the presence or absence of the metabolic 
syndrome and its five underlying risk factors.   Specifically, the metabolic syndrome was 
represented as a dichotomized measure which classified participants as having the metabolic 
syndrome if three or more of the following risk factors were present: (1) high waist 
circumference (≥ 102 cm for men and ≥ 88 cm for women); (2) elevated triglycerides (≥ 150 
mg/dL or on drug treatment); (3) attenuated HDL-C (< 40 mg/dL for men and < 50 mg/dL for 
women, or on drug treatment); (4) elevated blood pressure (≥ 130 / ≥ 85 mmHg or on drug 
treatment); and (5) impaired fasting glucose (≥ 100 mg/dL or on drug treatment)27.  The five 
underlying risk factors of the metabolic syndrome were also dichotomized based on the 
aforementioned criteria and were included as formative indicators (i.e., direct effects) of the 
metabolic syndrome in the structural equation models.   
 Accelerometer data collection and analysis 
Ambulatory individuals examined in the MEC were eligible participants for the 
accelerometer component. Eligible participants were instructed to wear an ActiGraph model 
7164 accelerometer for seven days on their right hip during waking hours and to take it off for 
swimming or bathing22.  Details of the accelerometer protocol can be found on the Centers for 
Disease Control and Prevention (CDC) website28.  The ActiGraph model 7164 is a uniaxial 
accelerometer measuring vertical acceleration in one-minute epochs.  The vertical accelerations 
obtained from the device are filtered, full-wave rectified, and integrated over time29; resulting in 
“activity counts per minute” which correspond to the intensity of ambulatory movement30.     
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In this study, accelerometer data was analyzed using the SAS macro provided by the 
National Cancer Institute website31.  Non-wear time was defined as ≥ 60 consecutive minutes 
with zero accelerometer counts, allowing up to two minutes with limited movement (< 100 
counts per minute).  Daily wear time was determined by subtracting non-wear time from 24 
hours.   A valid day was defined as a day with 10 or more hours of monitor wear32.  Only 
participants with at least four days of valid monitor wear time were included in this analysis.   
The variable total activity counts per day (TAC) was created by summing the counts 
accumulated on each valid day and averaging them over the total number of valid wear days.  As 
TAC captured all counts accumulated during valid wear times it therefore included time spent in 
sedentary activity and all PA intensity sub-categories.  Using thresholds described by Troiano16, 
LPA was defined as the total number of 1-min epochs between 100 – 2019 counts while MPA 
and VPA were defined as the total number of 1-min epochs between 2020 – 5998 and ≥ 5999 
counts, respectively.  LPA, MPA, and VPA were averaged across all valid days.  
Covariates  
Several variables known to confound the relationship between PA and the metabolic 
syndrome, served as covariates in this study.  Demographic covariates included: age (six 
categories representing 10 y age increments from 20 y to ≥ 70 y), race/ethnicity (non-Hispanic 
[NH] white, NH black, and Mexican American/Other), education (< 9th grade, 9th – 11th grade, 
high school or GED, some college or Associates, and ≥ college graduate), and household income 
(eight categories starting from < $20,000, then $5,000 increments to ≥ $75,000).  Family history 
of coronary heart disease (CHD) also served as a covariate in this analysis.  Specifically, 
participants were classified as having a family history of CHD if they reported a parent and/or 
sibling had been told by a doctor they had CHD.   
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Statistical Analysis 
 Data were recoded and descriptive analyses were performed using SAS 9.2 (SAS 
Institute, Inc., Cary, NC).  In addition, the SAS macro provided by the National Cancer Institute7 
was used to recode accelerometer-derived measures of PA.  Descriptive analyses did not account 
for the complex sampling design of the NHANES in order to make comparisons to the results 
obtained from the structural equation modeling (SEM) analyses.   
Specifically, SEM was performed using AMOS 20.0 (AMOS Development Corp., 
Meadville, PA), which is unable to take into account the NHANES sampling weights and 
sampling design variables that adjust for the complex sampling design.  SEM is an advanced 
statistical technique which tests hypotheses about the relationships between observed (manifest) 
variables and latent constructs33.  Latent constructs are comprised of multiple measures that are 
classified as being exogenous or endogenous.  Exogenous variables are not dependent on any 
other variables and are therefore thought of as the independent variables.  Endogenous variables 
are considered mediating or dependent variables as these constructs are dependent on at least one 
other construct.  SEM simultaneously estimates the relationship between exogenous and 
endogenous latent constructs, the loadings of manifest variables onto each construct, and 
measurement and prediction error23,33,34.   
In the present analysis, SEM was used to test three hypothetical models that were 
stratified by gender and used various accelerometer-derived measures of PA to examine the 
association between the prevalence of the metabolic syndrome and PA.  The dependent variable 
in these models was prevalence of the metabolic syndrome, which had five manifest variables 
(e.g., waist circumference, blood pressure).  The independent variable, accelerometer-derived 
PA, was measured continuously, with each model including different accelerometer-derived 
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measures of PA.  In model 1, the PA latent construct was comprised of two manifest variables: 
accelerometer-derived minutes of MPA and VPA.  Model 2 had the following three manifest 
variables loading onto the PA latent construct: accelerometer-derived minutes of LPA, MPA, and 
VPA.  For model 3, TAC was the only manifest variable loading onto the PA latent construct.    
Maximum likelihood estimation was used to estimate model parameters (i.e., factor 
loadings and standardized regression weights).  This estimation method is the most commonly 
used procedure in SEM as it is robust against moderate non-normality.  Factor loadings were 
used to determine the relative contribution of each PA manifest variable in explaining the PA 
latent construct.  A higher factor loading indicated a stronger contribution of the variable to the 
PA latent construct.  Standardized regression weights or path weights assessed the standard 
deviation change in an outcome variable (e.g., the metabolic syndrome) for every one standard 
deviation unit change in a predictor variable (e.g., PA). As the metabolic syndrome variable and 
the five risk factors were dichotomized (0 = does not meet criteria, and 1 = meets criteria), the 
standard deviation represents the prevalence of the variable.  Thus, multiplying the standard 
deviation of the outcome variable by its respective standardized path weight provided an 
estimate of the prevalence of the outcome variable for every standard deviation change in the 
predictor variable.    
The fit of each model was also compared to determine which accelerometer model best 
explained the association between the reduction in the prevalence of the metabolic syndrome, the 
components of the metabolic syndrome, and PA.  This analysis evaluated four different fit 
indices: chi-square (χ2) to degrees of freedom (df) ratio (χ2/df), Root Mean Square Error of 
Approximation (RMSEA), Comparative Fit Index (CFI), and Akaike Information Criterion 
(AIC).  The χ2/df ratio assesses the fit of a model and the data, with ratios < 4 indicating 
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reasonable fit and < 2 suggesting very good fit.  RMSEA indicates the fit of the model in the 
population’s covariance matrix, with 0.05 considered to be a “close” fit, < 0.08 reflecting 
moderate fit, and >0.10 indicating unacceptable fit35.  CFI compares the independence model 
(i.e., worst possible fitting model) to the substantive model (i.e., tested model), with values ≥ 
0.90 indicating good fit35.  AIC was used to compare the adequacy of the three models; with the 
smallest AIC representing the best model36.    
Results 
Table 6.1 displays the demographic characteristics and prevalence estimates of the 
metabolic syndrome and its components by gender for subjects included in this study.  A 
majority of participants were over 50 years of age, NH White, had attained a high school 
education/GED or greater, and reported an annual household income of $35,000 or greater.  
Several gender differences were also noted.  In particular, females were more likely than males 
to report a family history of CHD (15.3 vs. 11.7%, p = 0.013) and had a higher prevalence of 
central adiposity (67.9 vs. 43.6; p < 0.001).  Males had a higher prevalence of elevated 
triglycerides (36.3 vs. 28.0%; p < 0.001), attenuated HDL-C (57.3 vs. 27.3%; p < 0.001), 
impaired fasting glucose (47.5 vs. 36.5%; p < 0.001), and the metabolic syndrome (56.8 vs. 
43.2%; p < 0.001) (Table 6.1).  Physical activity also varied by gender (Table 6.2), with men 
found to accumulate significantly greater amounts of MPA (26.87 vs. 14.91; p < 0.001) and TAC 
(292749 vs. 229065; p < 0.001) compared to females.  The accelerometer wear time was also 
found to be significantly higher in males (14.36 vs. 14.03; p < 0.001), however, no significant 
difference in LPA or VPA was found between genders.   
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Table 6.1: Characteristics of Participants by Gender 
  Males Females   
Characteristic n Percent n Percent p-value 
Age (years)     0.136 
 20 – 29  147 12.7 117 10.9  
 30 – 39  186 16.0 150 13.9 
 40 – 49  207 17.8 214 19.9 
 50 – 59  173 14.9 170 15.8   
 60 – 69 203 17.5 221 20.5 
 ≥ 70 244 21.0 206 19.1 
Race/Ethnicity     0.233 
 NH white 629 54.2 581 53.9 
 NH black 201 17.3 214 19.9 
 Mexican American/Other 330 28.4 283 26.3 
Education     0.103 
 < 9th grade 163 14.1 122 11.3 
 9 – 11th grade 155 13.4 123 11.4   
 High school grad/GED 285 24.6 272 25.2 
 Some college or AA 315 27.2 332 30.8   
 ≥ College graduate 242 20.9 229 21.2 
Household income     0.293 
 < $20K 208 17.9 232 21.5 
 $20 – 24.9K 84 7.2 89 8.3 
 $25 – 34.9K 168 14.5 156 14.5 
 $35 – 44.9K 128 11.0 104 9.6 
 $45 – 54.9K 124 10.7 117 10.9 
 $55 – 64.9K 92 7.9 81 7.5 
 $65 – 74.9K 83 7.2 59 5.5 
 ≥ $75K 273 23.5 240 22.3 
CHD Family History 136 11.7 165 15.3 0.013 
Metabolic Syndrome Components 
 Central Adiposity 506 43.6 732 67.9 <0.001  
 Elevated Blood Pressure 587 50.6 510 47.3 0.065  
 Elevated Triglycerides 421 36.3 302 28.0 <0.001 
 Attenuated HDL-C 665 57.3 294 27.3 <0.001  
 Impaired Fasting Glucose 551 47.5 393 36.5 <0.001  
Metabolic Syndrome 541 56.8 412 43.2  < 0.001 
Note: NH, non-Hispanic; AA, Associates of Arts; CHD, coronary heart disease; HDL-C, high 
density lipoprotein cholesterol.  
*p-values are based on a χ2 test. 
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Table 6.2: Accelerometer-derived physical activity levels of male and female participants. 
  Males Females   
Physical Activity Variable Mean SE Mean SE P value 
Light PA (min.) 345.49 3.21 338.30 2.95 0.10 
Moderate PA (min.) 26.87 0.75 14.91 0.47 <0.001 
Vigorous PA (min.) 0.85 0.09 0.62 0.08 0.06 
Total Activity Counts 292740 4570 229065 3391 <0.001 
Wear Time (hr/day)  14.36 0.06 14.03 0.05 <0.001 
Note: Light, moderate, and vigorous intensity physical activity represent total daily non-bout 
minutes. SE, standard error; PA, physical activity; min., minutes; hr, hours. 
 
 
 
Physical Activity Factor Loadings 
 Figures 6.1 – 6.3 display the three gender-specific structural equation models.  For 
simplicity, covariate paths of age, race/ethnicity, socioeconomic status, and family history of 
CHD are not presented.  For expanded models and standardized regression weights please refer 
to Appendices A and B.  Across all models, the PA indictors had significant loadings on the 
latent construct PA.  In model 1 (MPA+VPA) and model 2 (LPA+MPA+VPA), MPA had a high 
loading for both genders (Figures 6.1 – 6.2) with VPA having substantially lower loadings.  LPA 
(model 2) had a high loading that was similar to MPA for males (0.51) but did not load as high 
for females (0.31) (Figure 6.2).  For both males and females, TAC (Figure 6.3) had a high 
loading that was similar to MPA and male's LPA. 
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Figure 6.1: Model 1 of moderate and vigorous intensity physical activity and the metabolic 
syndrome in adult (A) Males and (B) Females, NHANES 2003 - 2006. 
 
Note: Model fit (A): CMIN/DF=4.25, CFI = 0.95, RMSEA = 0.05, AIC = 324.59;  
Model fit (B): CMIN/DF = 4.26, CFI = 0.96, RMSEA = 0.05, AIC = 325.27. Adjusted for age, 
race/ethnicity, socioeconomic status, and family history of coronary heart disease. 
Abbreviations: MPA, moderate physical activity; VPA, vigorous physical activity; WC, waist 
circumference; HDL-C, high density lipoprotein cholesterol. Ellipse indicates latent construct; 
box indicates observed variable; straight line represents a direct effect; dashed line represents an 
indirect effect.   
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Figure 6.2: Model 2 of light, moderate, and vigorous intensity physical activity and the 
metabolic syndrome in adult (A) Males and (B) Females, NHANES 2003 - 2006. 
 
Note: Model fit (A): CMIN/ CMIN/DF = 5.09, CFI = 0.93, RMSEA = 0.06, AIC = 431.72;  
Model fit (B): CMIN/DF = 4.57, CFI = 0.94, RMSEA = 0.06, AIC = 339.09. Adjusted for age, 
race/ethnicity, socioeconomic status, and family history of coronary heart disease. 
Abbreviations: LPA, light physical activity; MPA, moderate physical activity; VPA, vigorous 
physical activity; WC, waist circumference; HDL-C, high density lipoprotein cholesterol. Ellipse 
indicates latent construct; box indicates observed variable; straight line represents a direct effect; 
dashed line represents an indirect effect.   
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Figure 6.3: Model 3 of total activity counts and the metabolic syndrome in adult (A) Males and 
(B) Females, NHANES 2003 - 2006.  
 
Note: Model fit (A): CMIN/DF = 3.67, CFI = 0.97, RMSEA = 0.05, AIC = 247.21;  
Model fit (B): CMIN/DF = 3.70, CFI = 0.97, RMSEA = 0.05, AIC = 248.28. Adjusted for age, 
race/ethnicity, socioeconomic status, and family history of coronary heart disease. 
Abbreviations: TAC, total activity counts; WC, waist circumference; HDL-C, high density 
lipoprotein cholesterol. Ellipse indicates latent construct; box indicates observed variable; 
straight line represents a direct effect; dashed line represents an indirect effect.   
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Association of Physical Activity with the Metabolic Syndrome Components   
 Table 6.3 summarizes the standardized path weights from PA to the metabolic syndrome 
and its components for each model by gender.  These results indicate that for both genders, 
across the three models, there is a significant inverse association between PA and the 
components of the metabolic syndrome.  Across all models, regardless of gender, PA had the 
greatest association with waist circumference (M: -0.75 to -1.09; F: -0.74 to -1.04) and had the 
least association with hypertension (M: -0.40 to -0.51; F: -0.39 to -0.54).   
 Several gender differences were also seen in the three models, with the association 
between PA and HDL-C found to be larger for men (-0.71 to -0.97) than women (-0.50 to -0.76).  
In model 1 (MPA+VPA) and model 2 (LPA+MPA+VPA), PA was more strongly associated 
with fasting glucose and triglycerides in women compared to men.  Examining the paths of each 
model, it was also found that TAC had the greatest association with all five metabolic syndrome 
components (Table 6.3).  
Association of the Metabolic Syndrome Components with the Metabolic Syndrome 
 Table 6.3 displays the standardized regression weights between all five components of 
the metabolic syndrome and the prevalence of the metabolic syndrome.  As the prevalence of the 
metabolic syndrome was a formative indicator, the path weight of each metabolic syndrome risk 
factor to the prevalence of the metabolic syndrome varied little across models for each respective 
gender.  For males, HDL-C (0.31) had the greatest association and hypertension (0.26) and had 
the least association with the risk of being classified with the metabolic syndrome.  In females, 
fasting glucose (0.37) was found to have the strongest association and waist circumference the 
least association (0.18) with the prevalence of the metabolic syndrome.  
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Table 6.3: The association of physical activity intensity and volume with the risk of metabolic syndrome diagnosis: summary of factor 
loadings and standardized path weights for models 1 – 3 by gender.  
 Model 1 (MPA + VPA) Model 2 (LPA + MPA + VPA) Model 3 (TAC) 
 Males Females Males Females Males Females 
PA Factor Loadings       
 LPA -- -- 0.513*** 0.305*** -- -- 
 MPA 0.570*** 0.558*** 0.574*** 0.518*** -- -- 
 VPA 0.240*** 0.363*** 0.155*** 0.267*** -- -- 
 TAC -- -- -- -- 0.594***  0.519*** 
 Wear Time 0.157 0.166 0.157 0.147 0.134 0.129 
 
PA to MetS Risk Factors      
 PA  WC -0.871*** -0.740*** -0.755*** -0.826*** -1.093*** -1.038*** 
 PA  Hypertension -0.408*** -0.391*** -0.405*** -0.453*** -0.514** -0.537** 
 PA  Glucose -0.466*** -0.488*** -0.454*** -0.613*** -0.598*** -0.766*** 
 PA  Triglycerides -0.483*** -0.492*** -0.493*** -0.605*** -0.661*** -0.759***  
 PA  HDL-C -0.712*** -0.498*** -0.744*** -0.602*** -0.968*** -0.761*** 
 
PA to MetS Diagnosis       
 PA - -> MetS -0.883*** -0.704*** -0.861*** -0.838*** -1.145*** -1.040*** 
 
MetS Risk Factors to MetS       
 Hypertension  MetS 0.261*** 0.267*** 0.263*** 0.265*** 0.259*** 0.264*** 
 WC  MetS 0.324*** 0.182*** 0.327*** 0.18*** 0.322*** 0.180*** 
 Triglycerides  MetS 0.298*** 0.333*** 0.301*** 0.331*** 0.297*** 0.329*** 
 HDL-C  MetS 0.308*** 0.239*** 0.311*** 0.237*** 0.307*** 0.237*** 
 Glucose  MetS 0.280*** 0.372*** 0.283*** 0.369*** 0.279*** 0.368*** 
Note: LPA, minutes of light intensity physical activity; MPA, minutes of moderate intensity physical activity; VPA, minutes of vigorous 
intensity physical activity; WC, waist circumference, HDL-C, high density lipoprotein cholesterol; 
--, Not applicable as measure not included in model 
, Direct effect;  
- ->, Indirect effect; 
* p ≤ 0.05 
** p ≤ 0.01 
*** p ≤ 0.001 
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Association of Physical Activity with the Metabolic Syndrome 
 For both genders, the indirect association of the PA construct with the metabolic 
syndrome was the highest when PA was measured using TAC in model 3 (M: -1.14; F: -1.04) 
compared to MPA and VPA in model 1 (M: -0.88; F: -0.70) or LPA, MPA, and VPA in model 2 
(M: -0.86; F: -0.84) (Table 6.3).  The reduction in the prevalence of the metabolic syndrome for 
a standard deviation increase in the PA indicator variables (i.e., LPA, MPA, VPA, and TAC) is 
displayed in table 6.4.  For an expanded table please refer to Appendix C.  In models 1 and 2, 
increasing MPA by 6.1 - 6.8 minutes per day in males and 4.9 - 5.3 minutes per day in females 
was associated with a reduction in the prevalence of the metabolic syndrome of 3.4% and 2.5 - 
3.0%, respectively.  Increasing VPA, by 0.5 - 0.6 minutes per day in males and 0.6 - 0.7 minutes 
per day in females was associated with a 1.4 to 1.7% and 1.5 to 2.1% reduction in the metabolic 
syndrome, respectively.  Every additional 22 minutes per day of LPA in females and 24 
additional minutes per day in males was associated with a reduction in the prevalence of the 
metabolic syndrome of 1.9 and 3.2%, respectively.  In model 3, the prevalence of the metabolic 
syndrome was reduced by 4.6% in females and 3.5% in males for an increase of 39,721 and 
35,910 TAC, respectively.   
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Table 6.4: Reduction in metabolic syndrome prevalence with increased physical activity  
 Model 1  Model 2 Model 3  
 SDPA ∆ MetSa SDPA ∆ MetSa SDPA ∆ MetSa 
Males       
 MPA - -> MetS 6.8 -3.4% 6.1 -3.4% -- -- 
 VPA - -> MetS 0.6 -1.4% 0.5 -1.7% -- -- 
 LPA - -> MetS -- -- 24 -3.2% -- -- 
 TAC - -> MetS  -- -- -- -- 39721 -4.6% 
Females       
 MPA - -> MetS 5.3 -2.5% 4.9 -3.0% -- -- 
 VPA - -> MetS 0.7 -1.5% 0.6 -2.1% -- -- 
 LPA - -> MetS -- -- 22.0 -1.9% -- -- 
 TAC - -> MetS -- -- -- -- 35910 -3.5% 
Note: ∆, change; MetS; metabolic syndrome; SDPA; standard deviation of the physical activity (PA) variable; 
MPA, moderate PA; VPA, vigorous PA; LPA, light PA; TAC, total activity counts. 
aMetS change represents the percent change in the metabolic syndrome for every SD increase in the physical 
activity indicator variable.   
--, Not applicable as measure is not included in model. 
 
 
Model Fit of Physical Activity with the Metabolic Syndrome 
The model fit for the three gender-specific structural equation models is presented in 
Table 6.4.  All models displayed good fit, with CFIs ranging from 0.93 to 0.97 and the RMSEA 
at or above 0.05.  The best fitting model for both genders, however, was model 3 (TAC) as the 
χ
2/DF ratio was lower than three and the AIC was substantially lower than the other two models.  
Model 1 (MPA + VPA) had the second best fit followed by model 3 (LPA + MPA + VPA).   
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Table 6.5: Fit indices of the final structural models 
 Model 1 Model 2 Model 3
 (MPA + VPA)  (LPA + MPA + VPA)  (TAC) 
Χ
2/DF    
 Males 4.25 5.09 3.67 
 Females 4.26 4.57 3.70 
CFI    
 Males 0.95 0.93 0.97 
 Females 0.96 0.94 0.97 
RMSEA    
 Males 0.05 0.06 0.05 
 Females 0.05 0.06 0.05 
AIC   
 Males 324.59 431.72 247.21 
 Females 325.27 399.09 248.28 
Note: MPA, moderate physical activity; VPA, vigorous physical activity; LPA, light physical 
activity; TAC, total activity counts; Χ2, chi-square; df, degrees of freedom, CMIN/DF, minimum 
chi-square;  CFI, Comparative Fit Index; RMSEA, Root Mean Square Error of Approximation; 
AIC, Akaike Information Criterion. 
 
 
Discussion 
The present study highlights the utilitarian value of SEM in examining the relationship 
between PA and the prevalence of the metabolic syndrome.  In particular, the results provide 
insight into the complex relationship between PA intensity and volume and the reduction of the 
prevalence of the metabolic syndrome.  To our knowledge, this is the first study to determine the 
relative contributions of TAC and various intensities of PA to the prevalence of the metabolic 
syndrome and its underlying risk factors.  The major finding was that a model with TAC 
provided the best fit for assessing the association between PA and the metabolic syndrome.  In 
addition, the PA construct had stronger associations with the metabolic syndrome and its 
components when represented by TAC.   
This finding is due in part to the measurement of PA in each model.  In particular, TAC is 
a continuous measure that weights each minute according to the intensity of the movement.  This 
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allows TAC to serve as a proxy for the total volume of PA while preserving the variability of the 
measure within a sample.  In addition, TAC provides an alternative to traditional approaches to 
accelerometer data reduction as it avoids the pitfalls of misclassification error associated with 
these techniques.   
While the TAC appears to be the best metric by which to estimate the association of PA 
with the metabolic syndrome, the results of this study indicate that both TAC and PA intensity 
subcategories are significantly associated with the metabolic syndrome.  This is consistent with 
previous research that found LPA17,37,38 and MVPA14,37,39,40 both have a significant and 
independent contribution to the risk reduction of the metabolic syndrome.  These results also 
support previous work of Wolff and colleagues, who demonstrated that TAC had stronger 
associations with cardiometabolic biomarkers (i.e., blood pressure, body mass index, cholesterol, 
etc.) than accelerometer-derived minutes spent in MVPA bouts of 10 minutes or greater (Part 
IV).   
The results of this study are also consistent with 2008 Physical Activity Guidelines 
Advisory Committee (PAGAC) report41.  In particular, the report proposes that minutes of VPA 
count twice as much as MPA and the health benefits derived from PA are likely accrued in 
proportion to intensity.  In the present study, models 1 and 2 revealed that increasing VPA by 
less than a minute per day (0.5 - 0.7 minutes) was associated with a 1.4 - 2.1% drop in the 
prevalence of the metabolic syndrome.  However, greater than 5-minutes of MPA per day was 
needed to produce a 2.5 - 3.5% reduction in the prevalence, respectively.  The PAGAC report41 
also indicated that the total volume of activity is more closely related to health outcomes.  Our 
findings revealed the importance of total volume as reflected in models 2 and 3.  Specifically, 
model 2 demonstrated that increasing LPA by 22 minutes per day in women and 24 minutes per 
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day in men significantly reduced the prevalence of the metabolic syndrome by 1.9 and 3.2%, 
respectively.  In addition, model 3 (TAC) was found to have the greatest association with the 
metabolic syndrome and its components as well as the best overall fit for capturing the 
relationship between the metabolic syndrome and PA.      
 While model 2 (LPA+MPA+VPA) and model 3 (TAC) reflected the total volume of PA, 
the results were not comparable, with model 2 performing the worst of the three models.  One 
explanation is that the TAC metric included counts accrued in sedentary time, while model 2 
(LPA + MPA + VPA) did not include a measure of sedentary time.  However, the average daily 
counts accumulated due to sedentary behavior accounted for less than 2% of the daily TAC.  A 
more plausible explanation is the cut-points for LPA (100 – 2019 counts/min) and MPA (2020 – 
5998 counts/min), which may have resulted in misclassification of PA at both ends of the 
intensity spectrum.  For example, one study found the total amount of time spent in MVPA, 
regardless of bout duration, was underestimated by 50% when using NHANES ActiGraph cut-
points19.  In another study, Lyden et. al42 evaluated the ability of different regression equations 
for the ActiGraph, Actical, and RT3 accelerometers to accurately classify time spent in PA 
intensity sub-categories and found none of the regression equations examined were able to 
correctly classify minutes spent in each intensity category.  In particular, the misclassification 
error of these equations ranged from 8.9 - 34.3% for MPA and 28.2 - 54.5% for VPA.  The 
authors noted that the misclassification error of MPA may be related to the insensitivity of the 
regression equations to distinguish LPA due to the high y-intercept of 2.6 METs.  While 
regression equations with a lower y-intercept had increased sensitivity to LPA, they tended to 
underestimate MPA and VPA42.    
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Due to this misclassification error, the PA estimates derived from cut-points vary widely.  
This was demonstrated by Loprinzi et al., using the NHANES data, who found the time spent in 
MVPA ranged from 17 to 59 minutes per day and the percentage meeting PA guidelines ranged 
from 6.2 – 59.3%, depending on the regression equation used75.   Therefore, it is unclear which 
cut-point(s), if any, provide an accurate representation of the time spent in LPA, MPA, and VPA.  
This is a limitation to the present study as well as other studies using cut-points to classify the 
intensity of PA, as the misclassification error may affect the relationship with disease leading to 
conflicting results.  In addition to the estimation error associated with cut-points derived from 
regression equations, the numerous cut-points also hinders the ability to draw comparisons 
between studies76,77.  Freedson et al.43 have therefore urged researchers to discontinue the 
development of cut-points to categorize accelerometer-derived PA and explore alternative 
accelerometer data reduction techniques.   
There are two key strengths of the current study. The first is the use of accelerometers, an 
objective measure of PA, which improves the precision with which PA is measured.  The second 
is the statistical approach utilized in this study.  Specifically, SEM uses multiple, correlated 
measures to define a construct.  This allowed for the inclusion of multiple PA intensity levels, 
which can’t be modeled simultaneously in traditional regression due to violations of 
multicollinearity33,44,45. 
There are also several limitations of this study.  Specifically, SEM was performed using 
AMOS 20.0, which is unable to account for complex sampling design inherent within the 
NHANES.  Also, due to the cross-sectional design of this study, causality cannot be determined.   
Other health variables (i.e., smoking, alcohol intake, poor diet) involved in the interplay between 
PA and the metabolic syndrome were not controlled for in this study.  In particular, dietary 
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factors (i.e., saturated fat levels, caloric intake) were not controlled for in this study due to the 
complexity of the dietary data file within the NHANES.  It is also important to note that 
accelerometer counts are dependent on the characteristics of the PA monitor used.  Therefore, 
counts obtained from different accelerometer brands are not comparable.  However, the 
ActiGraph is the most common accelerometer used in PA research and has been shown to 
provide adequate reliability and validity of PA measurements across multiple generations of the 
device46-49.  
  In summary, the results of this study indicate that both the intensity and volume of PA 
are significantly associated with the prevalence of the metabolic syndrome and its components.  
However, compared to models with intensity sub-categories, the TAC model resulted in a 1.8% 
and 2.0% greater reduction in the prevalence of the metabolic syndrome in men and women, 
respectively.  More importantly, a model with TAC provided the best fit for assessing the 
relationship between PA and the prevalence of metabolic syndrome and its components.  These 
findings suggest TAC may be a better measure of PA when examining the association with the 
metabolic syndrome.  Future studies, however, should further explore this relationship using 
prospective study designs and different chronic disease states.  
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In order to explore the efficacy of TAC as a measure of PA, this dissertation used data 
from the 2003 - 2006 National Health and Nutrition Examination Survey to: 1) investigate 
whether TAC was more strongly associated with cardiometabolic biomarkers than minutes of 
moderate-to-vigorous PA (MVPA), 2) determine population-referenced TAC percentiles for the 
U.S. population, and 3) determine which accelerometer-derived measure(s) of PA intensity and 
volume provided the best fit for assessing the association with the metabolic syndrome.   
The findings presented within this dissertation provide insights into the objective 
measurement of physical activity (PA) using accelerometers, and has implications for 
epidemiological and public health research.  Specifically, this dissertation explored the efficacy 
of total activity counts (TAC) as a measure of PA using data from the 2003 – 2006 National 
Health and Nutrition Examination Survey.  The first study (Part IV) investigated whether TAC 
was more strongly associated with cardiometabolic biomarkers than minutes of moderate-to-
vigorous PA (MVPA).  The major finding this study was that TAC consistently displayed 
stronger associations with cardiometabolic biomarkers than MVPA accumulated in ≥ 10 minute 
bouts.  More importantly, TAC remained more strongly associated with biomarkers after 
adjustment for BMI.   
The second study (Part V) determined the population-referenced TAC percentiles for the 
U.S. population.  The findings presented within this section describe the population-referenced 
TAC percentiles, for the U.S. adult population.  These percentiles provide PA and public health 
researchers with a measure of the total volume of PA that can be expressed relative to others of 
the same age and gender (i.e., as percentiles).   Furthermore, these results provide insights into 
how the intensity and volume of PA changes throughout adulthood. 
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The third study (Part VI) determined which accelerometer-derived measure(s) of PA 
intensity and volume provided the best fit for assessing the association with the metabolic 
syndrome.  The results of this study highlight the utilitarian value of SEM in examining the 
relationship between PA and the prevalence of the metabolic syndrome.  In particular, the results 
provide insight into the complex relationship between PA intensity and volume and the reduction 
of the prevalence of the metabolic syndrome.  To our knowledge, this is the first study to 
determine the relative contributions of TAC and various intensities of PA to the prevalence of 
the metabolic syndrome and its underlying risk factors.  The major finding was that a model with 
TAC provided the best fit for assessing the association between PA and the metabolic syndrome.  
In addition, the PA construct had stronger associations with the metabolic syndrome and its 
components when represented by TAC.   
 The findings of these three studies reveal that TAC may be the best metric by which to 
estimate the association with cardiometabolic disease states.  The advantage to using TAC is that 
it incorporates all intensities and patterns of PA.  Additionally, TAC is the most direct expression 
of what the accelerometer measures.  If a uniform method of accelerometer data collection were 
established, TAC could be reported as a standardized measure.  This could allow for 
comparisons to be drawn across studies using waist-worn ActiGraph accelerometers.  TAC could 
also complement other measures of PA as it still allows reporting of other PA variables (e.g., 
minutes spent in various intensity categories).  Future research, however, should explore this 
relationship with other chronic diseases and should utilize a prospective design in order to 
establish causality.   
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Figure A.1: Final model 1 depicting the relationship between moderate- and vigorous- intensity physical activity and the metabolic 
syndrome, NHANES 2003-2006. 
Note: MPA, moderate-intensity physical activity; VPA, vigorous-intensity physical activity; HDL-C, high density lipoprotein 
cholesterol. Ellipse indicates latent, unobservable constructs; box indicates observed variable; straight line with one arrowhead 
denotes a direct effect; curved line with a double-headed arrow indicates a correlation; e, error of manifest variable; z, residual error 
term of latent construct. 
  
Figure A.2: Final model 2 depicting the relationship between light
metabolic syndrome, NHANES 2003-2006. 
 
Note: LPA, light-intensity physical activity; MPA
HDL-C, high density lipoprotein cholesterol.  Ellipse indicates latent, unobservable constructs; box indicates observed variable; 
straight line with one arrowhead denotes a direct effect; curved line with a double
manifest variable; z, residual error term of latent construct
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Figure A.3: Final model 3 depicting relationship between total activity counts and the metabolic syndrome, NHANES 2003-2006. 
 
Note: TAC, total activity counts; HDL-C, high density lipoprotein cholesterol.  Ellipse indicates latent, unobservable constructs; box 
indicates observed variable; straight line with one arrowhead denotes a direct effect; curved line with a double-headed arrow indicates 
a correlation; e, error of manifest variable; z, residual error term of latent construct. 
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Table B.1: Model 1 standardized weights for the full structural model of 
relationships among moderate and vigorous physical activity and the metabolic 
syndrome  
Path Males Females 
Age  Physical Activity -0.763*** -0.505*** 
Age  Hypertension 0.097 0.321*** 
Age  WC -0.533*** -0.222*** 
Age  Triglycerides -0.357*** -0.116* 
Age  HDL-C -0.613*** -0.388*** 
Age  Glucose -0.116 -0.022 
SES  Education 0.764 0.738 
SES  Income 0.553*** 0.572*** 
SES  Physical Activity 0.11 0.392*** 
SES  Hypertension -0.019 0.092 
SES  WC 0.143* 0.142 
SES  Triglycerides 0.024 0.044 
SES  HDL-C -0.081 -0.006 
Ethnicity  Physical Activity 0.153** 0.049 
Ethnicity  Hypertension 0.013 0.044 
Ethnicity  WC 0.02 0.087 
Ethnicity  Triglycerides 0.099* 0.013 
Ethnicity  HDL-C 0.02 0.017 
Ethnicity  Glucose 0.086* 0.068* 
Ethnicity  Metabolic Syndrome 0.004 -0.019 
CHD History  Hypertension -0.022 0.016 
CHD History  WC 0.04 0.082** 
CHD History  Triglycerides 0.064* 0.053 
Physical Activity  MPA 0.57*** 0.558*** 
Physical Activity  VPA 0.24*** 0.363*** 
Physical Activity  Wear Time 0.157 0.166 
Physical Activity  Hypertension -0.408*** -0.391*** 
Physical Activity  WC -0.871*** -0.74*** 
Physical Activity  Triglycerides -0.483*** -0.492*** 
Physical Activity  HDL-C -0.712*** -0.498*** 
Physical Activity  Glucose -0.466*** -0.488*** 
Hypertension  Metabolic Syndrome 0.261*** 0.267*** 
WC  Metabolic Syndrome 0.324*** 0.182*** 
Triglycerides  Metabolic Syndrome 0.298*** 0.333*** 
HDL-C  Metabolic Syndrome 0.308*** 0.239*** 
Glucose  Metabolic Syndrome 0.28*** 0.372*** 
Note: WC, waist circumference, HDL-C, high density lipoprotein cholesterol; CHD, coronary 
heart disease; MPA, minutes of moderate intensity physical activity; VPA, minutes of vigorous 
intensity physical activity 
* p ≤ 0.05 
** p ≤ 0.01 
*** p ≤ 0.001  
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Table B.2: Model 2 standardized weights for the full structural model of 
relationships among light, moderate, and vigorous physical activity and the 
metabolic syndrome  
Path Males Females 
Age  Physical Activity -0.796*** -0.678*** 
Age  Hypertension 0.088 0.212*** 
Age  WC -0.476*** -0.407*** 
Age  Triglycerides -0.381*** -0.279*** 
Age  HDL-C -0.657*** -0.544*** 
Age  Glucose -0.095 -0.177* 
SES  Education 0.817 0.747 
SES  Income 0.514*** 0.565*** 
SES  Physical Activity -0.143* 0.254** 
SES  Hypertension -0.117** 0.056 
SES  WC -0.084 0.062 
SES  Triglycerides -0.103* 0.002 
SES  HDL-C -0.258*** -0.05 
Ethnicity  Physical Activity 0.151** 0.106 
Ethnicity  Hypertension 0.015 0.073 
Ethnicity  WC -0.01 0.137* 
Ethnicity  Triglycerides 0.098* 0.051 
Ethnicity  HDL-C 0.029 0.055 
Ethnicity  Glucose 0.133*** 0.124*** 
Ethnicity  Metabolic Syndrome 0.004 -0.019 
CHD History  Hypertension -0.024 0.013 
CHD History  WC 0.038 0.075** 
CHD History  Triglycerides 0.063* 0.049 
Physical Activity  LPA 0.513*** 0.305*** 
Physical Activity  MPA 0.574*** 0.518*** 
Physical Activity  VPA 0.155*** 0.267*** 
Physical Activity  Wear Time 0.157 0.147 
Physical Activity  Hypertension -0.405*** -0.453*** 
Physical Activity  WC -0.755*** -0.826*** 
Physical Activity  Triglycerides -0.493*** -0.605*** 
Physical Activity  HDL-C -0.744*** -0.602*** 
Physical Activity  Glucose -0.454*** -0.613*** 
Hypertension  Metabolic Syndrome 0.263*** 0.265*** 
WC  Metabolic Syndrome 0.327*** 0.18*** 
Triglycerides  Metabolic Syndrome 0.301*** 0.331*** 
HDL-C  Metabolic Syndrome 0.311*** 0.237*** 
Glucose  Metabolic Syndrome 0.283*** 0.369*** 
Note: WC, waist circumference, HDL-C, high density lipoprotein cholesterol; CHD, coronary 
heart disease; LPA, minutes of light intensity physical activity; MPA, minutes of moderate 
intensity physical activity; VPA, minutes of vigorous intensity physical activity 
* p ≤ 0.05 
** p ≤ 0.01 
*** p ≤ 0.001  
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Table B.3: Model 3 standardized weights for full structural model of relationships 
among total activity counts and the metabolic syndrome  
Standardized Estimates Males Females 
Age  Physical Activity -0.871*** -0.774*** 
Age  Hypertension -0.038 0.104 
Age  WC -0.823*** -0.649*** 
Age  Triglycerides -0.565*** -0.456*** 
Age  HDL-C -0.91*** -0.725*** 
Age  Glucose -0.261* -0.355** 
SES  Education 0.79 0.751*** 
SES  Income 0.534*** 0.562 
SES  Physical Activity -0.052 0.211** 
SES  Hypertension -0.085 0.054 
SES  WC -0.018 0.074 
SES  Triglycerides -0.065 0.008 
SES  HDL-C -0.207*** -0.042 
Ethnicity  Physical Activity 0.166** 0.098 
Ethnicity  Hypertension 0.039 0.078 
Ethnicity  WC 0.064 0.153 
Ethnicity  Triglycerides 0.134** 0.061 
Ethnicity  HDL-C 0.074 0.067 
Ethnicity  Glucose 0.149*** 0.132** 
Ethnicity  Metabolic Syndrome 0.004 -0.019 
CHD History  Hypertension -0.023 0.013 
CHD History  WC 0.038 0.075** 
CHD History  Triglycerides 0.064* 0.049 
Physical Activity  TAC 0.594***  0.519*** 
Physical Activity  Wear Time 0.134 0.129*** 
Physical Activity  Hypertension -0.514** -0.537** 
Physical Activity  WC -1.093*** -1.038*** 
Physical Activity  Triglycerides -0.661*** -0.759*** 
Physical Activity  HDL-C -0.968*** -0.761*** 
Physical Activity  Glucose -0.598*** -0.766*** 
Hypertension  Metabolic Syndrome 0.259*** 0.264*** 
WC  Metabolic Syndrome 0.322*** 0.18*** 
Triglycerides  Metabolic Syndrome 0.297*** 0.329*** 
HDL-C  Metabolic Syndrome 0.307*** 0.237*** 
Glucose  Metabolic Syndrome 0.279*** 0.368*** 
Note: WC, waist circumference, HDL-C, high density lipoprotein cholesterol; CHD, coronary 
heart disease; TAC, total activity counts. 
* p ≤ 0.05 
** p ≤ 0.01 
*** p ≤ 0.001 
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Table C.1: Change in the prevalence of the metabolic syndrome & its risk factors related to physical activity for females.  
 Model 1 (MPA + VPA) Model 2 ( LPA + MPA + VPA) Model 3(TAC) 
  Beta SDPA % Change Beta SDPA %Change Beta SDPA % Change  
MPA to Risk Factors 
 MPA  WC -0.417 0.053 -0.079 -0.487 0.049 -0.093 -- -- -- 
 MPA  Hypertension -0.220 0.053 -0.040 -0.267 0.049 -0.048 -- -- -- 
 MPA  Glucose -0.275 0.053 -0.047 -0.361 0.049 -0.065 -- -- -- 
 MPA  Triglycerides -0.335 0.053 -0.064 -0.442 0.049 -0.084 -- -- -- 
 MPA  HDL-C -0.340 0.053 -0.065 -0.417 0.049 -0.079 -- -- -- 
VPA to Risk Factors          
 VPA  WC -0.269 0.007 -0.051 -0.342 0.006 -0.065 -- -- -- 
 VPA  Hypertension -0.142 0.007 -0.026 -0.186 0.006 -0.033 -- -- -- 
 VPA  Glucose -0.177 0.007 -0.030 -0.252 0.006 -0.045 -- -- -- 
 VPA  Triglycerides -0.218 0.007 -0.041 -0.283 0.006 -0.054 -- -- -- 
 VPA  HDL-C -0.219 0.007 -0.042 -0.282 0.006 -0.054 -- -- -- 
LPA to Risk Factors  
 LPA  WC -- -- -- -0.398 0.220 -0.076 -- -- -- 
 LPA  Hypertension -- -- -- -0.218 0.220 -0.039 -- -- -- 
 LPA  Glucose -- -- -- -0.295 0.220 -0.053 -- -- -- 
 LPA  Triglycerides -- -- -- -0.328 0.220 -0.062 -- -- -- 
 LPA  HDL-C -- -- -- -0.326 0.220 -0.062 -- -- -- 
TAC to Risk Factors          
 TAC  WC -- -- -- -- -- -- -0.568 359 -0.108 
 TAC  Hypertension -- -- -- -- -- -- -0.294 359 -0.053 
 TAC  Glucose -- -- -- -- -- -- -0.419 359 -0.075 
 TAC  Triglycerides -- -- -- -- -- -- -0.395 359 -0.075 
 TAC  HDL-C -- -- -- -- -- -- -0.378 359 -0.072 
PA Measure to MetS          
 LPA - -> MetS -- -- -- -0.305 0.220 -0.019 -- -- -- 
 MPA - -> MetS -0.414 0.053 -0.025 -0.498 0.049 -0.030 -- -- -- 
 VPA - -> MetS -0.252 0.007 -0.015 -0.351 0.006 -0.021 -- -- -- 
 TAC - -> MetS -- -- -- -- -- -- -0.570 359 -0.035 
PA Construct to MetS -0.740 1 -0.043 -0.838 1 0.051 -1.040 1 -0.063 
Note: %, percent; SDPA; standard deviation of physical activity variable; WC, waist circumference; HDL-C, high density lipoprotein cholesterol; MPA, 
moderate intensity physical activity; VPA, vigorous intensity physical activity; LPA, light intensity physical activity; TAC, total activity counts; MetS; the 
metabolic syndrome; --, Not applicable as measure is not included in model.  , Direct effect; - ->, Indirect effect.  
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Table C.2: Change in the prevalence of the metabolic syndrome & its risk factors related to physical activity for males. 
  Model 1(MPA + VPA) Model 2 (LPA + MPA + VPA) Model 3 (TAC) 
  Beta SDPA % Change Beta SDPA % Change Beta SDPA % Change 
MPA to Risk Factors          
 MPA  WC -0.512 0.068 -0.082 -0.461 0.061 -0.069 -- -- -- 
 MPA  Hypertension -0.240 0.068 -0.036 -0.247 0.061 -0.035 -- -- -- 
 MPA  Glucose -0.274 0.068 -0.038 -0.277 0.061 -0.039 -- -- -- 
 MPA  Triglycerides -0.402 0.068 -0.064 -0.423 0.061 -0.063 -- -- -- 
 MPA  HDL-C -0.499 0.068 -0.080 -0.535 0.061 -0.086 -- -- -- 
VPA to Risk Factors          
 VPA  WC -0.209 0.0056 -0.033 -0.228 0.0052 -0.034 -- -- -- 
 VPA  Hypertension -0.098 0.0056 -0.015 -0.122 0.0052 -0.017 -- -- -- 
 VPA  Glucose -0.112 0.0056 -0.016 -0.137 0.0052 -0.019 -- -- -- 
 VPA  Triglycerides -0.166 0.0056 -0.027 -0.18 0.0052 -0.027 -- -- -- 
 VPA  HDL-C -0.205 0.0056 -0.033 -0.246 0.0052 -0.039 -- -- -- 
LPA to Risk Factors          
 LPA  WC -- -- -- -0.428 0.240 -0.064 -- -- -- 
 LPA  Hypertension -- -- -- -0.23 0.240 -0.032 -- -- -- 
 LPA  Glucose -- -- -- -0.258 0.240 -0.036 -- -- -- 
 LPA  Triglycerides -- -- -- -0.388 0.240 -0.058 -- -- -- 
 LPA  HDL-C -- -- -- -0.494 0.240 -0.079 -- -- -- 
TAC to Risk Factors          
 TAC  WC -- -- -- -- -- -- -0.684 397 -0.109 
 TAC  Hypertension -- -- -- -- -- -- -0.322 397 -0.048 
 TAC  Glucose -- -- -- -- -- -- -0.374 397 -0.052 
 TAC  Triglycerides -- -- -- -- -- -- -0.570 397 -0.091 
 TAC  HDL-C -- -- -- -- -- -- -0.713 397 -0.114 
PA Measure to MetS          
 LPA - -> MetS -- -- -- -0.486 0.240 -0.032 -- -- -- 
 MPA - -> MetS -0.518 0.068 -0.034 -0.52 0.061 -0.034 -- -- -- 
 VPA - -> MetS -0.211 0.0056 -0.014 -0.26 0.005 -0.017 -- -- -- 
 TAC - -> MetS -- -- -- -- -- -- -0.707 397 -0.046 
PA Construct to MetS -0.883 1 -0.057 -0.861 1 -0.056 -1.145 1 -0.074 
Note: %, percent; SDPA; standard deviation of physical activity variable; WC, waist circumference; HDL-C, high density lipoprotein cholesterol; MPA, 
moderate intensity physical activity; VPA, vigorous intensity physical activity; LPA, light intensity physical activity; TAC, total activity counts; MetS; the 
metabolic syndrome; --, Not applicable as measure is not included in model.  , Direct effect; - ->, Indirect effect.  
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